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ABSTRACT 
In the field of microvascular blood flow, particularly to the skeletal muscle, there has 
been a considerable history of reference to the incongruity of total limb blood flow and 
actual myocyte perfusion. Embedded in such an idea is the concept that flow to skeletal 
muscle should be composed of two physiologically distinct circulations — one that 
perfuses the myoctes (and therefore may be called "nutritive") and another which must 
act as a form of physiological shunt or "non-nutritive". The "nutritive and non-nutritive 
flow" hypothesis was renewed by the muscle research group of the Biochemistry 
Department at the University of Tasmania to explain perfusion dependent metabolic 
effects of vasoconstrictors on skeletal muscle. 
This thesis focuses on the assessment of microvascular perfusion, compared to total flow, 
in skeletal muscle and in particular in relation to reports of direct and indirect effects of 
insulin to increase microvascular perfusion of this tissue in vivo. Initially laser Doppler 
Fluxmetry technology (LDF) was applied to estimate muscle perfusion. For the purposes 
of verification and comparison two other techniques under development by our group, 
contrast enhanced ultrasound (CEU) and 1-methyl xanthine metabolism, were also used. 
In the first section of this thesis the variable of total flow is eliminated by using a constant 
flow (pump perfused) rat hindlimb. During the application of vasoconstrictors that 
caused either predominantly nutritive or non-nutritive flow LDF estimation of perfusion 
was found to be highly variable in spite of the constant total flow. LDF comprises a non 
vectorial voltage measurement generated by particle movement through a volume of 
tissue illuminated by the laser light. 
LDF measurement using a large probe was highly correlated with the metabolic changes 
induced by changes in nutritive and non-nutritive flow. However, LDF measurement 
using a smaller implantable probe which measures particle movement in a smaller 
volume of muscle tissue, showed that there is considerable heterogeneity of response. 
To better understand the factors that influence changes in the LDF measurement LDF 
measurements were made of flow controlled through fabricated glass capillary arrays of 
various architectures. 
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The third study addressed changes induced by insulin in vivo, in anaethetised rats during 
a hyperinsulinaemic euglycaemic clamp. Using a large surface LDF probe the LDF 
signal from the muscle increased during the administration of insulin. In contrast the 
LDF signal did not increase during epinephrine administration even though the 
epinephrine caused a comparable increase in femoral artery blood flow as seen with 
insulin. Furthermore the time course of LDF change in the presence of insulin was more 
closely aligned with changes in glucose uptake than it was with changes in femoral blood 
flow. 
In the final series of experiments using LDF, changes due to insulin in human muscle was 
assessed. The results suggested that physiological hyperinsulinaemia stimulated not only 
total blood flow and skin microvascular perfusion, but also augmented human skeletal 
muscle microvascular recruitment and vasomotion as detected directly by laser Doppler 
measurement. 
In the second technique, CEU, microbubbles (an albumin membrane encapsulating an 
inert gas in the form of a 4 micron diameter sphere) act as contrast when tissue is 
visualised using ultrasonography. Analysis of the rate and extent of contrast 
(microbubble) appearance during imaging of the target tissue allows us to calculate 
indicators of the microvascular velocity and microvascular volume. 
The third technique based on capillary endothelial metabolism of the exogenous substrate 
1-methylxanthine, was developed at the University of Tasmania. 1-Methylxanthine is a 
reporter substrate, which as it passes through the nutritive capillary route of the muscle is 
metabolized to 1-methyl urate; metabolism is proportional to available capillary surface 
area. 
To consolidate the LDF findings, the two additional techniques for assessing changes in 
capillary recruitment were used. Once again, the hyperinsulinaemic euglycaemic clamp 
was used but on this occasion a physiologic dose of insulin was infused. Microvascular 
recruitment (measured by 1-MX metabolism as well as by CEU) increased during insulin 
xviii 
administration. Furthermore, at certain time points microvascular recruitment occurred 
without changes to femoral artery flow. From these studies it was evident that insulin 
increases tissue perfusion by recruiting microvascular beds, and at physiological 
concentrations this precedes increases in total muscle blood flow by 60-90 min. Since 
there was no change in the mean red cell velocity, it seem likely that insulin had 
increased capillary recruitment by redistributing blood flow from other vessels possibly 
non-nutritive. 
In the final study capillary recruitment was again measured by the metabolism of infused 
1-methyl xanthine and used to assess responses to insulin in normal colony rats as well as 
lean and obese Zucker rats (an animal model for type 2 diabetes). It was concluded that 
muscle insulin resistance of obese Zucker rats is accompanied by impaired hemodynamic 
responses to insulin including markedly impaired capillary recruitment and femoral blood 
flow when compared to lean Zuckers or colony control rats. 
Taken together, the findings embodied by this thesis show that the three techniques of 
LDF, CEU and 1-MX metabolism, each detect a vascular effect of insulin in vivo, 
characterized by capillary recruitment. This was detectable at physiologic insulin and 
occurred in both muscle of rats and humans. In addition, LDF added a further aspect of 
insulin action of an insulin-mediated increase in vasomotion at low frequency, very likely 
suggesting increased neural activity. 
xix 
Chapter 1 — General Introduction 
CHAPTER 1 
General Introduction  
1.1 The haemodynamic actions of insulin 
1.1.1 Early studies 
The clinical use of insulin began in the 1930's but was not limited to the treatment of 
diabetes. Early literature shows that massive doses (40-280 units) of insulin were 
employed in the treatment of schizophrenia. Thus in 1939 (1) we find the first report of 
increased blood flow in the forearm, hand and leg of seven schizophrenic patients as a 
result of insulin administration. In the same report systolic and diastolic blood pressure 
were also elevated and there was a slight decrease in oxygen consumption across the 
forearm. Other researchers had noted earlier that lower doses (40-80 units) induced 
hypoglycaemia and the attendant expected symptoms of elevated pulse rate, blood 
pressure and perspiration (59). However, the hypoglycaemic stress endured by patients to 
whom the large doses of insulin were administred was profound and considered at the 
time to be the main cause of the accompanying haemodynamic changes, even when 
experiments of this kind were repeated at lower doses of insulin. 
French and Kilpatrick in 1955(63) investigated the role of adrenaline in the 
hypoglycaemic response to 150 mU insulin/kg. Blood flow changes were detected at 
40min after injection of insulin but comparison of responses between hypertensive 
patients, patients after splanchnicectomy or sympathectomy led these workers to 
conclude that adrenaline was not responsible for the majority of the clinical features of 
the acute hypoglycaemia, including the increased hand blood flow. Ginsberg and Paton 
in 1956 (66) specifically examined the effects of bilateral adrenalectomy on insulin 
action. They found that 30 min after insulin (100 mU/kg) there was a 100% rise in blood 
flow to the forearm. In adrenalectomised patients forearm blood flow remained elevated 
even though hypoglycaemia and the immediate reactions to the hypoglycaemia had 
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passed. Allwood et at (3) applied similar doses of insulin (100mU/kg) to study the 
forearm circulatory changes specifically during the insulin-induced hypoglycaemia. Both 
cutaneous and muscle blood flow increased; skin to approximately twice the resting value 
and muscle, slightly less, to 175% of the resting value. Interestingly, skin blood flow 
decreased initially and this was attributed to either the adrenaline release or an increased 
sympathetic vasoconstrictor activity. However, neither the increase in skin blood flow 
that followed, nor the increase in muscle blood flow was concluded to be fully the result 
of such changes. These workers also showed that adrenaline (10tig i.v.) markedly 
increased muscle blood flow and decreased skin blood flow. 
Administration of highly supraphysiological ("pharmacological") doses of insulin 
revealed other effects that were less visible at the lower doses. For example, Pereda et al 
(132) found that, in lightly anaesthetized dogs treated with a neuromuscular blocking 
agent, insulin (2-3units/kg i.v.) gave an early transient pressor response 2-9 min after 
injection. This response occurred in the presence of hyperglycaemia and in the absence 
of hypoglycaemia. Furthermore, the response could be produced when insulin was given 
in the carotid artery in doses . that caused no effect when injected in a systemic vein. The 
authors concluded that insulin was having a direct effect on the brain. 
One early study in rats where blood flow was measured following insulin (1 unit/100g) or 
glucose (100mg/110g) administration reported an increase in hepatic blood flow and 
attributed this to vasodilatation resulting from the hypoglycemia (55). A similar increase 
in liver blood flow due to glucose, however, could not be explained. The gastrocnemius 
muscle showed no increase in blood flow due to the single injection of 1 unit of insulin 
per 100g. 
From this older literature, it is apparent that pharmacologic doses of insulin mostly 
produced marked increases in limb and skin blood flow that were not the result of the 
accompanying hypoglycaemia, adrenaline or elevated sympathetic outflow. 
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1.1.2 Contemporary views 
Contemporary literature contains certain parallels to the older literature, but 
contemporary techniques for measuring limb blood flow, particularly with thermal 
dilution catheters, and labelled microspheres, are more refined. Thus there are a number 
of in vivo studies ((43;62;65;80;102;146), but not all (50;51;78;79;198), that have 
reported an effect of insulin to increase plasma or blood flow to skeletal muscle in 
humans (43;62;65;146) and in animals (80;102). 
Interest in this area was hightened in the 1990s by Baron and his colleagues when they 
reported insulin's ability to increase total blood flow to skeletal muscle, and suggested 
that this may in fact enhance insulin action by augmenting the delivery of insulin and 
glucose to muscle cells (96). The observations were made in human subjects during a 
hyperinsulinaemic euglycaemic clamp (i.e. glucose is infused concomitantly with the 
insulin to maintain blood sugar levels at baseline) to minimise the possible counter-
regulatory effects of responding to glucose levels altered by the insulin. Some research 
groups repeated these findings in both humans (e.g.(5;52)) and animals (102;143); 
however, there was considerable variation between studies in the magnitude of the 
response, and in fact some groups have failed to observe changes in flow with insulin 
(e.g.(61;198)) . Changes in flow after insulin administration were detected not only by 
thermodilution, but by dye dilution, plethysmography, and by positron emission 
tomography (PET) combined with [ 150]-120 in human subjects and by ultrasound in 
animals (see (36) for refs.). Infusion of insulin systemically versus local intra-arterial 
infusion also does not seem to explain the difference, as vasodilation has been reported in 
both situations. One group did report greater increases in flow when the local intra-
arterial infusions in the forearm were combined with an infusion of a physiological 
concentration of glucose. Even so, the magnitude of vasodilation was similar in forearm 
and calf during systemic insulin infusion. (see (36) for refs.) 
While the hyperinsulinaemic, euglycaemic clamp is a commonly used technique which 
has many advantages for scientific research, it is unphysiological because high insulin 
3 
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levels are not normally sustained for long periods following a meal. It is therefore 
important to note that in less artificial experiments, an increase in skeletal muscle blood 
flow was demonstrated following an intravenous glucose (101;183) oral glucose load (14) 
and a carbohydrate meal (154). 
In the fullest perspective, the role of the increase in total blood flow mediated by insulin 
must be seen as controversial. For example, one research group has claimed that insulin-
mediated changes in total blood flow relate poorly to muscle glucose uptake under a 
number of circumstances (197), including insulin dose and time course. In addition there 
have been studies where total flow changes persist when glucose uptake is inhibited 
(152). Also, most vasodilators that augment total blood flow to the limbs do not enhance 
insulin action nor do they overcome insulin resistance (97;115;117). Thus, on balance, a 
role for increased total blood flow in insulin-stimulated glucose uptake is not compelling. 
The issue that the insulin-mediated vasodilatory effect is the result of increased SNS 
activity also is still not fully resolved. This has been addressed by Spraul, Ravussin and 
Baron (163) who examined the relationship between vasodilation, muscle sympathetic 
nerve activity (MSNA) and insulin action during sequential euglycemic clamps at low 
and high insulin doses. These authors found that there was no correlation between 
incremental MSNA and leg blood flow, whole body glucose uptake or leg glucose 
uptake. But insulin was found to stimulate MSNA more rapidly than vasodilation, 
characteristically occurring only after 45 min in insulin sensitive subjects. 
Overall, there remains considerable interest in the possibility that insulin-mediated 
changes in muscle blood flow are somehow linked to improving access for insulin and 
perhaps glucose (96), more particularly, that a defect in this process might be responsible 
for part of the insulin resistance in muscle of Type II diabetics. Research from Bergman 
and his colleagues has played a key role in the general concept that mechanisms proximal 
to insulin-stimulated cellular glucose uptake, and possibly related to altered vascular 
function, could contribute to insulin resistance (196). They sought to explain a 
fundamental characteristic of insulin action: the paradox of the differential time course of 
4 
Chapter 1 — General Introduction 
insulin action between cells versus intact tissues in vivo. Thus, the in vivo sluggishness 
was proposed to be due to insulin transport across the capillary endothelium of skeletal 
muscle and to test this they examined the temporal relationship between insulin 
concentrations in plasma versus interstitial fluid (lymph) during euglycaemic clamps in 
dogs. In all situations the insulin concentration in the interstitium was only 50-70% of 
that in the plasma, even under steady state conditions (17). These findings implied that 
the plasma insulin signal is both retarded and attenuated at the site of insulin action: the 
skeletal muscle cell. Interestingly, the 3:2 concentration gradient was not eliminated even 
at the highest insulin concentrations leaving the group to conclude that a transendothelial 
insulin gradient is present which is not receptor-mediated and is nonsaturable. More 
importantly, Bergman et al. proposed that the transport step is rate-limiting for insulin 
action since the rate of glucose uptake by skeletal muscle cells is exactly proportional to 
the interstitial and not the plasma insulin concentration (196). Subsequent measurement 
of interstitial levels of insulin by microdialysis have confirmed the findings from 
Bergman's group (82) by showing that interstitial levels of insulin are indeed lower than 
arterial levels. 
A number of research groups seized on the idea that impaired vascular function might 
contribute to insulin resistance and set out to explore the mechanistic basis of insulin-
induced vasodilation. For example, Scherrer's group showed insulin-induced vasodilation 
was opposed by the cortisol analog, dexamethasone (153). Dexamethasone also induced a 
comparable insulin resistance with or without the fatty acid oxidation inhibitor, acipimox, 
even though acipimox had normalised muscle blood flow (174). It thus seemed likely that 
products of fatty acid oxidation specifically impaired insulin-mediated vasodilatory 
effects. However, Intralipid infusion in humans blunted GIR and total glucose uptake but 
not the increase in limb blood flow, although Intralipid alone acutely increased limb 
blood flow (182). More extensive exposure to Intralipid (8h) did block the insulin-
mediated increase in leg blood flow and the indices of NO production, along with an 
inhibition of whole-body glucose uptake (168). This was one of a number of reports that 
linked NO production to insulin-mediated vasodilation. For example, L-NMMA was 
found to block insulin-stimulated muscle blood flow during a 2h clamp, but did not affect 
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insulin-induced stimulation of whole body glucose uptake (152). This finding differed 
somewhat from that of Baron's group who found that L-NMMA blocked approx. 21% of 
the insulin-mediated glucose uptake by the leg (15). Baron et al also showed that the NO-
dependent vasodilator, methacholine increased leg blood flow in the human and increased 
leg glucose uptake (15). This remains the only vasodilator that has been reported to 
augment insulin-mediated muscle glucose uptake in association with increased limb 
blood flow (150). 
1.2 Evidence for two vascular flow routes in muscle 
A number of studies done at the University of Tasmania (discipline of Biochemistry) over 
the last fifteen years using the perfused rat hincllimb support earlier proposals by others 
that there are two flow routes in muscle. One appears to be in intimate contact with the 
myocytes and able to exchange nutrients and hormones freely and thus regarded as 
nutritive. Another with essentially no contact with myocytes and regarded as non-
nutritive [the history and background of this concept together with references can be 
found elsewhere (32),(33)]. Some of the non-nutritive route may supply muscle 
associated connective tissue (septa and tendon) (122) and there is indirect evidence that 
the non-nutritive route for the myocytes is in fact nutritive for associated adipocytes (39). 
In addition, there are indications that the non-nutritive vessels carry a flow reserve which 
can redistribute to the nutritive route during periods of high metabolic demand, such as 
during exercise (35) or following a meal to allow insulin-mediated glucose uptake into 
muscle. The balance between these two circuits is controlled by vasomodulators and 
neural input. In the constant flow pump-perfused hindlimb, our group has classified 
vasoconstrictors according to whether they increase or decrease metabolism (type A and 
type B respectively) (32). Examples of type A vasoconstrictors include low dose 
norepinephrine, angiotensin II, vaspressin and low frequency SNS activation and all type 
A vasoconstrictors increase oxygen consumption. Serotonin, a-methyl serotonin, high 
dose NE and high frequency SNS activation are all type B vasoconstrictors and these 
decrease oxygen consumption and metabolism generally (32). 
6 
Chapter 1 — General Introduction 
Changes in flow redistribution due to the vasoconstrictors are suggested from vascular 
casts and changes to the pattern of red cell washout (121). In addition, aerobic contraction 
of the calf muscle group of the constant-flow perfused rat hindlimb when stimulated by 
an electrode placed on the sciatic nerve, is increased or decreased by infusion of type A 
or B vasoconstrictors, respectively (53;141). Furthermore, there is evidence that oxygen 
uptake by resting muscle is a function of oxygen delivery (90), thus offering an 
explanation why the vasomodulator-mediated redistribution of flow within muscle has 
such profound effects on oxygen uptake. It now appears likely that a large proportion of 
the muscle undergoes a physiological hypoxia during type B vasoconstrictor activity. But, 
as indicated above, the constant vasomotion activity may allow the sharing of this over 
the entire muscle with time. Thus, only the phosphocreatine/creatine ratio (not 
ATP/ADP) is compromised by a low ratio of nutritive/non-nutritive flow. For example 
during serotonin-mediated vasoconstriction, and this is reversed when the nutritive/non-
nutritive ratio is increased upon serotonin withdraw( (181). Our group has proposed that 
the presence of the non-nutritive route in muscle may explain two phenomena which are 
developed further in sections below. These are a), the ability of many systemic 
vasodilators (e.g. bradykinin, nitroprusside or adenosine) to markedly increase limb blood 
flow without affecting insulin-mediated glucose uptake (115;124) or ameliorating insulin 
resistance (117); and b), the ability of insulin to increase capillary recruitment without 
either an increase in limb blood flow or a slowing in mean cell velocity in the capillaries 
(180). The notion of a non-nutritive route or functional shunt to explain the differences in 
clearance of intramuscular injected or infused markers due to exercise or vasodilators is 
not new and was invoked in the past by other researchers [see (35) and references 
therein]. 
1.3 The need to measure microvascular flow - possibilities including a flow through 
metabolised substrate and imaging of tissue perfusion 
The need to be able to assess changes in muscle microvascular flow became apparent to a 
number of laboratories in the 1990s, but methods were largely indirect. For example, 
Bonadonna et al., (20) utilised a pulse injection into the brachial artery of 14 3H]-L- 
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glucose, an extracellular marker that fills both blood vessels and the interstitial space. 
Data from the washout curve allowed an estimate of the amount of tissue drained by the 
deep forearm vein to be estimated. The workers showed there was no change in the 
amount of muscle tissue drained comparing saline and a physiological dose of insulin 
(400 pM). But there was an increase in the extracellular volume in response to 
supraphysiological levels of insulin (5600 pM) suggestive that capillary recruitment had 
occurred. Yet other researchers have used intravital microscopy to directly assess 
capillary flow in the spinotrapezius muscle (143). These studies showed that a 
subcutaneous injection of insulin to anaesthetised rats dilated precapillary arterioles but 
did not alter vasomotion, whereas following glucose infusion to obtain similar insulin 
levels, there was an increased vasomotion, and a small constriction. Such changes were 
interpreted as evidence that insulin may have both a vasoconstrictor action and a larger 
vasodilatory action that must act in a coordinated manner to achieve a more optimal 
perfusion of the microvasculature. (143). 
Our laboratory, cognizant of the controversy concerning the role of total blood flow in 
insulin action to control muscle glucose uptake and aware that contemporary methods 
were inadequate to assess microvascular perfusion, set out to develop new, more direct 
methods. 
The initial intent was to design a method where metabolism of an introduced exogenous 
substrate would be a reflection of the extent of exposure of the substrate to an enzyme 
located in the nutritive capillaries. A number of criteria needed to be met. First, that the 
substrate was not vasoactive itself and therefore unable to influence the distribution of 
flow (i.e. the nutritive/ non-nutritive ratio). Second, that the substrate was metabolised to 
only one product by the capillary enzyme and that both the substrate and product were 
each recoverable from plasma and assayable. Third, that changes in metabolism of this 
substrate matched the change in nutritive/ non-nutritive flow that could be manipulated 
by the type A and B vasoconstrictors described above. A number of candidate substrates 
were tested, including those for phosphatases, 5'nucleotidases, proteases (angiotensin 
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converting enzyme), and xanthine oxidase. The substrate that fulfilled each of these 
criteria was 1-methylxanthine (1-MX), and this was targeted for xanthine oxidase. 
Immunohistochemical evidence had shown that xanthine oxidase is concentrated in the 
muscle capillaries and is much less expressed in larger vessels and muscle itself (70;83). 
In the perfused rat hindlimb at constant flow there was a stoichiometric conversion of 1- 
MX to 1-methyl urate and both substrate and product were recovered without further 
metabolism. In addition, the changes in 1-MX metabolism correlated positively with 
changes in the proportion of nutritive flow in pump-perfused muscle under a number of 
conditions (137;199;199). More importantly, when applied to anaesthetised ad lib fed 
rats in vivo insulin (at doses which increased insulin levels 4-fold) increased 1-MX 
metabolism (138) in association with increased glucose uptake of hindlimb muscle. The 
changes in 1-MX metabolism were considered indicative of capillary recruitment that 
was nutritive to the muscle cell. Although at this relatively high dose, the insulin-
mediated increase in capillary recruitment was accompanied by an increase in femoral 
artery blood flow, epinephrine infusions which produced similar increases in femoral 
artery blood flow did not affect capillary recruitment (measured by 1-MX metabolism), 
indicating that the two processes, capillary recruitment and total flow, could be 
dissociated. This finding suggested that a vasodilator, such as epinephrine, could 
increase total leg blood flow in vivo without increasing capillary recruitment or glucose 
uptake and could thus explain the human data where a number of vasodilators similarly 
increase flow but differentially affect glucose uptake. As alluded to above, the total flow 
increase in these circumstances is likely to be carried by the non-nutritive route. 
There are now a number of experimental situations where our group has deliberately 
attempted to test the association between capillary recruitment and glucose uptake as 
regulated by insulin. In the first of these, a vasoconstrictor (a-methyl serotonin), that 
decreases nutritive flow in perfused muscle (120), was found to inhibit insulin 
stimulated hindlimb 1-MX extraction in vivo and to impair insulin-mediated glucose 
uptake in the same hindlimb muscles (139). The serotonin agonist thus induced a state 
of insulin resistance with hypertension by preventing capillary recruitment and 
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presumably causing predominantly non-nutritive flow. Another approach involved 
TNFa, which is elevated in various insulin resistant states. When this was administered 
acutely it completely blocked the haemodynamic actions of insulin, including the 
increase in 1-MX metabolism and approximately 50% of the insulin-mediated glucose 
uptake (200). A third intervention involved the effect of acutely elevated free fatty acids 
through the infusion of Intralipid and heparin. Insulin-mediated capillary recruitment 
was markedly impaired in conjunction with impaired muscle glucose uptake (38). Taken 
together, insulin-stimulated glucose uptake by the hindleg in vivo was found to correlate 
tightly with 1-MX metabolism, an indicator of capillary recruitment, but showed no 
significant correlation with total limb flow (139) that was measured in these same 
studies. Thus, it would seem likely that this vascular action of insulin enhances 
perfusion of muscle, independently of changes in total flow, particularly in a time 
perspective. We have speculated that if this proves to be so, then insulin-mediated 
redistribution of blood flow from the non-nutritive route is likely (36). 
A reasonable criticism that might be leveled at the 1-MX method is that it is an indirect 
method and cannot indicate relative flow distribution. Thus 1-MX reports only on the 
change in available capillary area for nutrient exchange. Our second technique is based 
on ultrasound imaging of the perfused microvasculature and not only has the potential to 
confirm the findings with 1-MX but to extend the information to relative flow 
distribution. Contrast-enhanced ultrasound (CEU) imaging as we, along with our 
collaborators at the University of Virginia, have now adapted for skeletal muscle 
microvasculature is based on that described by Wei et al. (191) for cardiac muscle in 
which microbubbles of albumin provide the contrast medium. Using a modified medical 
ultrasound / echocardiography machine the ultrasound probe is positioned over the target 
tissue (in this case skeletal muscle) and emits sonic energy and simultaneously 
transduces reflected energy to form a transverse sectional image through the muscle. The 
tissue to be measured receives the microbubbles via the vascular route at a steady state 
concentration, usually by way of systemic infusion. Under normal ultrasound imaging 
conditions the microbubbles resonate and become highly visible to the transducer 
therefore acting as a "contrast". The acoustic signal that is generated from the 
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microbubbles exposed to ultrasound is proportional to the concentration of microbubbles 
within the volume of tissue being imaged. The bubbles can consist of many different 
materials but the essential components are a hydrophobic — hydrophillic bilayer that 
encapsulates an inert gas. Furthermore the bubbles themselves must have no metabolic 
or vascular effect on the organism. These microbubbles can be destroyed (i.e. burst) by 
a pulse of high energy ultrasound thereby clearing the volume of tissue being imaged of 
any intact (and therefore contrast capable) microbubbles. Undestroyed bubbles from the 
neighbouring tissue then flow into the field of the ultrasound image to be reimaged after 
a set period of time. During an imaging sequence, the interval between the destructive 
high energy pulses (which is also used for imaging) is progressively prolonged to allow 
more replenishment of the microbubbles into the microcirculation. Once the images are 
collected a background subtraction (representing large vessels which fill rapidly) is 
made to isolate effects on capillaries and allow calculation of the "microvascular 
volume". The time rate of appearance of the microbubbles allows an estimate of the 
microvascular average filling velocity. 
1.4 A place for Laser Doppler Flowmetry in assessing microvascular flow in 
muscle? 
Another technique that could be applied to measuring microvascular perfusion in muscle 
is laser Doppler flowmetry (LDF). This has been used for a number of years to study 
skin blood perfusion and several research groups have documented impaired skin 
microvascular reactivity in diabetic subjects (23;77;158). In such studies microvascular 
function was assessed by measuring vasodilation in the forearm skin in response to 
iontophoresis of acetylcholine (77;158) although hyperemic response to local heating 
(23) was also used. Most significantly, Serne et al (157) have shown that iontophoresed 
insulin directly vasodilates skin microvasculature. 
11 
Chapter 1 — General Introduction 
1.4.1 What does LDF measure? 
The interpretation of Doppler frequency shifted light backscattered from tissue to 
measure particle velocity was described (46) only four years after the first working Laser 
was demonstrated (111). However, the concept of laser Doppler flowmetry (LDF) as a 
means of measuring tissue perfusion is attributed to Stern (169) in 1975. In that work, 
spectral analysis of the photocurrent produced by backscattered Helium — Neon red Laser 
light from a human fingertip showed a clear difference between normal flow and after 
occlusion of the brachial artery. In the following years the instrument was redesigned 
and refined, most significantly by firstly allowing the laser light to be transmitted and 
received via fibre optic cables to allow more ease of positioning a probe head over the 
tissues. Additionally an empirically based processor was added in order to give a real 
time index of LDF value. 
It may be argued that the term "flowmeter" or "flowmetry" is a misnomer as the 
technology is not usually able to estimate "flow" per se (i.e. volume per unit time). 
However, this terminology has been in widespread use and persists today although 
attempts have been made to refer to the technology as laser Doppler fluxmetry instead. 
laser Doppler flowmetry is purported to give a "real time measurement of microvascular 
blood cell perfusion through tissue" [Oxford Optronix, Oxford, UK literature 1998]. 
The theoretical basis of LDF is the utilisation of the well known Doppler frequency shift 
phenomenon that occurs when any type of regular wave pattern is reflected from an 
object in motion relative to the observer. A laser Doppler flowmeter consists of a probe 
attached to the main laser generating and detecting unit. The probe cable has one or more 
fibre optic cables that transmit the laser light to the tissue which then reflects and refracts 
throughout the tissue illuminating a volume of it. Via a separate, or the same, fibre optic 
cable, Laser light is transmitted from this volume back to the unit for sensing and 
• processing. Laser light has the advantage over other types of light because it is 
monochromatic and relatively noise-free making interpretation of Doppler shifts possible 
even though the particle speeds are extremely small compared to the speed of the laser 
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light. When the laser light enters the target tissue (which must be translucent) the light is 
repeatedly reflected, refracted and absorbed. This multiple scattering process produces a 
volume of isotropic illumination in front of the probe head within the target tissue. This 
volume is not fixed for each unit/probe setup and depends upon the intensity of the laser 
light, the optical qualities of the target tissue, and the angle of incidence of the laser from 
the probe (tilting the angle of incident light increases the amount of light deflected before 
it enters the tissue). All moving solid objects capable of reflecting red light traversing the 
volume of illumination will be struck by beams of scattered laser light, and on each 
Occasion the light reflects from a moving object it will be Doppler shifted. Thus the 
volume of illumination will contain a proportion of Doppler shifted laser light and the 
rest will be unshifted. Most of the light from the volume of illumination will diffuse into 
the tissues or be emitted away from the tissues. But the efferent optical fibres will carry 
some of the light "back scattered" from the volume of illumination back to the 
photodetectors in the laser Doppler flowmeter unit. The photodetectors convert the 
constituent light frequencies into electrical frequencies which are then immediately 
combined to generate new frequencies. This can involve either the sum of the two 
component frequencies or the difference between the component frequencies. The 
former frequencies have magnitudes of the order of 10 15 HZ and are too high to be 
contained by electrical circuitry and are promptly dissipated. The remaining frequencies 
are identical to the Doppler evoked frequency differences and appear as a standard 
magnitude distribution (power spectrum) of frequencies lying within the range of 0 to 20 
khz. (Oxford Optronix, UK, literature supplied with instrument, 1998). It is this product 
of power spectral area and mean frequency that is given the name "flux" which, within 
certain limitations (but suitable for physiologic purposes) is linearly related to the 
perfusion of a tissue by erythrocytes. The flux signal represents perfusion and is related 
to the mean particle (in biological tissue this can exclusively refer to erythrocytes) 
velocity and to the concentration of erythrocytes. 
Having considered the theory behind the generation of the LDF signal it is now worth 
considering what it is that is actually measured by the instrument and some of the 
limitations in the use of the instrument. Although the LDF signal is linearly related 
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(within certain circumstances) to erythrocyte concentration and mean erythrocyte speed, 
it is not possible to calibrate this signal in terms of real units of flow. The missing 
parameter is that of sampling volume, which as alluded to earlier cannot be accurately 
predicted and is different each time the probe is directed at a different area of each tissue 
and at each different tissue. A thorough definition of "perfusion" is still lacking. For the 
purposes of helping to define what the LDF measures Leahy et al. (99) proposed the 
following definition: "Perfusion is the product of local speed and concentration of blood 
cells". The general sense of meaning of "perfusion" in physiological parlance is as an 
indication to the degree to which the tissues are nourished by the microcirculation and it 
is quite possible to imagine two separate examples of where the mathematical definition 
of perfusion are identical, but conceptually the degree of nourishment is quite different. 
What can cause an increase in LDF signal "flux" or "perfusion" even though the total 
inflow to the organ is constant? One possibility is that flow has been diverted from 
outside the measurement field (ie outside the volume of illumination) into it. 
Alternatively, particularly in the case of vasoactive substances (e.g. vasoconstrictors such 
as norpinephrine or serotonin and vasodilators such as insulin) redistribution of blood 
flow between vessels of different architecture, may also explain a change in LDF signal. 
This will be a particular focal point of this thesis. 
It is important to note that use of LDF probes to measure muscle microvascular blood 
flow has generally been restricted to resting muscle. This is not because the method per 
se would be invalid but because it cannot be assured that muscle movement and 
particularly muscle fibre contraction does not dislodge the placement of the probe. 
1.4.2 Biological zero 
Any solid particle traversing the sampling volume of the LDF probe contributes to the 
flux signal, in most instances where living vertebrate tissue is the target the predominant 
signal generation will be due to the movement of erythrocytes (and to a much lesser 
extent other blood cells such as leukocytes and platelets). But an unpredictable portion of 
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the signal generation will be due to the movement of any number of other structures that 
are not necessarily blood borne such as vascular smooth muscle, skeletal muscle, cell 
membranes, organelles and vesicles. In addition to this, a volume of stationary blood is 
also capable of generating an LDF signal, probably through the process of Brownian 
motion. (108). When the LDF probe is targeted at a truly inanimate object the flux will 
register as zero with no baseline drift. But when the LDF probe is positioned over targets 
of organic tissue in vivo or in vitro and the blood flow is dropped to zero (e.g. by pressure 
cuff or artery clamp) the flux value does not drop all the way to zero. This value 
represents the amount of the flux signal which is not due to blood cell perfusion and is 
called the biological zero. This is subtracted from all LDF measurements previously 
taken from that exact spot. Otherwise, percentage changes in the flux will not reflect true 
changes. Historically, the biological zero has been found to be quite variable and often 
quite large when compared to the signals gained from basal flow. Chaplin and Hill (26) 
found the biological zero in murine tumours to vary from 4 to 77% and (108) reported an 
average biological zero of 73% of the basal in rabbit tenuissimus muscle. 
As discussed earlier, LDF measures "microvascular perfusion", a product of local speed 
and concentration of erythrocytes (99). But this exists only within certain limits and LDF 
signal does not always correlate with total flow to the organ being monitored. For 
example, Kuznetsova et al. (93) measured LDF signal recorded from the biceps femoris 
muscle of anaethetised and ganglion blocked rats. Total muscle blood flow as assessed 
by radioactive microspheres was unchanged with the administration of angiotensin II 
(All) and phenylephrine whilst LDF signal was increased. In further experiments they 
found that isoproterenol decreased LDF signal despite a large increase in total blood flow 
to the limb. 
We have seen in previous work from this laboratory and discussed earlier in this Chapter 
how nourishment and perfusion of the rat hindlimb changes in spite of a constant total 
arterial inflow (32). Furthermore other in vivo studies have indirectly measured changes 
in capillary recruitment (by the 1-MX method) occurring independently of changes in 
total flow (138;139). These same vasomodulators also markedly alter muscle metabolism 
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only when they are being delivered by the vascular route (ie in vitro perfusion or in vivo 
but NOT when the muscle is incubated with the vasomodulators, (140)). Therefore a key 
question must surely be "what changes are occurring in the microvascular flow 
distribution to cause these metabolic alterations?" The approach of this thesis will be to 
assess LDF as a means of measuring changes in nutritive flow in muscle. Comparisons 
will be made to data from the two other methods referred to earlier of 1-MX metabolism 
and CEU. Attempts will be made to rationalise LDF signal changes from changes in cell 
speed in the absence of perfusion changes, flow being diverted into and out of the volume 
of illumination, modified pattern of flow within volume of illumination, and changes in 
haematocrit. 
1.5 Aim 
The aim of this thesis was to compare LDF with 1-MX metabolism and contrast 
enhanced ultrasound for the assessment of microvascular flow in skeletal muscle and in 
particular in relation to reports of direct and indirect effects of insulin to increase 
microvascular perfusion of this tissue in vivo. 
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CHAPTER 2 
General Methods 
2.1 Animal care 
Animals were of either of three strains: Hooded Wistar (University of Tasmania), Wistar 
(University of Virginia) or Zucker (brought into Tasmania from Monash University 
Animal Breeding Facility, Melbourne). Hooded Wistar rats were raised on a commercial 
diet (Gibsons, Hobart) containing 21.4% protein, 4.6% lipid, 68% carbohydrate, and 6% 
crude fiber with added vitamins and minerals together with water ad libitum. Rats were 
housed at a constant temperature of 21 ± 1°C in a 12h112h light/dark cycle. All 
procedures adopted and experiments undertaken were approved by the University of 
Tasmania Animal Ethics Committee, in accordance with the Australian Code of Practice 
for the Care and Use of Animals for Scientific Purposes (1990). Unless indicated 
otherwise rats were 'fed', in having had free access to food and water up to the time of 
experimentation. 
2.2 Hindlimb perfusion 
The surgical and perfusion procedures were essentially as described by others (149) with 
modifications by Colquhoun et al. (42). Briefly, animals were anaesthetised via an 
intra-peritoneal injection of pentobarbital sodium (60 mg.kg  body wt) and the tail and 
tarsus of the perfused legs tied off firmly. An incision was made along the midline of the 
abdomen and the epigastric vessels and the iliolumbar vessels all ligated. Following this 
the testicles were ligated and removed. Ligatures were then placed around the duodenum 
and the rectum, and the large and small intestines were excised. Since only one hindleg 
was perfused, flow was prevented from entering the contralateral leg by ligation of the 
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opposite common iliac artery and vein. Prior to cannulation of the abdominal aorta and 
vena cava, heparin (1000 I.U.kg body weight -1 ) was injected into the vena cava. A further 
ligature was placed around the abdomen (at the level of the L3—L4 vertebrae region) to 
prevent access of the perfusate to the muscles of the back. The perfusion medium used 
for perfusions was a modified Krebs-Henseleit bicarbonate buffer containing 7.1% 
(wt/vol.) bovine serum albumin (BSA, fraction V; Boehringer Mannheim, Australia), 8.3 
mM glucose, 2.54 mM CaC12, 118 mM NaCI, 4.7 mM KCI, 1.2 mM KH2PO4,1.2 mM 
MgSO4 , and 25 mM NaHCO3. Once made, the perfusion buffer was filtered using a 
0.45 p.m pore filter under pressure to ensure, that it was free of any particulate matter. The 
buffer was maintained at a pH of 7.4 by saturation with 95% air-5% CO2 This was 
combined with washed bovine erythrocytes to give a final haematocrit of 38%. Heparin 
(0.2 m1.1: 1 ) and pyruvate (0.1 g.L -1 ) were added to the blood mixture. The fresh bovine 
erythrocytes were filtered through four layers of pre-washed cheesecloth and washed 
three times using saline (0.9% NaCl). They were then washed twice more in saline and 
stored in Krebs-Henseleit bicarbonate buffer gassed with 95% air-5% CO 2 at 4°C until 
use. Erythrocytes were never more than 3 days old when used. As with previous similar 
studies (141), this perfusion medium resulted in minimal oedema. 
Hindlimb perfusions of 205 ± 5g rats (local strain of hooded Wistar) were conducted 
essentially as described previously (141). Modifications included two heat exchangers, 
bubble trap and a small magnetically stirred injection port (1.0 ml capacity) immediately 
prior to the arterial cannula (arterial perfusate temperature was 37°C). In addition the rat 
was placed on a water-jacketed platform heated to 37°C, so that the hindlimb could be 
maintained at 37°C. The whole apparatus including the rat was contained within a heat-
controlled cabinet at 37 °C. The buffer reservoir was kept on ice and continuously stirred, 
whilst being gassed with 95% air-5% CO2. Perfusate was then pumped at a constant flow 
rate by a peristaltic pump (Masterflex, Cole-Palmer, USA) to a heat exchanger coil where 
the temperature was brought to 37 °C prior to passing through a silastic lung, also gassed 
with 95%air-5% CO2. Venous oxygen tension was continuously monitored using a 
thermostatically controlled (37 °C) in-line Clark-type oxygen electrode (0.5 ml capacity). 
Arterial perfusion pressure was monitored continuously via a pressure transducer located 
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proximally to the aorta. Recording of PO2 and pressure was performed continually by an 
IBM compatible PC computer with WINDAQ data acquisition software (DATAQ 
Instruments). Oxygen content was determined using an in-line oxygen analyser (A-Vox 
Systems Inc, San Antonio, Texas). Oxygen consumption was calculated as described in 
the respective chapter. 
2.3 Hyperinsulinaemic clamp 
For in vivo studies using rats, the hyperinsulinaemic euglycaemic clamp was used. The 
following details for the insulin clamps have been sourced from other publications from 
this laboratory (138;139). 
Rats were anaesthetized using Nembutal (50 mg.kg -I ) and had polyethylene cannulas 
(PE-50, Intramedice) surgically implanted into the carotid artery, for arterial sampling 
and measurement of blood pressure (pressure transducer Transpac IV, Abbott Critical 
Systems) and into both jugular veins for continuous administration of anaesthetic and 
other intravenous infusions. A tracheotomy tube was inserted, and the animal was 
allowed to spontaneously breathe room air throughout the course of the experiment. 
Small incisions (1.5 cm) were made in the skin overlaying the femoral vessels of both 
legs, and the femoral artery was separated from the femoral vein and nerve. The 
epigastric vessels were then ligated, and an ultrasonic flow probe (Transonic Systems, 
VB series 0.5 mm) was positioned around the femoral artery of the right leg just distal to 
the inguinal ligament. The space surrounding the artery created by its isolation 
surrounding the flow probe was filled with lubricating jelly (H-R, Mohawk Medical 
Supply, Utica, NY) to provide acoustic coupling to the probe. The probe was then 
connected to the flow meter (Model T106 ultrasonic volume flow meter, Transonic 
Systems). This was in turn interfaced with an IBM compatible PC computer which 
acquired the data (at a sampling frequency of 100 Hz) for femoral blood flow and blood 
pressure using WINDAQ data acquisition software (DATAQ Instruments). The surgical 
procedure generally lasted approximately 30 min and then the animals were maintained 
under anaesthesia for the duration of the experiment using a variable infusion of 
Nembutal (0-0.6 mg.min-l .kg-1 ) via the left jugular cannula. The femoral vein of the left 
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leg was used for venous sampling, using an insulin syringe with an attached 29G needle 
(Becton Dickinson). A duplicate venous sample was taken only on completion of the 
experiment (120min) to prevent alteration of the blood flow from the hindlimb due to 
sampling, and to minimize the effects of blood loss. The body temperature was 
maintained using a water-jacketed platform and a heating lamp positioned above the rat. 
Following a 1 hour equilibration, various protocols as stipulated in each chapter were 
undertaken. In general the protocols involved hyperinsulinaemic euglycaemic clamps or 
appropriate controls and occurred over a 2h period. 
2.4 Contrast Enhanced Ultrasound 
CEU has been used extensively in the past to measure microvascular flow in the 
myocardi urn (109;130;190). Estimates of microvascular flow using CEU have been 
validated using 11-tim radiolabeled microspheres to show that there is a strong 
correlation between the two techniques (I- ---- 0.96, P < 0.001) (190). The technique was 
modified for its use for the rat as follows: a linear-array transducer interfaced with an 
ultrasound system (IDI-5000; ATL Ultrasound) was positioned over the right leg of the 
rat and secured for the course of the experiment. The adductor magnus and 
semimembranosus muscles of the hindlimb were imaged in short-axis with intermittent 
harmonic imaging at a transmission frequency of 3.3 MHz. The mechanical index ([peak 
negative acoustic pressure] X [frequency] -I/2), a measure of acoustic power, was set at 0.9. 
The acoustic focus was set at the mid-portion of the muscle group. Gain settings were 
optimized and held constant for the duration of each experiment. Data were recorded on 
1.25-cm videotape using a S-VHS recorder (Panasonic MD830; Matsushita Electric). 
Albumin microbubbles containing octafluoropropane gas (Optison; Mal linckrodt 
Medical) were infused intravenously at 120 ul/min for the duration of data acquisition. 
The acoustic signal that is generated from the microbubbles exposed to ultrasound is 
proportional to the concentration of microbubbles within the volume of tissue being 
imaged. This greater acoustic signal is represented as a brighter video intensity which is 
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later quantified by image analysis of the videotape recording. Essentially, all 
microbubbles within the ultrasound beam are simultaneously imaged and destroyed in 
response to a single pulse of high-energy ultrasound (190). As the time between 
successive pulses is prolonged, the beam becomes progressively replenished with 
microbubbles (190). Eventually, the beam is fully replenished, and further increases in the 
time between each pulse do not affect microbubble signals in the tissue (Fig. 2.1). The 
rate of microbubble reappearance within the ultrasound beam provides an indication of 
microvascular flow velocity (13), and the plateau video intensity reached at long pulsing 
intervals provides a measurement of MV (190). 
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FIG. 2.1. 
A: Schematic depiction of the replenishment of microbubbles in capillaries after a pulse 
of high-energy ultrasound. As the time between each ultrasound pulse is prolonged, more 
microbubbles reappear. PI, pulsing interval. 
B: A typical relation between pulsing interval and acoustic signal, measured as video 
intensity. As the pulsing interval is prolonged, the number of microbubbles within the 
capillaries increases, resulting in a higher video intensity. Eventually a plateau is reached 
where the time interval between each pulsing interval does not cause a further increase in 
video intensity due to complete replenishment of the vessels in the beam. The asymptote 
that intercepts they-axis is the maximal video intensity signal and a measurement of MV. 
The x-intercept of the y-axis asymptote and the tangent to the upward sloping hyperbolic 
function is a measure of the rate constant of video intensity rise (fi), an indicator of 
microvascular flow velocity. 
A 
22 
Chapter 2 — General Methods 
For the current study, images were acquired during continuous imaging and at pulsing 
intervals from 1 to 20 s. Image analysis was performed off-line. Frames were aligned by 
cross-correlating several frames at each pulsing interval and were separately averaged and 
digitally subtracted from averaged frames obtained during continuous imaging (obtained 
at a pulsing interval of30 ms), which served as background. Using continuous imaging 
frames as background allowed for the elimination of the contribution by larger vessels 
(velocity >100 pm/s) to overall video intensity. The background-subtracted video 
intensity at each pulsing interval was measured within the area of interest in muscle, and 
pulsing interval versus video intensity data were fitted to the function fy = A (1 - 
where y is video intensity, t is the pulsing interval, A is plateau video intensity (an index 
of MV), and B is the rate constant, which provides a measure of microvascular flow 
velocity (Fig. 2.1, (190)). 
2.5 Laser Doppler Flowmetry 
LDF has a history now dating back almost 30 years in its application to the measurement 
of blood perfusion in tissue (169). In his work Stern (169) proposed that when coherent 
light from a device such as a laser emitter impinges on tissue, some of it will be scattered 
by the moving red blood cells and some by static tissue. If this light which is spectrally 
broadened due to the Doppler effect is brought to the surface of a sensitive photodetector, 
optical beating will produce an audio-frequecy photocurrent output. Spectral analysis of 
the photocurrent produced by the backscattered He-Ne red laser light showed changes 
consitent with perturbation to flow such as arterial occlusion. For skin Stern (169) noted 
changes in LDF signal that matched known effects on blood flow due to temperature, 
posture, respiratory pattern and emotional stimulation. With the introduction of 
fibreoptics for light delivery and collection, it soon became evident that the distance 
between delivery and collection fibres determined the volume of tissue under 
measurement. So, in this thesis a variety of probes were used, including micro-probes that 
could be impaled into muscle with minimal tissue damage and which because of their 
small size were able to detect heterogenity of sites. In addition macro-probes were used 
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which were insensitive to the heterogeneity but rather, detected signal change from the 
majority site at the surface of the muscle. For all stationary probes there was considerable 
variation in range of absolute signal, but this was largely attributable to the background 
scattering and encompassed by the 'biological zero'. In one study a scanning laser probe 
was used and the LDF signal measured at each point on the surfae of a muscle could be 
represented as a colour-coded picture of the changes before and after perturbation. Full 
details on the use of each of these probes, along with a technical description of each 
apparatus are given in the relevant Chapters. 
2.6 Analytical methods 
A glucose analyser (Model 2300 Stat plus, Yellow Springs Instruments, Yellow Springs, 
OH) was used to determine whole blood glucose (by the glucose oxidase method) during 
the experiment. A blood sample of 25 pi was required for each determination. Insulin 
levels at the beginning and end of the experiment were determined from arterial plasma 
samples by ELISA assay (Mercodia AB, Sweden). Perchloric acid treated plasma 
samples were centrifuged for 10 min and the supernatant used to determine I-MX, 
allopurinol and oxypurinol concentrations by reverse-phase HPLC as previously 
described (138). 
2.7 1-MX metabolism 
Since 1-MX (Sigma Aldrich Inc) clearance was very rapid, it was necessary to partially 
inhibit the activity of xanthine oxidase. To do this, an injection of a specific xanthine 
oxidase inhibitor, allopurinol (10 [tmol.kg -I ) was administered as a bolus dose 5 minutes 
prior to commencing the 1-MX infusion (0.4 mg.min -i .kg-1 ). This allowed constant 
arterial concentrations of 1-MX to be maintained throughout the experiment. At the end 
of the experiment blood was sampled from the femoral vein and carotid artery. From the 
arteriovenous difference multiplied by the flow, hindleg glucose uptake and 1-MX 
disappearance were calculated. The latter was used as an indicator of perfused capillary 
surface area. 
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2.8 Muscle glucose uptake using 2-deoxyglucose 
A bolus dose of [ 3 1-1]2-deoxyglucose (50pCi) was given 45 minutes before the end of the 
experiment. The removal of 2-deoxyglucose from the blood was determined in plasma 
samples taken at 5, 10, 15, 30 and 45 minutes following the injection. Muscles were 
excised at the completion of the experiment and freeze clamped in liquid nitrogen to 
assess the [31-1]2-deoxyglucose-6-phosphate as described previously (200). 
The total blood volume withdrawn from the animals before the final arterial and venous 
samples did not exceed 1.5 ml and was compensated by the volume of fluid infused. 
Details on Data Analysis and Statistical Analysis can be found in each of the relevant 
individual Chapters. 
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CHAPTER 3 
Laser Doppler Flowmetry: measuring nutritive flow in blood perfused rat hindlimb 
muscle 
3.1 Introduction 
Skeletal muscle microvascular perfusion is not always directly related to the total blood 
flow of muscle. This has been noted in vivo rat muscle using LDF (93). This observation 
is not new, indeed studies from the 1940s and 1950s (129,186,144,8,9,76,162) have all 
produced results that point out a discrepancy between total flow and perfusion of the 
muscle tissue. Although there may be other explanations, such evidence seems to 
strongly suggest that skeletal muscle does in fact have (at least functionally speaking) two 
quite separate circulatory systems. To produce a discrepancy between total flow and 
organ perfusion it was proposed that a functional shunt must exist, acting by denying the 
opportunity for nutrient exchange to occur between the muscle cells and the constituents 
of the blood. The two circulations have been referred to as "nutritive" and "non-
nutritive" (8;9), and on account of the physiological description of "shunting" in skeletal 
muscle there was obviously a desire to describe these shunts anatomically. Histological 
studies (69) had found that there did not exist in muscle a similar arrangement to skin 
where large diameter (approx 50 gm) arteriovenous anastomoses allowed wholesale 
shunting of arterial to venous blood. Additionally failure of the hindlimb to pass 12um 
microspheres through perfused hindlimb (121) muscle essentially disproved the 
possibility of arteriovenous shunts greater than this size. Grant and Wright (67) first 
described the anatomical difference of tendon capillaries to those capillaries normally 
associated with myocytes. It has been theorised that the slightly larger diameter, shorter 
length and physical isolation of these vessels would conduct flow from the arterial to 
venous circulation with minimal opportunity for nutrient exchange with the myocytes and 
therefore possibly be an anatomical explanation of non-nutritive flow. Vessels in the 
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nutritive pathway were considered to be those in direct contact with the skeletal muscle 
cells (75). 
Research from our laboratory using the constant-flow perfused rat hindlimb has shown 
that skeletal muscle metabolism including oxygen uptake and lactate release as well as 
aerobic contractile performance is controlled by vasomodulators that act to alter flow 
distribution within muscle (32;34). Because of the quite distinctly opposing effects of 
these vasomodulators they have been classified into two groups, "Type A" and "Type B" 
vasoconstrictors. Type A vasoconstrictors act to increase metabolism (as indicated by 
oxygen uptake and lactate release (32) and contractile performance (141)) by redirecting 
flow from a putative non-nutritive route to nutritive capillaries within muscle (121). 
Conversely the second group of vasoconstrictors, referred to as Type B, has the opposite 
effect and acts to decrease oxygen uptake, lactate release (32) and aerobic contractile 
activity (53). These vasoconstrictors affect metabolism only in a perfusion and not 
during incubation (140) and their effects are reversed by vasodilators (regardless of the 
vasodilator mechanism of action) (41;140). Because the changes to metabolism occur in 
a constant flow perfusion situation they do not exert their effects by altering total flow to 
muscles but presumably do so by redirecting flow within the hindlimb muscles 
(121;141). In other words flow is being directed away from the nutritive route (which is 
most likely to consist of capillaries in intimate and extensive contact with the myocytes) 
to the non-nutritive route (i.e. functional shunts). Because non-nutritive flow has a 
converse effect on metabolism it stands to reason that non-nutritive vessels should have 
the anatomical characteristics to limit the opportunity for nutrient exchange as the blood 
passes from the arterial to the venous systems. Examples of such anatomical 
characteristics include: physical isolation from the myocytes (the non nutritive vessels 
may be located in muscle associated connective tissue), non-nutritive capillaries are 
shorter, may have larger diameters, or may have endothelial characteristics which impair 
diffusion. Evidence that vessels associated with connective tissue behave in a 
pharmacologically different manner from other vessels in muscle can be found in 
observations made by intravital microscopy in response to hypoxia, beta adrenergic 
agonists, etc. (104). Grant and Wright (67) anatomically identified vessels in the 
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connective tissue which they thought may be part of the non nutritive network. More 
recent studies (122) demonstrated an inverse relationship between perfusion of tendon 
vessels and muscle metabolism. Indeed, direct evidence for these latter vessels has been 
obtained by Ley and colleagues (100), who showed them to be major routes for the 
shunting of leukocytes. 
In this Chapter, an investigation was made of the LDF signal responses of macro surface 
and implantable micro probes positioned on or in hindlimb skeletal muscles, respectively. 
The responses to changes in total flow and to vasoconstrictors that are known to alter 
hindlimb metabolism between nutritive and non-nutritive flows were characterised. 
3.2 Methods 
3.2.1 Hindlimb Perfusions 
Hindlimb perfusions of 205 ± 5g rats (local strain of hooded Wistar) were conducted 
essentially as described previously in Chapter 2. In brief, the hindlimb was maintained at 
37°C for all blood perfusions. Significant differences from the standard perfusion 
procedure to help achieve this goal included the use of two heat exchangers (instead of 
one), and additional bubble traps including a smaller than usual magnetically stirred 
bubble trap (1.0 ml capacity) downstream from the injection port immediately prior to the 
arterial cannula specifically to allow bolus injection of vasomodulators. In addition the 
rat was placed on a water-jacketed platform heated to 37°C, with a thermometer kept in 
close contact with the dorsum of the hindquarter for monitoring purposes. Initially the 
flow rate was increased to 15 ml/min for 5 min to clear all red cells of rat origin. Due to 
the hindlimb being almost fully vasodilated (147), supra-physiological flow rates were 
required to obtain physiological levels of pressure. Consequently the flow rate of 4.0 ± 
0.1 ml/min, equivalent to 0.27±0.01 ml/min/g of muscle, was selected as a compromise. 
Previous studies using fluorescent microspheres for determining regional flow (137) have 
suggested that the muscles of the thigh, hip and calf receive flow at approx. 76% of the 
total hindlimb rate (or 0.20±0.02 ml/min per g). Selected agents known to have 
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metabolic effects through vasomodulation on the hindlimb were administered either as a 
bolus injection (NE, angiotensin II, vasopressin, or 5-HT) or in separate experiments as 
continuous infusions (NE and 5-HT). To hasten complete removal of preceding dose or 
agent following its administration, flow was momentarily increased to 8m1/min for 2 min. 
This also improved the reproducibility of subsequent identical doses. 
3.2.2 LDF 
3.2.2.1 Surface measurements 
A small hole (approx. 4 mm diameter) was made in the skin over the middle of the biceps 
femoris corresponding to the point "bf" in Figure 3.1. The hindlimb was then clamped by 
the foot so that the laser Doppler flow probe (Perimed PF 2, operating wavelength of 632 
nm) could be positioned over the center of the hole. The probe was placed vertically 
above and approx. 1 mm from the surface of the muscle, and preliminary experiments 
showed that such an arrangement produced a LDF signal that was linearly related to 
changes in perfusion total flow rate, verifying that it was likely that perfusion by blood 
cells was being detected by the instrument. The probe comprised three fibres each 800 
Jim diameter with one for illumination and two for detection. Settings on the detector 
unit were 4 kHz (gain setting 10) with a time constant of 3 s, unless otherwise indicated. 
The signal (0-5 volts) was continuously recorded on an IBM compatible PC using a DI-
190 I/O module and WINDAQ ® software. The data are expressed as volts. 
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Figure 3.1. General areas chosen for positioning of LDF probe either on or impaled 
into muscles of the perfused rat hindlimb. The macro LDF probe (3 x 800 gm) was 
always positioned over the biceps femoris at the site designated 'br through a hole in the 
skin. The micro optic fibre probe (0.26mm diameter) was inserted through a small 
incision in the skin in the approximate positions shown on either the tibialis (tib), vastus 
(vs), biceps femoris (bf), or gastrocnemius (gs) muscles. The mechanism for insertion of 
the micro optic fibre probe involved an initial right angle puncture of the muscle surface, 
insertion for 1 or 2 mm then gentle rotation of the probe so as to be in parallel with the 
muscle axis, and a further insertion for 3 to 6mm. Apart from the general region 
indicated, positioning of the micro probes including precise site, initial depth and final 
penetration was randomly chosen. 
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3.2.2.2 Impaled microprobe for within muscle measurement 
A Moor Instruments Lab Server and Lab Satellite fitted with two PlOM master probes 
was used with two P 10s TCG 260 pm slave probes each fitted with TCG fixed fibre. The 
operational wavelength of the laser light source was 780 nm. The fibre consisted of a 
single core of optic fibre (200 p.m diameter) surrounded by protective flexible outer 
sheath. Following prior skin incision using surgical scissors, the optical fibre was found 
to be sufficiently robust as to be able to be inserted into the muscle unaided by prior 
needle puncture. Measurements were made using the PO setting (MoorLAB V36 
embedded software). This setting scales the raw LDF output by a factor of 10-fold and 
was used to improve the quality of the recorded signal. Subsequently, LDF values were 
scaled to express the results in perfusion units (PU) by a factor from measurements made 
on the manufacturer's calibration fluid for each probe. Small incisions were made into 
the skin covering the mid-region of any two of the tibialis, vastus, gastrocnemius or 
biceps femoris (Figure 3.1) of the perfused leg and the two probes inserted. The 
procedure for insertion of each probe involved initial puncturing of the epimysium and 
muscle body to a depth of approx. 2 mm with the probe at right angles to the muscle 
surface, followed by rotation of the probe through 90° to be parallel to the longitudonal 
direction of the muscle fibers. The probe was then inserted a further 3 to 6 mm and taped 
in place. This procedure avoided wounding and only 4 of the 97 sites were considered 
corrupted due to bleeding. Apart from the evidence of bleeding it was impossible to 
entirely rule out tissue damage. Indeed, as pointed out by Oberg (126) using very thin 
optical fibers (50-200), the trauma can be minimal with little disturbance to blood flow. 
After completion of the perfusion the final placements were confirmed by surgical 
examination. In some animals the probes were repositioned in other muscles up to two 
additional times. This allowed assessment of as many as six different sites per hindlimb. 
The LDF signal (0-5 volts) was continuously recorded on an IBM compatible PC using a 
DI-190 I/O module and WINDAQ ® software. The data are expressed as perfusion units 
(PU), to be consistent with the manufacturer's recommendations and to be distinguished 
from those of the surface probe which differed in size and operating wavelength. 
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For each perfusion "biological zero" was determined by switching off the perfusion pump 
for 5 min and waiting until venous perfusate flow ceased, with the LDF probe still in 
position. Biological zero was not subtracted from any of the data shown. 
3.2.3 Vasoconstrictor infusions 
To determine linearity of LDF response, perfusion flow rate was varied from 4 through 6 
to 8 ml/min and LDF signal recorded. With flow set at 4 ml/min, administration of 
norepinephrine (NE, 0-0.3 nmol), angiotensin 11 (0.3 nmol), vasopressin (0.03 nmol), or 
serotonin (5-HT, 0-3 nmol) was made as a 12.5 or 25 1.11 bolus (over 2s) into the stirred 
injection port. In some experiments constant infusions of NE (85 nM) or 5-HT (850nM) 
were made by infusing into the injection port a concentrated stock solution of each agent 
at 1.7% of the perfusate flow rate. 
3.2.4 Perfusion pressure and oxygen uptake 
Perfusion pressure was also continuously recorded using WINDAQ ® . Perfusate entering 
and leaving the hindlimb was passed through an in-line oxygen analyser from A-Vox 
Systems, Inc, San Antonio, Texas and the signal continously recorded also using 
WINDAQ® . V02 was then calculated using the following equation: 
V02 (gmol.hd .g-1 ) = A — V 0, 	02/100ml) x flow rate (ml/min) x 321.43  
Rat weight (g) 
3.2.5 Statistical analysis 
Data were analysed using Sigma Stat TM (Jandel Scientific). Comparison of basal signal 
strength for nutritive, non-nutritive, and mixed, unpaired analysis (Students' t-test) was 
used. For comparison of basal signal strength of nutritive, non-nutritive, and mixed sites, 
unpaired analysis (Students' t-test) was used. For effects of vasoconstrictors and flow on 
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LDF signal, paired analysis (Students' t-test) was used. Potential correlations were 
assessed by regression analysis using Sigma Stat TM (Jandel Scientific). 
3.3 Results 
.3.3.1 Surface measurements 
The macro LDF probe was designed primarily for measurement of human skin blood 
flow. It was therefore necessary to consider the suitability of using this instrument to 
monitor microvascular perfusion in erythrocyte perfused rat hindlimb studies. Others 
have shown that capillary red cell velocity in resting muscle does not exceed Imm.s -I for 
a blood flow of 0.05ml.min-l .g-1 (178), thus at a flow rate of 0.27m1.min -l .g-1 as used in 
the present perfusions, cell velocities should still be less than the critical limit of 8mm.s -I . 
This was tested by measuring the LDF signal from the muscle at flow rates between 1 
and 10 ml.min -1 . Within this range of flow rates the signal was found to be linear 
(r=0.833; P<0.001, n=59). At flow rates above this, the critical limit of red cell velocity 
of 8 mm.s 1 is likely to have been exceeded. 
Slight movements of the perfused hindlimb in relation to the probe must not significantly 
affect the LDF value. This was tested by proving no significant variation in LDF as 
probe to target distance was varied (whilst directed at the same region of muscle) from 0 
to 1.5 mm (not shown). 
Positioning of the probe was found to be important and was placed in the same location 
in the centre of the anterior end of the biceps femoris. Without exception, when measured 
with the -PeriMed macro probe, this site always behaved the same displaying increased 
LDF signal response to NE and decreased signal response to 5-HT injection. Other sites 
responded differently. Thus from a total of 28 sites involving 11 in the center of the 
biceps femoris (all responding as above), 8 on the tibialis anterior and 9 on the tibial 
tendon of the biceps femoris, 20 responded as above, 3 responded in an opposite manner 
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(NE inhibitory and 5-1-1T stimulatory) and 5 appeared as intermediate with no response to 
either NE or 5-HT. 
A time course from a typical experiment is shown in Figure 3.2 where LDF signal on the 
surface of the biceps femoris muscle vessels was measured as well as perfusion pressure 
and oxygen uptake for the hindlimb during successive injections (25 1.1.1) of 300 pmol NE 
and 3 nmol 5-HT. NE (300 pmol), equivalent to a peak concentration of 15-50 nM 
(estimated from injection and perfusion flow rates), increased LDF signal in association 
with increased perfusion pressure and a stimulation of oxygen uptake. Values for LDF 
and oxygen uptake returned to basal approx. 3 min following NE injection. 5-HT 
(3nmol), equivalent to a peak concentration of 150-500 nM, decreased LDF signal in 
association with increased perfusion pressure and an inhibition of hindlimb oxygen 
uptake (Figure 3.3). 
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Figure 3.2 Typical trace of LDF signal from the macro surface probe positioned at 
the centre of the anterior end of the biceps femoris muscle. (A), arterial perfusion 
pressure (B) and oxygen uptake (C) following injection of 300 pmol of NE (Type A 
vasoconstrictor) and 3 nmol of 5-HT (Type B vasoconstrictor) into the constant-flow 
perfused rat hindlimb. Biological zero has not been subtracted. 
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Figure 3.3 Relationship between peak change in oxygen uptake and LDF signal 
from the surface macro probe for the constant-flow perfused rat hindlimb. Values 
for LDF signal are (5) NE, (0) vehicle, and (w) 5-HT. 
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3.3.2 Impalable probes 
The macro probe has a total diameter, including housing, of 6 mm and could therefore not 
be impaled into the muscle without serious tissue disruption. As indicated above, 
provided the probe was positioned over muscle, only NE-positive sites were observed. 
Thus to investigate signal changes at higher spatial resolution smaller ("micro") 
impalable probes were used. Figure 3.4 shows the properties of LDF signal from 
randomly positioned micro probes placed in the tibial is, vastus, biceps femoris, or 
gastrocnemius muscles. The majority of sites responded positively to norepinephrine 
bolus (Figure 3.4A) with an increase in LDF signal of greater than 5% of basal, but some 
clearly responded negatively with a decrease in LDF signal (decreasing by more than 5% 
of basal). In addition, there was a group that did not respond (i.e. less than ± 5% of basal 
signal). Panel B of Figure 3.4 shows the responses of these same sites to serotonin bolus. 
Again, three types of response were discernable with the majority responding negatively 
to serotonin and two other groups where the response was positive (signal increasing) or 
showing no change. In some sites the negative response to serotonin was so marked that 
the LDF signal was effectively reduced to biological zero. Invariably, the sites that 
responded positively to norepinephrine were those that responded negatively to serotonin. 
These are thus designated as "NE-positive". The other two types of site are designated 
"NE-negative" or "mixed" depending upon whether the LDF signal decreased in response 
to norepinephrine and increased in response to serotonin, or showed less than 5% change 
to either vasoconstrictor, respectively. It is important to note that although 
norepinephrine and serotonin each cause a pressure rise (vasoconstriction), they have 
stimulatory or inhibitory effects on whole hindlimb oxygen consumption metabolism, 
respectively. 
37 
16 
14 
12 
10 
8 
6 
4 
2 
0 
-100 -50 	0 	50 	100 150 200 
Chapter 3 — Laser Doppler Flowmetry measuring nutritive flow 
% Change LDF 
-50 	0 	50 	100 
	
150 
	
200 
% Change LDF 
Figure 3.4 Distribution of LDF signal changes from impaled micro probes. Values 
obtained after NE (A) or 5-HT (B) were expressed as a percentage of the basal signal and 
grouped in intervals of 10% starting from +5% and —5%. 
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Characteristic traces of NE-positive, NE-negative sites and mixed are shown in Figure 
3.5. NE-positive sites showed LDF signal changes in parallel to oxygen uptake, i.e. 
increases and decreases with NE and 5-HT, respectively. NE-negative sites showed LDF 
signal changes opposite to oxygen uptake. For the total of 97 sites examined 56.7% were 
found to be NE-positive, 16.5% NE-negative and 24.7% mixed. Only 2.1% were 
corrupted due to bleeding. Table 3.1 also shows that basal LDF signal strength was 
greater at NE-negative sites than either NE-positive or mixed sites and all three sites 
responded significantly to a doubling of flow rate from 4 to 8 ml/min. Although not 
shown by the data of Table 3.1 a break down of the data revealed there were differences 
between the muscle types with basal signal from NE-positive sites in tibialis (24.7 ± 2.2; 
n=28) similar to gastrocnemius (21.7 ± 4.5; n=12) but greater than either biceps femoris 
(12.9 ± 2.3; n=6, P<0.01) or vastus (12.4 ±2.8 PU; n=9, P<0.02). 
Table 3.2 summarizes the response of NE-positive sites to flow and vasoconstrictors, 
including 5-HT, NE, vasopressin and angiotensin II. Whole hindlimb oxygen uptake as 
well as perfusion pressure are also shown. Increasing the pump flow rate progressively 
from 4, though 6 to 8 ml/min increased the LDF signal from 14.2 ± 1.0 to 22.8 ± 1.4 PU. 
Allowing for a biological zero of approximately 7.4, the increase due to flow represents 
a 2-fold increase. Whole hindlimb oxygen uptake and perfusion pressure increased by 
29.4% and 65.3%, respectively. Three of the vasoconstrictors, NE, vasopressin, and 
angiotensin II each increased the LDF signal in parallel to their effects on oxygen uptake. 
5-HT inhibited both and in many cases the signal strength due to 5-HT was 
indistinguishable from biological zero for that site. 
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Table 3.1 Properties of LDF signal from the randomly positioned muscle micro 
probes 
Site Identity Fraction of 
Total, % 
Basal Signal 
at 4 ml/min, 
PU 
Range, 
PU 
Signal at 
8 ml/min, 
PU 
NE-positive 56.7 20.7 ± 1.8 3.4 - 61.9 35.8 ± 3.4* 47 
NE-negative 16.5 33.2 ± 5.4# 10.4 - 87.4 53.7 ± 10.5* 16 
Mixed 24.7 22.3 ± 2.7 5.0 - 60.1 35.7 ± 6.1* 22 
Corrupted 2.1 
Sites were classified as NE-positive, NE-negative or mixed depending on responses to the 
vasoconstrictors NE and 5-HT as shown in Fig. 3.4. Those deemed as "corrupted" 
resulted from bleeding at the point of probe insertion. A total of 97 sites were assessed 
from 35 hindlimb perfusions involving sites on each of the tibialis, vastus, biceps 
femoris, and gastrocnemius muscles. Response to flow was assessed when flow was 
increased from 4 to 8 ml/min. Otherwise, flow was maintained constant at 4m1/min. 
Values are expressed in perfusion units and are means ± SE; *, P< 0.05 relative to basal. 
#, P< 0.05 relative to 'NE-positive'. Biological zero has not been subtracted. 
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Figure 3.5 LDF tracings for NE-positive (A), NE-negative (B) and mixed (C) sites 
from impaled micro probes. Bolus injections of 3 nmol of NE or 5-HT were made as 
shown during perfusion of the rat hindlimb at constant total flow and sites classified as 
described in the text. Perfusion pressures as well as arterial-venous oxygen difference for 
the whole hindlimb were also recorded. Tracings are representative of the groups whose 
'n' values are given in Table 3.1. 
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Table 3.2 Characteristics of the NE-positive sites 
Flow, 
ml/min 
Additions Peak LDF, 
PU 
Peak V02, 
umo1.11 1 .g 1 
Peak pressure, 
mmHg 
4 none 14.2 ± 1.0 (8) 43.5 ± 1.4 (8) 32.6 ± 1.8 (9) 
6 none 18.8± 1.2(8)* 51.6 ± 1.9 (8)* 43.7 ± 1.7 (9)* 
8 none 22.8± 1.4(8)* 54.6 ± 2.4 (8)* 53.9± 1.9(9)* 
4 none 15.2 ± 1.2 (9) 44.1 ± 1.3 (9) 32.6 ± 2.0 (9) 
4 5-HT 6.5 ± 0.7 (9)* 31.8 ± 1.7 (9)* 104.8 ± 15.5 (9)* 
4 none 15.3 ± 1.0 (9) 44.1 ± 1.5 (9) 33.7± 1.8(9) 
4 NE 31.0 ± 5.3 (9)* 56.4 ±2.6 (9)* 55.9 ± 5.1 (9)* 
4 none 15.5 ± 0.8 (8) 43.5 ± 1.6 (9) 35.3 ± 2.2 (8) 
4 AVP 40.3 ± 10.3 (8)* 53.7 ± 2.9 (9)* 69.9 ± 5.3 (8)* 
4 none 13.9± 1.0(9) 43.4 ± 2.0 (7) 34.2 ± 2.3 (8) 
4 All 35.5 ± 4.0 (9) 51.8 ± 2.3 (7)* 47.9 ± 7.2 (8)* 
Sites identified as NE-positive in initial assessment were further assessed in response to flow change and to 
bolus injections of serotonin (5-HT, 3 nmol), norepinephrine (NE, 3 nmol), arginine vasopressin (AVP, 30 
pmol) or angiotensin II (All, 300 pmol) Values are mean ± SE with n values shown in parentheses; *, P<0.05 
relative to 4m1/min "none". LDF values have not been corrected for biological zero. 
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Figure 3.7 LDF tracing from NE-positive (top, left) and NE-negative (bottom, left) 
sites using micro impaled probes following the constant infusion of 750 nM 
serotonin (filled bar). Hindlimbs were perfused at constant total flow and an infusion of 
a stock solution of 50 p.M 5-HT introduced for the period shown. Representative tracings 
for perfusion pressure, as well as arterial-venous oxygen difference for the whole 
hindlimb are also shown. 
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3.4 Discussion 
This study represents the second (see also (93)) where there is a major divergence 
between total flow and LDF measurements in muscle and raises the question as to how 
this might occur. We believe that two issues have an important bearing; one concerning 
what LDF probes actually detect and the second, the influence of vessel architecture. For 
LDF measurements, it is generally thought that movement of the blood cells causes a 
frequency shift with some of the photons also back-scattered or absorbed by the tissue. 
Doppler broadened and back-scattered light carry information about the movement and 
concentration of the cells. LDF probes are thus considered to measure "tissue perfusion". 
Although this has not been fully defined, Leahy et al. (99) propose that "tissue perfusion" 
is the product of local speed (non-vectorial) and the concentration of moving cells. 
However, it is far from clear whether the product derives from equal quantitative input 
from each or whether one or other has a dominant effect. Equal input would mean that if 
total (volume) flow remained constant then changes in vessel diameter, distribution of 
flow from few to many vessels, or the distribution of flow from short to tortuous vessels, 
should not affect the signal from a LDF probe. To put it another way, the relationship 
between LDF signal and total flow should always hold. The findings in this present study 
which clearly show a divergence between total flow and LDF signal have thus 
necessitated an evaluation of the relationship between vessel architecture and LDF signal. 
So, in a separate study (Chapter 4) we have constructed models of different vessel 
architecture from commercially available polymer tubes of a size that even with complex 
formations fitted comfortably within the field of measurement of a standard LDF probe. 
We examined the effect of tube architecture on LDF signal using polymer tubes of 250, 
100 and 50pm internal diameter. At 3% hematocrit the LDF signal was linear for each of 
the three tube sizes from 10 to 80pl/h. The signal strength was greatest from the smallest 
tube and least from the largest tube even though volume flow was the same in each. For a 
single tube (100gm) that doubled back on itself twice to cross the field of measurement 
three times, the LDF signal at any flow (10-80p1/hr, hematocrit 3%) was approx. 3-fold 
greater than that for the same tube crossing the field of measurement once. The effect of 
progressively switching flow (constant at 120pl/h, hematocrit 9%) from five to one tube 
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in a manifold of five tubes (100 [tm) gave rise to a progressive increase in signal. Overall, 
the data underscore the predominant role of cell speed (non-vectorial), rather than 
velocity or cell number in determining LDF signal. If these models can be used as 
representative of the microvasculature of tissues in vivo, then they may help explain a 
recent report in skeletal muscle where changes in total (volume) flow failed to correlate 
with LDF signal, in vivo (93) as well as the present data in perfused rat hindlimb. In the 
present experiments which were conducted at constant-flow, norepinephrine (NE) 
increased the LDF signal at the majority of sites and increased overall hindlimb oxygen 
uptake. A decrease in vessel diameter due to NE-mediated vasoconstriction of the vessels 
under the probe could account for the increase the LDF signal. However, while this 
might explain the effects of NE to increase the LDF signal, it could not account for the 
effects of serotonin (5-HT), which in the hindlimb also caused vasoconstriction, but at the 
same LDF sites as where NE was stimulatory, caused a decrease in LDF signal and a 
decrease in overall hindlimb oxygen uptake. From the tube manifold studies where the 
LDF signal decreased when flow was switched from one to five identical tubes, it would 
seem likely that any vasoconstrictor that acts to decrease capillary flow by de-recruiting 
the number of capillaries perfused without affecting total flow would increase the LDF 
signal. Thus 5-HT which decreases oxygen uptake and presumably muscle capillary flow 
might be expected to increase, not decrease, the LDF signal. 
One explanation from the perfused tube studies (30) that might account for the effects of 
NE and 5-HT to increase and decrease the LDF signal, respectively, is that blood flow is 
redirected to (by NE) or from (by 5-HT) tortuous multiple pass capillaries much as used 
in the model described above. This would mean that the two networks comprise on the 
one hand, the long tortuous capillaries that could be considered as nutritive and on the 
other, relatively short single pass capillaries (possibly "non-nutritive"). Switching the 
blood flow from one to the other by site-specific vasoconstrictors might then account for 
the changes in metabolism reported herein. Type A vasoconstrictors such as NE are 
known to constrict at the region of terminal arterioles. The rise in pressure may be 
sufficient to overcome the intrinsic resistance of the longer capillaries allowing flow. 
This would account for the previously observed increase in red cell washout and newly 
recruited vascular space detected by FITC dextran that accompanied NE-mediated 
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vasoconstriction (121). In contrast, Type B vasoconstritors such as 5-HT, are thought to 
vasoconstrict higher in the vascular tree and dilate the arterioles [see (32) and refs 
therein] lowering the pressure in the vicinity of the capillary networks. Under these 
conditions flow in the lower resistance short "non-nutritive" capillaries would be favored. 
Whereas the short "non-nutritive" capillaries are near to the muscle fibers it is also 
possible that some are contained within the connective tissue that surrounds the bundles 
of muscle fibers (the epimysium). As such, these would be sufficiently insulated from 
muscle cells to be functionally non-nutritive. From our previous studies it is clear that 
some of the non-nutritive connective tissue vessels are located in tendons (8;67;122) 
therefore outside the present regions of LDF measurement which were located more 
centrally. 
In the present study a distinct heterogeneity of sites was identified from micro LDF 
probes placed at random in various muscles in the perfused rat hindlimb. The 
heterogeneity was not detected with the much larger surface probe unless the probe was 
moved to regions where tendon vessels were apparent. Of the sites examined with the 
micro probes either of three characters was displayed when the hindlimb was injected 
with bolus amounts of the vasoconstrictors NE or 5-HT. Some responded with increased 
LDF signal from NE and decreased LDF signal from 5-HT and were designated as 'NE-
positive'. Those responding with decreased LDF signal from NE and increased LDF 
signal from 5-HT were designated as 'NE-negative' Sites failing to respond to either NE 
or 5-HT were deemed as 'mixed'. Since the vasoconstrictors, norepinephrine and 
serotonin have been previously described as increasing or decreasing muscle nutritive 
flow based on their respective effects to stimulate or decrease muscle metabolism (32), 
we propose that the NE-positive sites are located in the nutritive vascular route. Similarly, 
since NE and 5-HT have been previously shown to decrease or increase, respectively, 
putative non-nutritive flow in tibial tendon vessels of the biceps femoris (122), the NE-
negative sites reflect the positioning of the probe in the non-nutritive vascular route. A 
'mixed' site could represent a location where nutritive and non-nutritive sites are 
juxtaposed so a positive response from one is obscured by a negative response of similar 
magnitude from the other. Indeed, close inspection of 'mixed' traces (e.g. Fig. 3.5C) 
shows LDF signal fluctuation at the points when NE and 5-HT were injected. It is 
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unlikely that mixed sites were where there was no blood flow as increasing the flow from 
4 to 8 ml/min significantly increased LDF signal at these sites (Table 3.1) and the basal 
LDF signal was greater than biological zero. 
In addition to their differing character with respect to responses to the vasoconstrictors 
NE and 5-HT two other differences were detected. Firstly, the proportion of sites assessed 
favored NE-positive over NE-negative by a factor of 56.7% to 16.5%, or approximately 
3.5: 1. The ratio may be closer to 2.4: 1 if the assumption that mixed sites comprise equal 
proportions of NE-positive (nutritive) and NE-negative (non-nutritive) components. 
Secondly, NE-negative sites, in general, showed a higher basal LDF signal than NE-
positive sites (Table 3.1). Together these additional properties suggest that non-nutritive 
vessels are relatively fewer than nutritive. 
Anatomical models of the muscle microvasculature depicted by Lindbom and Arfors and 
their colleagues (22) as well as those of Myrhage and Eriksson (114) provide a possible 
explanation for the close co-existence of nutritive and non-nutritive sites within the 
muscle body. Detailed drawings of the microvasculature of the rabbit tenuissimus muscle 
(22) show feed arteries that branch to supply transverse arterioles which in turn cross the 
muscle body (which in this muscle is flat) to firstly supply terminal arterioles and 
capillaries of the muscle then to end in vessels supplying the connective tissue. Our own 
recent studies suggest that these vessels nourish attendant adipocytes (39) and thus can 
only be considered "non-nutritive" for the more metabolically active muscle cells. 
Furthermore, these connective tissue vessels and their adipocytes are seen in close 
proximity of the muscle nutritive capillaries (33). Thus two vascular networks operate in 
parallel and a number of studies using intravital microscopy has shown that relative flow 
in the two networks can be influenced by various physiologically relevant agents and 
conditions (22;103-105) that redistribute flow consistent within the two regions 
representing the nutritive and non-nutritive routes of muscle (35). For the tenuissimus 
muscle the region containing nutritive capillaries is approximately 3000 pm wide and 
somewhat less for the non-nutritive (104). Thus a LDF probe of 200 gm dia. could be 
placed to detect exclusively one or the other route. For muscles other than the tenuissimus 
that are cylindrical, the same vascular unit is observed (114), but now the transverse 
arteriole radiates out from the center of the muscle fibril and the connective tissue vessels 
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are contained in the perimysium. The dimensions are similar but because of the 
cylindrical nature of the perimysium the probability of positioning a 2001..tm probe to 
measure non-nutritive flow exclusively would be less than for the tenuissimus and the 
probability of receiving a mixed signal greater. The data obtained in this present study 
and the conclusions drawn from the perfused polymer tube studies (30) are not 
inconsistent with this vascular arrangement. 
There are relatively few studies deploying intramuscular micro LDF probes (e.g. see 
(126)) and none has addressed the issue of heterogeneity of response to vasoconstrictors. 
There are, however, a number of studies where larger LDF probes have been used on the 
surface of skinned muscle similar to the one reported herein. The larger surface probe 
records frequency changes from much larger volumes of tissue, in many cases 
approaching 1mm 3 and therefore penetrates considerably below the surface. Of particular 
interest are studies of muscle blood flow where total and regional flow has been 
manipulated by pharmacological agents. The findings suggest that the surface LDF 
probes detect predominantly flow we would characterize as nutritive. In one such study 
(68), adenosine was infused into anesthetized rabbits. Mean arterial blood pressure 
decreased, there was an increase in flow heterogeneity, a decrease in local oxygen 
consumption (vastus medialis) and a decrease in LDF signal in the same region on the 
contralateral leg. The authors concluded that adenosine had caused a markedly reduced 
capillary flow with increased tissue oxygenation. The studies herein using the constant-
flow perfused rat hindlimb show that vasodilators, such as adenosine, strongly oppose the 
effect of Type A (cf. Type B) vasoconstrictors such as NE and redirect flow from the 
nutritive to the non-nutritive route (31). 
In a study by Kuznetsova et al. (93), muscle surface LDF signal was recorded from the 
biceps femoris muscle of anesthetized rats that had been injected with clorisondamine 
chloride, an autonomic blocking agent that blocks nicotinic ganglionic transmission, as 
well as the (3 1 -blocker, atenolol. Total muscle blood flow was assessed with radioactive 
microspheres. Infusion of angiotensin II or phenylephrine increased LDF signal without 
affecting total muscle blood flow. In a separate series of experiments, isoproterenol 
decreased LDF signal despite a large increase in total blood flow. These findings are 
consistent with our observations in the constant-flow perfused rat hindlimb where 
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angiotensin II and phenylephrine are both Type A vasoconstrictors and increase oxygen 
uptake, by increasing nutritive flow. Furthermore, we have found isoproterenol to be a 
vasodilator that opposes Type A vasoconstriction and redirects flow from the nutritive to 
the non-nutritive route. Thus oxygen uptake is inhibited (31). 
In skeletal muscle of the rat, LDF signal has been shown to correlate well with other 
measurements of flow, such as radioactive microspheres or electromagnetic flowmetry, 
each of which measure volume flow (161). However, as pointed out by Kuznetsova etal. 
(93), the linear correlation may not apply if tissue perfusion, estimated by LDF, changes 
without any significant change in volume flow to an organ. In fact the principal finding 
made by these authors was that certain types of vasoconstrictors, as outlined above, were 
able to cause a dissociation between volume blood flow and LDF signal. Kuznetsova et 
al. (93) were of the view that changes in LDF signal accompanying changes in vascular 
tone were best explained by changes in red cell velocity. Thus agents such as 
isoproterenol, that decrease LDF signal in the light of increased total blood flow do so by 
decreasing red cell velocity, the result of decreased arteriolar-venular pressure gradient. 
In view of the present studies I would argue that the LDF probe recorded signal from 
predominantly nutritive region and phenylephrine and angiotensin II increased, while 
isoproterenol decreased blood delivery to this region. The LDF signal reflected the extent 
of perfusion of the tortuous nutritive network as predicted from the perfused polymer 
tube studies (30). 
In our perfused hindlimb system, total flow was maintained constant and we have 
previously shown, using microspheres, that agents such as 5-HT do not alter total flow 
between muscles of high and low oxidative capacity, or between muscle and non-muscle 
tissue (137). The fact that 5-HT infusion results in a marked decrease in oxygen uptake, 
a change in flow pattern (121) and an increase in flow in connective tissue and tendon 
vessels (122), suggests that 5-HT acts to redirect flow from nutritive capillaries to non-
nutritive vessels within the same muscles, which may include tendon vessels. Takemiya 
and Maeda (173) have reported that at rest blood flow in the tendon of tibialis anterior, 
gastrocnemius, and soleus exceeds that of the same muscles by a factor of approx. 2-fold. 
In addition, they showed that norepinephrine, or exercise, decreased tendon vessel flow 
and that exercise-mediated decrease in tendon vessel flow occurred in conjunction with 
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increased muscle flow. Together their findings also imply that blood flow can be 
switched from either of the two routes to match demand. 
The proportion by which vasoconstrictors were able to alter muscle metabolism during 
constant infusion (oxygen uptake was stimulated by 69.5% by NE and inhibited by 29.5% 
by 5-HT) was similar to the amount that they changed flow indicated by LDF signal at 
the NE-positive sites ( NE= +51%; 5-HT= —61%). It would therefore seem likely that 
redistribution of flow between the `nutritive(NE-positive) route and nearby connective 
tissue (such as the perimysium, epimysium or tendon), albeit the 'non-nutritive' (NE-
negative) route, could account for the observed changes in metabolism as argued 
previously (32;35). 
In this Chapter nutritive flow is defined in terms of increases in metabolism, specifically 
oxygen uptake. Other groups have shown that oxygen uptake by the perfused rat 
hindlimb is dependent on total flow (21). In the present study when flow was increased 
under basal conditions (no vasoconstrictor) from 4 to 8m1/min, oxygen uptake for the 
whole hindlimb increased from 45.6 ± 1.9 to 60.9 ± 1.5 (P<0.05). Thus the perfused rat 
hindlimb responds with increased oxygen uptake if nutritive flow is increased by either 
an increase in total flow or switching flow from the non-nutritive route. However, it is 
important to note that changes in oxygen uptake should not always be considered as a 
surrogate indicator of changes in nutritive flow. There may be circumstances, for 
example when metabolism is increased without change in capillary recruitment (nutritive 
flow). One such condition would be when uncoupling of respiration occurs. There is 
evidence that changes in oxygen uptake by the perfused rat hindlimb are not the result of 
direct metabolic effects of the vasoconstrictors acting on skeletal muscle. Thus, if the 
vasoconstriction is blocked by the simultaneous infusion of a vasodilator, both the 
increase in pressure and oxygen uptake are blocked (41). Similarly, 5-HT shows none of 
the effects seen in perfused hindlimb muscle when added to isolated incubated muscle 
(140), and the effects in perfusion are blocked by vasodilators (137). Overall, nutritive 
flow might be defined more generally with regards to microvascular flow that is spatially 
related to a metabolically active compartment in muscle and facilitates nutrient exchange. 
In the perfused hindlimb limitation of nutritive flow (for example by serotonin) shunts 
microvascular flow away from a metabolically active compartment resulting in decreased 
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oxygen exchange between muscle and perfusate. If oxygen availability becomes limiting 
in some regions this may secondarily affect fuel metabolism. In addition, blood flow 
coursing through a muscle bed itself may engender some work on the muscle by 
mechanisms not yet defined, which alters oxygen consumption. Clearly, oxygen 
consumption is one particular manifestation of microvascular recruitment that is 
prominently affected in the perfused hindlimb. 
Finally, LDF probe dimensions may be important in determining the nature of the signal 
received. The surface LDF probe used in this study had a detector surface area of approx. 
1 mm2 (two optical fibers of 800 p.m dia. each) and when placed on the surface detected 
signal from a volume of approx. 1mm 3 of tissue. When positioned on the center of the 
anterior end of the biceps femoris the signal appeared to be only of one kind, responding 
positively to NE and negatively to 5-HT. This contrasts with measurements using a much 
smaller probe (0.03 mm 2) inserted in the muscle, where LDF signals were heterogeneous 
with some responding as above (i.e. NE-positive), some responding in an opposite 
manner to the above (i.e. NE-negative), and some failing to respond (mixed). With the 
smaller probe it was also noted that the NE-positive sites outnumbered the other two by 
approx. 3:1. Thus it appears likely that the larger probe receives signal from a mixture of 
sites that convey a character that is predominantly NE-positive. Alternatively, NE-
negative sites may not be located near the surface of the muscle, although for various 
reasons alluded to above this is unlikely. 
In summary, micro LDF probes when positioned randomly in the body of a number of 
hindlimb muscles identify sites that differ in their response to vasoconstrictors. This 
heterogeneity is not visible to larger probes on the muscle surface. Over half of the sites 
show properties consistent with a nutritive role for muscle metabolism. Non-nutritive 
sites are present but at a lower proportion and nearly a quarter of the sites are likely to 
represent a mixture of both nutritive and non-nutritive. Non-nutritive sites show a higher 
basal signal. The anatomical nature of these nutritive and non-nutritive vessels are further 
explored in the next Chapter (Chapter 4), particularly in relation to the effects vessel 
geometry has on the LDF signal. 
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CHAPTER 4 
Defining Nutritive Blood Flow in Skeletal Muscle — A Model Study Using Fabricated 
Capillaries of Differing Architecture  
4.1 Introduction 
LDF (laser Doppler flowmetry) is purported to measure microvascular perfusion, a 
product of local speed and concentration of blood cells (99) but there are now a number 
of reports where a linear correlation between LDF signal and total (volume) flow has 
been shown to break down (29;93). In one such study (93), LDF signal was recorded 
from the biceps femoris muscle of anesthetised rats that had been injected with the i3 1 - 
adrenergic blocker, altenolol and clorisondamine chloride, an autonomic blocking agent 
that blocks nicotinic ganglionic transmission. Total muscle blood flow was assessed with 
radioactive microspheres. Infusion of angiotensin II or phenylephrine increased LDF 
signal without affecting total muscle blood flow. In a separate series of experiments, 
isoproterenol decreased LDF signal despite a large increase in total blood flow (93). 
Similarly, the findings in the previous chapter (Chapter 3) using micro intramuscular or 
larger surface LDF probes have shown that vasomodulators can markedly alter signal 
strength in the constant flow blood perfused rat hindlimb (29). Since these same 
vasomodulators also markedly alter hindlimb muscle metabolism an obvious question 
arises as to how these changes in LDF signal occur. One possibility among a number, is 
that the vasomodulators have acted to modify the pattern of flow. For example, sharing 
the flow between a greater number of capillaries, or redirecting flow from short relatively 
straight to more tortuous vessels, or even redirecting flow from smaller to larger vessels 
etc. In this regard, there is very little information in the literature on vessel architecture 
and its effects on LDF signal [e.g. (99;123;125-127). The few papers that have appeared 
have only addressed hematocrit and the correlation between cell velocity and LDF signal 
(106;107). In the present study we have examined the effect of tube architecture on LDF 
signal. 
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The findings suggest that LDF signal, when measured in tissue can be markedly affected 
by vessel architecture and thus explain situations where a divergence between total flow 
and LDF signal occur following vasoconstrictor action in muscle. 
4.2 Methods 
4.2.1 LDF Measurements 
LDF was conducted using a Perimed PeriFlux PF2 unit operating at 632 nm. The probe 
(Pf 108) consisted of a bundle (2 mm dia.) of three optic fibers, one illuminating the 
tissue and two collecting reflected light, each 0.8mm in diameter. The distance from the 
center of the afferent fiber to the centers of the efferent probes was 0.8 mm and the total 
area of the detecting fibers was 1mm2 . Unless indicated otherwise, the signal was 
collected at 41(1-1z, gain setting 3 with a time constant of 3.0s. Flow was calibrated using 
a suspension of red blood cells (3% hematocrit) in gassed perfusion buffer. The cells 
were pumped at various rates through a single polymer tube 1001.1m diameter and lOmm 
in length. This served to establish that the LDF signal was linearly proportional to flow 
rate. Biological zero (0.30 ± 0.02 volts) was determined at pump setting of zero and was 
subtracted from all values. 
Preliminary data were collected to determine the hematocrit at which the LDF probe 
failed to see all of the cells. This was judged to have occurred when the LDF signal for a 
given tube "peaked" as a function of hematocrit. Figure 1 shows that a hematocrit of 3% 
was suitable for single tube studies of 250 mm and smaller. Preliminary data was also 
necessary to ascertain the cell velocity at which the LDF probe no longer showed a linear 
relationship between flow and signal. This was found to be approx. 8mm/s (data not 
shown) and similar to values noted by others (106). Cell speed, or cell velocity if the 
direction was known, was calculated from flow rate, cell density (hematocrit) and internal 
dimensions of the tube. 
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4.2.2 Red blood cells 
Red blood cells (rat or bovine) were collected and washed six times in BSA-containing 
and gassed perfusion medium. The perfusion medium was gassed with 95%02-5%CO2 
and contained 118mM NaCI, 4.7mM KCI, 1.2mM KH2PO4, 1.2mM MgSO 4 , 25mM 
NaHCO 3 , 8.3mM glucose, 2.5mM CaCl2 and 7.1% (w/v) bovine serum albumin 
(Boehringer Mannheim, fraction V). The cells were counted using a hemocytometer and 
the hematocrit adjusted using the same buffer. Cell suspensions were kept in tightly 
capped vials and used freshly on the day of preparation. The hematocrit was set at 3% for 
larger tube studies; higher hematocrits in tubes of 250 p.m obstructed the LDF signal (see 
Fig. 4.1). 
4.2.3 Artificial capillary systems 
Polymer tubes of 100 and 250vim internal diameter (MicroFilTm) were purchased from 
World Precision Instruments. These were supplied with Luer syringe fittings. The 50tim 
tube was from Applied Biosystems as routinely used for capillary electrophoresis and 
was uncoated fused silica. 
Single tube studies used a short length (10mm) of each tube fitted into polyethylene 
tubing, which in turn was fitted onto the needle of a Hamilton 10111 syringe (0.49mm ID). 
A syringe pump (Harvard Apparatus) was used to deliver constant-flow. The polymer 
tube was positioned in a V-shaped holder so that its relationship to the LDF probe was 
always the same. In addition, the probe was secured to a micromanipulator so that fine 
adjustments in two dimensions (vertical and horizontal) could be made. Polymer tube-
polyethylene tubing fittings could be interchanged without disturbance of the probe or its 
relationship to the tube. Measurements were made at five different flow rates (typically 
80, 40, 20, 10 and 5til/h) and were completed within 4 min before significant settling of 
red cells had taken place. As a check, periodic samples of blood emerging from the tube 
were counted using a hemocytometer to ensure that the hematocrit was consistent. 
A single tube that doubled back twice so that three segments of the same tube could be 
viewed by the LDF probe simultaneously, was used to compare LDF signal strength with 
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the same size tube that crossed the field of measurement only once. The flat array of three 
tubes side-by-side was constructed to fit into the V-shaped holder described above. 
Multiple tube measurements were made using a manifold of five 1001.tm tubes (40mm in 
length) glued (AralditeTM) into a single 23G syringe needle. The luer syringe fitting on 
the end of each tube was fitted with buffer-filled tubing (80mm in length) terminating 
with a three-way tap. Thus, with red blood cells being pumped into the 23G needle at a 
constant rate, flow could be directed to all five, or to any number less than five tubes by 
closing the appropriate taps. The tubes emerging from the 23G needle were secured flat 
under the LDF probe so that all five were completely visible (total width of field for the 
five = 0.82 mm;), when the probe was 1-1.5mm above the tubes. The tubing and taps 
were also firmly secured so that manipulation of the taps did not interfere with the LDF 
signal. Red blood cells were pumped from a lml syringe (4.76mm ID) at either 120, 80 
or 400h. LDF signals were recorded at 4k1-1z with gain settings of 3 (single tube) and 10 
(multiple tubes) with a time constant of 3s. The hematocrit used was 9%. This allowed a 
sufficiently strong signal without exceeding the limit of detection of all cells which was 
approx. 12% hematocrit for a tube of 100ptm ID (Fig. 1). 
4.2.4 Statistics 
As appropriate, data were analyzed by linear regression. Other assessments were made 
using unpaired Students' t-test. 
4.3 Results 
For each of the three tubes 50, 100 and 250 jim diameter, LDF signal was measured at a 
minimum of four different flow rates ranging from 10 to 1201.11/h and at various 
hematocrits ranging from 0.9 to 45%. Primary plots of LDF signal as a function of 
hematocrit at each flow rate were constructed to determine the hematocrit at which the 
signal became limiting. The resultant secondary plot (Fig. 4.1) shows the limiting 
hematocrit as a function of tube diameter. Thus for the 2501.tm tube, changes in flow rate 
for buffers containing hematocrits greater than 3% could not be quantitatively detected. 
Similarly, the value for the 1001.tm tube was 12% hematocrit. For the 501.tm tube the 
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upper limit could not be accurately determined. This suggested that at this size of vessel 
or smaller, any change in flow, providing it did not exceed a cell velocity of 8mm/s, 
would give rise to a corresponding proportional change in LDF signal, for any dilution of 
whole blood or hematocrit less than 45%. Flow appeared to be laminar in the larger tubes 
when pumped with buffer of low hematocrit. At higher hematocrit only the surface layer 
of cells could be visualized. 
Figure 4.2 shows the effect of tube size on LDF signal at various flow rates with a fixed 
hematocrit of 3%. The signal strength was found to increase as the diameter decreased 
from 250, through 100 to 5011m, increasing by approximately 50% for a decrease from 
250 to 50urn in tube diameter. At the maximum flow rate used (80 Oh) the cell speed 
was 0.45, 2.82 and 11.33 mm/s for tubes of 250, 100 and 50um, respectively. In addition, 
but not shown, there was an increase in LDF signal strength when similar flow variations 
were made using a hematocrit of 6% for the 100 and 501.tm tubes. 
If a single tube was doubled back on itself twice to cross the field of measurement three 
times (Fig. 4.3, left panel) and the signal recorded it was found to be approx. 3-fold 
greater than that for the same tube crossing the field of measurement once (Fig. 4.3, right 
panel). 
To determine the effect of flow redistribution from one to more than one tube, thereby 
simulating a situation of capillary recruitment, a tube manifold of five identical 100pirn 
tubes was constructed. Taps were fitted to extended tubing from each capillary so that 
flow in each could be either permitted or blocked. Total flow was kept constant and 
delivered into the manifold from a 23G hypodermic needle. The five emerging tubes 
were tightly grouped side by side so that the LDF probe detected change in cell flux in all 
of the tubes simultaneously (Fig. 4.4, left hand panel). Figure 4.4 shows the effect on 
LDF signal as flow was progressively allowed to enter each of the five tubes. When flow 
was distributed into all five tubes the signal strength was approx. 30% of that when flow 
was carried by only one. The change in LDF signal was reversible and identical results 
were obtained when flow was progressively restricted from five to one tube. Moreover, 
changing the order in which the taps were opened or closed, did not affect the results, 
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confirming that all five tubes were equally visible to the detector. The data shown in Fig. 
4.4 are from experiments involving a single constant flow rate of 1201.11/h which is 
equivalent to a cell velocity of 4.24mm/s when all of the flow is within one of the 1001.im 
tubes. Similar changes were noted when the lower flow rates of 80 and 40 Ill/h were used 
but a delay developed before the effect of closing or opening the taps became apparent. 
Higher flow rates approached the limiting velocity for the LDF detector. The study was 
conducted at only one hematocrit of 9%. This was a compromise, allowing a sufficiently 
strong signal and low background without exceeding the limit of detection for 1001.1m 
tubes of 12% hematocrit. 
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Figure 4.1 Limiting haematocrit as a function capillary tube diameter. For each tube, 
LDF signal was measured for a range of flow rates at various haematocrits ranging from 
0.9 to 45%. Primary plots of LDF signal as a function of haematocrit at each flow rate 
were constructed to determine the haematocrit at which the signal became limiting. The 
resultant secondary plot is shown. Values are means ± SE, with n-values shown in 
parentheses. 
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Figure 4.2 Effect of tube diameter on the relationship between LDF signal and flow 
rate. Tube sizes were 50 (*), 100 (NI) and 250 pm (A). The LDF probe was positioned 
centrally over each tube as shown (Left panel). Pump flow rate was varied as indicated 
with haematocrit set at 3%. Values are means ± SE for n = 5. In all cases the error bars 
are obscured by the symbol. 
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Figure 4.3 Effect of the tube crossing the field of measurement multiple times on 
LDF signal. Two 100 pm tubes were compared (Left panel) so that one crossed the field 
of measurement three times (*) and the other once ( • ). Flow rate in each was varied as 
indicated and the haematocrit was 3%. Values are means ± SE for n = 5. Error bars are 
occasionally obscured by the symbol. 
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Figure 4.4 Effect of flow sharing on LDF signal. A manifold of five identical 100 p.m 
tubes was positioned under the probe as shown (Left panel). The haematocrit was 9% and 
the flow rate constant at 0.12 ml/h. Flow could be controlled to enter only one or any 
number of the five tubes. Values are means ± SE for n = 6. 
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4.4 Discussion 
There is a paucity of information on what LDF probes actually detect when 
positioned in or on tissues. It is generally thought that movement of the blood cells causes 
a frequency shift with some of the photons also back-scattered or absorbed by the tissue. 
The back-scattered and Doppler broadened light carry information about the movement 
and concentration of the cells. The quantity that is measured in LDF studies is often 
referred to as "tissue perfusion". Leahy et al. (99) point out that although this quantity has 
been used extensively, a thorough definition is still lacking. These workers (99) propose 
that "tissue perfusion" is the product of local speed and concentration of moving blood 
cells. What is not known is whether the product derives from equal quantitative input 
from each or whether one or other has a dominant effect. In a practical sense, and without 
information of this kind, it means that if total (volume) flow remains constant then 
changes in vessel diameter, distribution of flow from few to many vessels, or distributing 
flow from short to tortuous vessels, should not affect the signal from a LDF probe. In 
other words, the relationship between LDF signal and total flow should always hold. 
With recent reports appearing that show a divergence between total flow and LDF 
measurements in muscle (93) and Chapter 3, it becomes necessary to explain how this 
might be so. Our approach has thus been to construct models of different vessel 
architecture from commercially available polymer tubes of a size that even with complex 
formations would fit comfortably within the field of measurement of a standard LDF 
probe. We wished to specifically address three key questions. Firstly, if total flow 
remains constant and flow is switched from large to smaller vessels, or vice versa, does 
the LDF signal change? This question is posed because recent studies (93) and those of 
Chapter 3 have employed vasoconstrictors that may act at a number of terminal arterioles 
in the field of measurement to cause an overall reduction in average vessel diameter. 
Secondly, if total flow remains constant and flow is switched from a single pass (crossing 
the field of measurement only once) to a multiple pass vessel (crossing the field multiple 
times), does the LDF signal change. There is evidence in the literature that several 
tissues, including muscle have short thoroughfare vessels as well as long tortuous 
nutritive vessels and that flow may be switched from one to the other by the action of 
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vasoconstrictors (32). Thirdly, there has been much recent interest in the possibility that 
the action of hormones, including insulin, may involve capillary recruitment in muscle 
(138). If this is so and total flow remains constant, can the LDF signal be expected to 
change? 
In all three of the above situations, we found that LDF signal was markedly affected 
by the architecture of the vessel in which red blood cells were moving. For the first 
experimental situation, the LDF signal increased as the vessel diameter decreased. Thus, 
when flow was switched from the 2501Am to the 501Am tube the LDF signal increased by 
approx. 50%. Since the number of cells moving through the tubes had not changed, the 
change in LDF signal appears to be attributable to the change in cell velocity. However, 
the relationship between LDF signal and cell velocity is clearly not linear and the signal 
did not increase proportionately. The increase in LDF signal was only 50% even though 
there was a corresponding theoretical 5-fold increase in cell velocity from 0.45 to 2.82 
mm/s. The failure to find a direct relationship may result from non-linear motion of the 
red blood cells at the slower cell velocity in the larger size tube. LDF detectors see cells 
moving in all directions and are thus non-vectorial in their measurement of motion. This 
line of reasoning is further developed when the data from the second question are 
considered (Figure 4.3). In these experiments, LDF signal was measured from a single 
tube crossing the field of measurement only once left to right with one that doubled back 
on itself twice and crossed the field a total of three times. For both tubes flow was equal 
and for the latter flow was left to right, right to left and finally left to right again. Since 
the LDF signal was approx. 3-fold greater for the multiple pass tube compared to the 
single pass tube the non-vectorial nature of the LDF signal is emphasised. 
In the third series of experiments the notion of capillary recruitment under 
conditions of constant total flow was explored. A manifold comprising one tube feeding 
to a maximum of five tubes was used (Figure 4.4). Signal strength was found to be 
greatest when flow was carried by one tube and least when shared between all five. 
Overall, the data underscore the predominant role of cell speed (non-vectorial), 
rather than velocity or cell number in determining LDF signal. If these models can be 
used as representative of the microvasculature of tissues in vivo, then the findings may 
help explain recent reports particularly in skeletal muscle where changes in total 
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(volume) flow failed to correlate with LDF signal, both in vivo (93) and in perfused rat 
hindlimb (Chapter 3). In the hindlimb perfusion experiments which were conducted at 
constant-flow, norepinephrine (NE) increased the LDF signal at the majority of sites and 
increased metabolism generally. A decrease in vessel diameter due to NE-mediated 
vasoconstriction of the vessels under the probe could account for the increase the'LDF 
signal. However, while this might explain the effects of NE to increase the LDF signal, it 
could not account for the effects of serotonin (5-HT), which in the hindlimb also caused 
vasoconstriction, but at the same sites as where NE was stimulatory, caused a decrease in 
LDF signal and a decrease in metabolism. 
From the tube manifold studies (Figure 4.4) it would seem likely that any 
vasoconstrictor that acts to decrease capillary flow by de-recruiting the number of 
capillaries perfused without affecting total flow would increase the LDF signal. Thus 5- 
HT which decreases oxygen uptake and presumably muscle capillary flow might be 
expected to increase, not decrease, the LDF signal. 
One explanation from this Chapter that might account for the effects of NE and 5- 
HT to increase and decrease the LDF signal, respectively, is that blood flow is redirected 
to (NE) or from (5-HT) tortuous multiple pass capillaries much as depicted by the model 
for Figure 4.3. This would mean that the two networks comprise on the one hand, the 
long tortuous capillaries that could be considered as nutritive and on the other, relatively 
short single pass capillaries (possibly "non-nutritive"). Switching the blood flow from 
one to the other by site-specific vasoconstrictors might then account for the changes in 
metabolism that have been reported. Type A vasoconstrictors such as NE are known to 
constrict at the region of terminal arterioles. The rise in pressure may be sufficient to 
overcome the intrinsic resistance of the longer capillaries allowing flow. This would 
account for the previously observed increase in red cell washout and newly recruited 
vascular space detected by FITC dextran that accompanied NE-mediated vasoconstriction 
(121). In contrast, Type B vasoconstritors such as 5-HT, are thought to vasoconstrict 
higher in the vascular tree and dilate the arterioles [see (32) and refs therein] lowering the 
pressure in the vicinity of the capillary networks. Under these conditions flow in the 
lower resistance short "non-nutritive" capillaries would be favored. Whereas the short 
"non-nutritive" capillaries are near to the muscle fibres it is also possible that some are 
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contained within the connective tissue that surrounds the bundles of muscle fibers (the 
epimysium). As such, these would be sufficiently insulated from muscle cells to be 
functionally non-nutritive and may be masked to some degree in terms of LDF signal. In 
addition, from our previous studies it is clear that some of the non-nutritive connective 
tissue vessels are located in tendons (8;67;122) therefore outside the present region of 
LDF measurement which is situated over the center of the muscle. 
Finally, this Chapter highlights yet another aspect that must not be ignored when 
considering data from in vivo studies. This concerns the effect of haematocrit to attenuate 
the LDF signal (e.g. Figure 4.1). Limiting LDF probe signals Were identified at 3 and 
12% haematocrit for 250 and 100 jim diameter tubes, respectively. Only for the 50 lam 
tubes was the signal not limited at higher haematocrits. It follows then, that shifts in the 
relative distribution between larger versus smaller microvessels with characteristically 
different haematcrits, could affect the observed LDF signal. Similarly, local changes in 
microvessel haematocrit could also alter the signal characteristics. 
In summary, studies presented in this Chapter have indicated the importance of tube 
architecture in relation to LDF signal strength. Non-vectorial cell speed appears to be a 
dominant determinant. Any change in vessel architecture that occurs at the site of LDF 
measurement in vivo or in perfused systems must be taken into account when interpreting 
the data. 
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CHAPTER 5 
Changes in Nutritive Blood Flow Patterns Induced by Insulin In Rat Muscle In  
Vivo: A Study Using LDF  
5.1 Introduction 
Recently, there has been considerable interest in reports that insulin has a 
hemodynamic vasodilatory effect as part of its action to increase glucose uptake by 
muscle and that this vascular effect of insulin is impaired in obesity and type 2 diabetes. 
The reports have generated some controversy where there have been claims and counter 
claims that glucose and insulin delivery or skeletal muscle perfusion (blood flow) plays 
an independent role in determining overall rates of insulin stimulated glucose disposal 
(13;197). All contributors to this controversy have placed considerable emphasis on the 
putative vasodilatory action of insulin to increase total blood flow. Studies in our 
laboratory have shown the importance of blood flow distribution in muscle in terms of 
controlling both metabolism and contractile performance (32). Chapter 3 of this thesis 
shows how perfusion redistribution associated with significant metabolic changes can 
occur within muscle even when total limb blood flow is kept constant. Access of 
nutrients and hormones is a key issue and there exists evidence that blood flow to muscle 
can be substantial without full access occurring (possibly because a proportion of the 
flow is carried by a non-nutritive route) (32;36). Thus in this Chapter the relationship 
between changes in nutritive flow and LDF signal obtained in the constant flow pump-
perfused rat hindlimb were then applied to measure changes in LDF signal during the 
hyperinsulinaemic euglycaemic clamp in vivo. Studies were also carried out during 
epinephrine infusion, as it is known to increase total blood flow to the leg without 
increasing nutritive (capillary) flow (138). 
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5.2 Methods 
5.2.1 Perfusion studies 
Perfused rat hindlimb studies were conducted as described in detail in Chapter 2, Section 
2.1. Total flow rate was maintained at 0.27 ml.min 1 .g-1 using medium containing red 
blood cells at 37 °C (199). A bolus of norepinephrine was injected to reach approx. 50 nM 
at the peak which from earlier studies was known to achieve a marked increase in 
nutritive flow (32). Similarly, a bolus of serotonin was injected to reach I 1.1,M at the peak 
and again, was previously known to cause a marked decrease in nutritive flow. Oxygen 
uptake, a surrogate indicator of nutritive flow in this system when manipulated by 
vasoconstrictors (32) was determined from the maximum arteriovenous difference and 
perfusate flow rate (set constant as above) using an in-line oxygen analyser (A-Vox 
Analyser, A-Vox Systems, Inc, San Antonio, Texas). A small hole (approx. 4 mm dia.) 
was made in the skin in the middle of the biceps femoris (see Figure 5.1). The hindlimb 
was then clamped by the foot so that the laser Doppler flow probe (Perimed PF 2, 
operating wavelength of 632 nm) could be positioned over the centre of the hole, and 
kept in the same position for the duration of each experiment. For the measurement of 
red cell flux, the probe was placed vertically above and approx. 1 mm from the surface of 
the muscle. Settings on the detector unit were 4 kHz (gain setting 10) with a time constant 
of 3 s, unless otherwise indicated. The signal (0-5 volts) was continuously recorded on 
an IBM compatible PC using a DI-190 I10 module and WINDAQ ® software. The data 
are expressed as volts x 10. 
5.2.2 Insulin clamps 
For in vivo studies, the tiyperinsulinaemic euglycaemic clamp was used as described in 
detail in Chapter 2 and elsewhere (138). In brief, limb blood flow of anaesthetised rats 
was determined by an ultrasonic flow probe (Transonic®)  fitted around the femoral 
artery. Blood pressure was monitored by a pressure transducer fitted to a carotid cannula. 
Insulin (10mU.min -l .kg -1 ), epinephrine 0.125 lig.min -1 .kg-1 ) or saline, as well as glucose 
69 
Chapter 5 — Changes in nutritive flow induced by insulin in rat measured by LDF 
(to maintain blood glucose at 5mM) were infused via a jugular cannula. Insulin was 
infused at a rate of 10mU.min -l .kg-1 to raise plasma insulin to the high physiologic 
concentration. Because the clearance of insulin by the rat is 3-4 fold more rapid than in 
the human, this infusion raises insulin to levels seen with a .2-3 mU/min/kg clamp in 
humans and the resulting concentrations mimic those seen in insulin resistant rats 
models.The protocol was similar to that described previously by Rattigan et al. (138) with 
60 min equilibration period before insulin or saline infusion, each of which was 
continued for an additional 80 min. The leg was carefully skinned and wrapped in clear 
plastic wrap (Saran WrapTM)  to prevent drying. 
5.2.3 LDF Measurements 
5.2.3.1 Scanning LDF 
Hindlimb muscle LDF signal was determined using a scanning LDF (Lisca Li PIM 1.0, 
Laser Doppler Perfusion Imager) at baseline before saline, insulin or epinephrine and at 
one hour after the commencement of infusion of saline or insulin and 15 min after 
epinephrine. Positioning of the scanner was made using the knee as a reference (Figure 
5.1); this ensured that the area and orientation were identical between animals. Triplicate 
scans of the hindlimb were made each taking 5min to complete and timed to occur 5 min 
before, on and 5 min after the times designated above. Each scan was brought on screen 
and analysed using the manufacturer's operational software to give average perfusion 
units (volts) of the area analysed. To assess muscle perfusion a square of 225 mm 2 in the 
top left hand corner of each scan and covering mostly muscle (biceps femoris) was 
analysed (Figure 5.1). Means from triplicate analyses before and after addition of saline 
(control), insulin, or adrenaline were used for comparison. The scanning probe covered a 
total area of approx. 900mm2 of skinned thigh muscles. 
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Figure 5.1 Representative scans of LDF before (A) and after (B) insulin in the same 
animal. The area analyzed by the scanning LDF is demonstrated by the red square in (C). 
The smaller red/blue square in the top left hand corner is predominantly muscle (biceps 
femoris). The position of the stationary probe is shown as a red dot, in (C). Colour coding 
to indicate relative perfusion in volts is shown in figure. Each coloured square or pixel 
represented approx. 0.2 mm 2 . 
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5.2.3.2 Fixed probe LDF 
In a separate series of experiments, using an identical protocol again with 60 min 
equilibration and a total period of 80 min for insulin or saline infusion, a stationary LDF 
probe (Perimed Periflux PF 4001with Probe 407) was used and signals were recorded 
continuously throughout the experiment. The stationary probe was positioned over a 
4rnm 2  area of skinned biceps femoris muscle in an identical position to that used in 
perfused hindlimb studies above (Section 5.2.1). 
Biological zero for both scanning and stationary probes used in the clamps was 
determined at the end of the experiment after the animal had been administered a lethal 
dose of anaesthetic and femoral blood flow and heart rate were zero. For the scanning 
probe this involved conducting a complete scan of the entire area exposed (e.g. Figure 
5.1). Values for biological zero were 0.22 ± 0.02 volts (total area), 0.23 ± 0.02 volts 
(biceps femoris muscle) and 0.21 ± 0.02 volts (connective tissue)(n = 5). For the surface 
probe changes in LDF signal as a result of insulin were expressed relative to the basal 
signal of 1.00. Absolute values for the basal signal and biological zero were 112 ± 20 and 
16 ± 3 perfusion units, respectively for 14 determinations. No value shown has been 
corrected for biological zero, unless indicated otherwise. 
5.2.4 Oxygen uptake studies 
In a further series of experiments a group of rats underwent identical clamp conditions for 
the purpose of assessing insulin induced changes in leg oxygen uptake and muscle-
specific uptake of 2-deoxyglucose. For oxygen uptake, blood samples were taken from 
the carotid artery (1000 and femoral vein after equilibration (approximately I h) and 2h 
after commencement of insulin infusion. Samples of femoral vein blood (100 1.11) were 
collected using a 29G insulin syringe. Total oxygen content of each blood sample was 
determined using a galvanic cell oxygen analyser (TasCon oxygen content analyser 
manufactured by the Physiology Department, University of Tasmania) that was 
standardised against air and corrected to standard temperature and pressure. The rates of 
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oxygen uptake were calculated from oxygen extraction and femoral blood flow at each 
time point and expressed per gram wet weight of perfused muscle, as estimated 
previously (54). For muscle-specific uptake of 2-deoxyglucose, the method of Kraegen et 
al (91) was used. In brief, this involved intra-arterial injection of a bolus of 501.1Ci 2- 
deoxy-D42,6- 3 1-1]glucose (specific activity 44Ci.mmo1 -1 , Amersham Life Science) at 45 
min before the end of the clamp. Following injection of the bolus, arterial plasma samples 
(50 pi) were collected at 5, 10, 15,30 and 45 min. Soleus, plantaris, gastrocnemius red, 
gastrocnemius white, extensor digitorum longus, and tibialis muscles were removed at the 
end of the clamp for analysis of [31-]2-deoxyglucose 6-phosphate content and calculation 
of 2-deoxyglucose uptake (91). 
5.2.5 Statistics 
Repeated measures two-way analysis of variance was used to determine differences and 
when significant differences were found paired Student's 1-test was used to test the 
hypothesis that there was no difference before and after treatment. For the time courses, 
one-way repeated measures analysis of variance (ANOVA) was performed and when 
significant difference was found, multiple comparisons (Dunnet's method) were made vs. 
the time point just before insulin (0 min). Significant differences were recognized at P < 
0.05. 
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5.3 Results 
5.3.1 LDF signal and nutritive flow in the constant flow pump-perfused rat hindlimb 
Figure 5.2 shows a positive correlation (r = 0.93 and P < 0.0001) for change in LDF 
signal as a function of change in nutritive flow as perturbed by either norepinephrine or 
serotonin. 
5.3.2 Glucose and oxygen metabolism during the insulin clamps 
In keeping with similar experiments conducted previously (138;139) arterial glucose 
concentrations were not significantly different between saline and insulin animals either 
before commencement of infusions or at the end of the experiment (data not shown). 
Insulin increased glucose infusion rate from zero to a maximum of 128 ± 11 lirnol.min -
l .kg-I at the end of the clamp (80 min). The time course which is shown in Figure 5.3 was 
similar to previously (138), so that following lh of insulin, glucose infusion had already 
reached the maximum. 
Muscle-specific uptake of 2-deoxyglucose is shown in Table 5.1. Insulin increased uptake 
in each of the six muscles with an overall average of 2.7-fold. Oxygen uptake was 
unaffected by insulin. 
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Figure 5.2 Change in LDF signal as a function of change in nutritive flow in the 
isolated pump-perfused rat hindlimb. Single hindlimbs were perfused at constant total 
flow and bolus amounts of vasoconstrictors injected. Oxygen uptake (irno1.h -1 .g-1 ) was 
used as a surrogate indicator of nutritive flow. Values are from individual perfusions 
were injections were either saline (M),norepinephrine (V), or seroton in (•). 
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Figure 5.3 Glucose infusion rates (GIR) required to maintain basal blood glucose at 
4.5 ± 0.2 mM during insulin infusion. Values are means ± SE for 11 animals. The initial 
(pre-insulin infusion), and steady-state plasma insulin concentrations attained were 390 ± 
165 and 1,580 1 110 pM, respectively (138). 
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Table 5.1 Effects of insulin on leg oxygen uptake and 2-deoxyglucose uptake by 
individual muscles in vivo 
Glucose infusion rate (imol.min -1 .kg-1 ) 
Saline Insulin 
100.7 ± 3.2 
Femoral blood flow (ml.min -1 ) 0.85 ± 0.05 1.2 ± 0.1 4 
Leg oxygen uptake Ounol.h -l .g-i ) 
Initial (pre-saline or -insulin) 27.5 ± 3.9 24.2 ± 2.2 
Final (post-saline or -insulin) 27.8 ± 3.1 22.9 ± 2.3 
2-Deoxyglucose uptake (..tmol.h -l .g-1 ) 
Soleus 2.9 ± 0.2 9.6 ± 1.5* 
Plantaris 2.4 ± 0.1 5.0 ± 0.5* 
Gastrocnemius red 3.1 ± 0.2 11.4 ± 1.2* 
Gastrocnem ius white 2.0 ± 0.1 4.2 ± 0.5* 
Extensor digitorum longus 3.4 ± 0.2 8.9 ± 1.0* 
Tibialis 3.2 ± 0.3 8.7 ± 0.9* 
All measurements were made at the completion of the clamp when steady-state had been 
achieved. Significance of difference: *P < 0.001, 111) < 0.01 compared with saline (n= 8- 
10). 
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5.3.3 LDF signal by scanning probe 
Figure 5.4 shows that insulin had not increased femoral blood flow at lh. (cf ref. (138)). 
However, at this same time point insulin had markedly increased the scanning LDF signal 
over the biceps femoris [top left hand square within the field of measurement (Figure 
5.1)] by 62±8% (P<0.05; n=5) (Figure 5.4). Saline infusion controls showed no increase 
in either femoral blood flow or scanning LDF signal over the biceps femoris at lh 
(P>0.05; n=4) (Figure 5.4). 
Epinephrine is a faster acting agent than insulin and as noted previously (138) increases 
femoral blood flow. In the present studies epinephrine 0.125 (tig.min -1 .kg-1 ) increased 
femoral blood flow by 49±8% (P<0.05; n=3) at 15 min. Despite this effect, scanning 
LDF signal was unchanged (4±8%; P>0.05) (Figure 5.4). The rise in LDF signal was 
greater with insulin than either epinephrine or saline (P<0.05; ANOVA). 
Figure 5.1 shows representative scans for a saline control (Figure 5.1A) and an insulin 
clamp (Figure 5.1B) at lh as well as an illustration to show the area scanned (Figure 
5.1C, large square) and the area corresponding to muscle (Figure 5.1C, smaller square). 
Settings on the scanner were high resolution, threshold voltage 5.30 and 64 x 64 pixels. 
Since the average area scanned was 900 mm 2 each pixel represented approx. 0.2 mm 2 . 
Analysis of the total scanned area and of the connective tissue region around the knee 
failed to reveal an effect of insulin on those scans where a significant increase in muscle 
signal due to insulin had occurred. Thus values before (Figure 5.1A) and after insulin 
(Figure 5.1B) were 1.13 ± 0.25 and 1.26 ± 0.22 volts (P>0.05; total area) and 2.51 ± 0.35 
and 2.69 ± 0.37 volts (P>0.05; connective tissue). 
5.3.4 LDF signal by stationary probe 
The stationary probe was positioned over the center of the anterior end of the biceps 
femoris as in perfused hindlimb studies above and shown in Figure 5.1C (depicted by the 
red dot). The signal was continuously recorded, and mean values are shown in Figure 5.5 
U
M
VE
-FI
Sl
lTY
 O
F
 T 
78 
Chapter 5 — Changes in nutritive flow induced by insulin in rat measured by LDF 
for 0-80 minute period following commencement of insulin infusion. For the stationary 
LDF probe experiments, insulin at lh increased femoral blood flow (47%, n=6; P < 0.05) 
and .LDF signal 47±12% (P<0.05) relative to saline controls (n=5) which did not affect 
FBF. Epinephrine also increased femoral blood flow (39%) but LDF signal did not 
change significantly (-0.3%; P = ns; n =5), data not shown. Figure 5.5 shows the time 
courses for insulin-mediated changes in femoral blood flow (upper panel) and LDF signal 
(lower panel). The change in LDF signal was significant at 20 min and preceded the 
increase in femoral blood flow which occurred at 60 min. 
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Figure 5.4 Scanning laser Doppler measurement of lateral surface of thigh muscles 
(muscle perfusion) and total femoral arterial blood flow (FBF) of anaesthetised rats 
before treatment (open bars) and following treatment (filled bars) with 
insulin/glucose (Ins, n = 5), epinephrine (Epi, n = 3) or saline infusions (Sal, n = 4). 
Values are means ± SE and were taken at 60 and 15 min after commencement of insulin 
or epinephrine infusion, respectively. * Significantly (P < 0.05) different from pre-
treatment values. 
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Figure 5.5 Time course for changes in FBF ( mlinin -1 , upper panel) and for 
stationary probe LDF signal in perfusion units (PU, lower panel) during 
hyperinsulinaemic euglycaemic clamp. Values are means ± SE for 6 animals.* 
Significantly (p < 0.05) different from zero time. 
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5.4 Discussion 
The data show that a constant infusion of insulin under euglycaemic conditions has 
increased the muscle surface LDF signal. This would appear to reflect an increase in 
nutritive flow in muscle consistent with our previously reported increase in capillary 
recruitment determined by increased metabolism of the marker substrate 1-MX seen at 
the same high physiologic dose of insulin (138). The current data show that insulin 
induces capillary recruitment and enhances glucose uptake, a finding consistent with a 
metabolic role for capillary perfusion through vessels that facilitate nutrient exchange. 
The finding that insulin leads to a an increase in muscle capillary flow as measured by 
LDF and that this occurs over a time course similar to that observed for whole body 
glucose uptake, is reminiscent of the strong correlation observed between LDF signal 
from similarly placed probes and oxygen uptake as altered by the two different 
vasoconstrictors, 5-HT (Type B) and NE (Type A) in the constant-flow pump-perfused 
rat hindlimb (Fig. 5.2). Oxygen uptake has proved to be a reliable indicator of nutritive 
flow in perfused hindlimb muscle. However, from several studies where flow has been 
manipulated by vasoconstrictors, increases in oxygen uptake have always been associated 
with pressure increase (e. g. see reviews (32;34) and thus the increased pressure may be 
critical as a positive influence for increased oxygen uptake. In the present series of 
experiments, and as noted previously (138)), there was very little change in blood 
pressure (data not shown) and no increase in oxygen uptake during the insulin clamp 
even though nutritive flow has increased. This finding is consistent with a number of 
human studies (52), where oxygen uptake by limb tissue (muscle) was also found not to 
increase. Thus insulin's action to increase muscle capillary flow as detected by the LDF 
probe in the present study can occur in the absence of an increase in oxygen uptake 
because there is no increase in pressure. This may be partly due to insulin's proposed 
NO-dependent vasodilatory action (152), which is discussed in detail later in this thesis. 
From the model studies (Chapter 4), it would also seem very likely that the increase in 
LDF signal due to insulin is attributable to the receiving nutritive capillaries being 
considerably more tortuous, crossing the LDF field of measurement a number of times. 
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The non-nutritive route that is constricted presumably comprises shorter more direct 
vessels that reflect a lower LDF signal even when carrying flow. 
The increase in capillary flow induced by insulin precedes by at least 30 min changes in 
total leg flow as detected by the flow probe positioned around the femoral artery. 
Furthermore, epinephrine which increased total flow had no effect on the LDF signal. An 
increase in nutritive flow due to insulin without an increase in total flow implies that flow 
has been redistributed from another route that may not visible to the LDF probe. This 
may be because of the position or size of the probe. Comparison with the perfused rat 
hindlimb is helpful in considering these issues. Although almost fully dilated, the isolated 
perfused hindlimb preparation responds to vasoconstrictors by either increasing or 
decreasing metabolism, under conditions of constant total flow. Vasoconstrictors that 
increase metabolism in the constant flow preparation do so by redirecting flow from a 
"non-nutritive" route located in the closely associated connective tissue of the 
perimysium and related sheaths. Some of the vessels are visible and relatively free from a 
background of muscle nutritive capillaries (67) and one study has shown that the 
vasoconstrictor, NE, that increased overall hindlimb metabolism redirected flow from 
these vessels to the muscle nutritive route (122). Accordingly, it would seem likely from 
the present study that insulin has acted similarly to redirect flow from the "non-nutritive" 
route to the nutritive route. As already discussed above, insulin does not affect blood 
pressure within this time frame (138), thus recruitment of nutritive flow at the expense of 
"non-nutritive" flow would appear to involve a combination of vasodilatory and 
vasoconstrictor activity. There are reports of both vasodilation and vasoconstriction 
activities of insulin. For example, Renaudin et al. (143) reported that insulin administered 
in vivo to anaesthetised rats caused a marked and durable vasodilation of the terminal 
arterioles of the spinotrapezius muscle. However, when similar plasma insulin levels 
(approx. 800 pM) were attained by glucose infusion, partial vasoconstriction of the 
terminal arterioles occurred (143). 
There is some evidence that the surface LDF signal response is heterogeneous for 
the hindlimb as a whole. Some sites away from the center of the biceps femoris in 
83 
Chapter 5 — Changes in nutritive flow induced by insulin in rat measured by LDF 
perfused rat hindlimb studies were found to respond oppositely to NE and 5-HT 
(consistent with them being "non-nutritive") or to not respond at all to either agent 
(possibly mixed) (unpublished observations). In addition, in the present clamp studies 
with the scanning LDF probe it was apparent that regions away from muscle such as 
those around the knee, or indeed the total area, including muscle, showed no significant 
response to insulin suggesting that in some areas flow may have decreased. In one 
experiment, flow in the connective tissue was actually decreased by insulin. 
LDF probe dimensions may be important in determining the nature of the signal 
received. The stationary LDF probes used in this study when placed on the surface 
detects signal from a hemisphere with a radius of about lmm. As shown in Fig. 5.1, 
when positioned on the center of the anterior end of the biceps femoris the signal 
appeared to be only of one kind, responding positively to NE and negatively to 5-HT. 
This contrasts with measurements using a much smaller probe (200 p.m) inserted in the 
muscle, where LDF signals were heterogeneous with some responding as above (i.e. NE 
positive or "nutritive"), some responding in an opposite manner to the above (i.e. NE 
negative or "non-nutritive"), and some failing to respond (Chapter 3). Thus it appears 
likely that the larger probe receives signal from a mixture of sites that convey a character 
that is predominantly nutritive. Alternatively, "non-nutritive" sites may not be located 
near the surface of the muscle. 
The present findings in the rat in vivo, where insulin increased femoral blood flow 
and increased LDF signal and where epinephrine, despite similar changes in femoral 
blood flow, did not, is similar to previously reported increase in 1-MX metabolism from 
this laboratory (138). In that study, 1-MX was infused as a target substrate for capillary 
endothelial xanthine oxidase. Increased metabolism of this substrate as a result of insulin 
action was concluded to reflect increased capillary recruitment or nutritive flow. A large 
part of this conclusion rested on prior knowledge gained from perfused rat hindlimb 
studies where 1-MX metabolism was shown to closely parallel relative changes in 
nutritive flow (137;199). Similarly, in the present study we have used prior findings with 
the perfused rat hindlimb to interpret the nature of the signal changes induced by insulin. 
Thus an increase in muscle LDF signal due to insulin and independent of changes in total 
flow support the contention that insulin increases capillary recruitment in human skeletal 
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muscle (11) and the observation that insulin increased blood volume in human muscle 
(136). 
In conclusion, insulin acts in rats in vivo to stimulate LDF signal consistent with 
capillary recruitment in skeletal muscle. The recruitment may be independent of changes 
in total blood flow as it precedes temporally the increase in total flow. This dissociation is 
further seen with infusion of epinephrine which also increased femoral blood flow but 
does not increase LDF signal. The present findings support previous observations by our 
group that insulin increases capillary recruitment in rat muscle as measured by 1-MX 
extraction. In addition, they suggest that recruitment of capillaries may be an important 
aspect of insulin's effect to increase muscle glucose uptake. The technique of using 
impaled LDF probes for measuring muscle microvascular flow changes may be 
applicable to human studies, and this theme is further developed in the next chapter. 
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CHAPTER 6 
Changes in Nutritive Blood Flow Patterns and Regulation Induced by Insulin In 
Human Muscle In Vivo: A Study Using Laser Doppler Flowmetry  
6.1 Introduction 
Skeletal muscle is the main peripheral site of insulin-mediated glucose uptake and 
insulin-mediated vasodilation (10). Defects in this haemodynamic effect of insulin may 
contribute to diminished insulin-mediated glucose uptake and therefore play an important 
pathophysiological role in insulin resistance in type 2 diabetes, obesity and hypertension 
(10). 
In the previous Chapter, insulin was shown to increase LDF signal and this was related to 
changes in skeletal muscle glucose uptake but was independent of changes in total blood 
flow. In addition, it was shown in Chapter 3 that laser Doppler flow measurements in the 
constant flow, erythrocyte-perfused rat hindlimb correlate with changes in muscle 
metabolism, indicative of the ability of this technology to measure erythrocyte movement 
which is proportional to nutritive flow and separate from total flow. 
In humans, hyperinsulinaemia has been demonstrated to induce an increase in the 
distribution volume of glucose (136) and specifically to increase capillary blood volume 
as measured with contrast-enhanced ultrasound (40). In human skin, it was recently 
shown that insulin is capable of inducing functional recruitment of capillaries (157). In 
addition, insulin has been demonstrated to influence rhythmic fluctuations of the skin 
microvasculature, so-called vasomotion, by increasing the relative contribution of the 
frequency interval between 0.01 and 0.02 Hz, in which local endothelial activity is 
thought to be manifested. This implies that insulin modulates microcirculatory flow 
through an endothelium-dependent mechanism (157). Although the above-mentioned 
studies are consistent with an insulin-mediated effect on intramuscular microvascular 
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perfusion, such an effect has never previously been assessed in humans directly with 
intramuscular laser Doppler measurements. 
In humans, the laser Doppler technique has been widely used for measurements of skin 
blood flow at rest and during provocational manoeuvres (95). In the human skin, reactive 
hyperaemia after arterial occlusion is commonly applied to assess the vasodilatory 
capacity of the microcirculation (159;184). The same technique can also be applied to the 
vasculature of human skeletal muscle. If the probe position remains unchanged, the 
reproducibility of intramuscular reactive hyperaemia measurements after arterial 
occlusion has been shown to be excellent (71;95). 
The aim of the present study was to apply the experience gained from previous work and 
shown in the earlier chapters to examine directly, in human muscle, insulin-mediated 
effects on microvascular reactive hyperaemia after arterial occlusion and on 
microvascular vasomotion with an implanted laser Doppler probe. It was also aimed to 
compare changes in LDF signal in muscle with insulin-mediated . effects on total blood 
flow and skin microvascular perfusion. 
6.2 Methods 
The experiments reported in this Chapter were conducted while on a visit to the Vrije 
Universiteit Hospital, Amsterdam. 
6.2.1 Subjects 
Characteristics of the study population are shown in Table 6.1. All volunteers were 
healthy as judged by medical history; were non-diabetic [(1997) Report of the Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 
1183-1197] and normotensive, (<1401<90 mmHg), as determined by a triple office blood 
pressure measurement. They all were non-smokers and did not use any medication. All 
participants gave informed consent for participation in the study. The study was 
undertaken with approval of the local Ethics Committee and performed in accordance 
with the Declaration of Helsinki. 
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6.2.2 Study design 
All individuals underwent the protocol as described in Figure 6.1. All measurements were 
performed in a quiet, temperature-controlled room (23.4 ± 0.5 °C) and started at 8:00 AM 
after a 10-hour fast. Baseline measurements were started after the insertion of two 
polytetrafluoroethylene catheters (Venflon; B-D, Helsingborg, Sweden): one in the right 
antecubital vein and one in a vein of the opposite arm. 
Throughout the study, laser Doppler measurements were performed to study peak 
reactive hyperaemia and vasomotion in the anterior tibial muscle. The laser Doppler 
signal which is called "laser Doppler perfusion" (99) is determined by the product of 
local speed and concentration of moving blood cells(99). The exact volume measured by 
laser Doppler cannot be determined, nor can the exact haematocrit of the measured blood 
and consequently, the laser Doppler signal cannot be transformed into a quantitative SI 
unit (such as volume of blood per unit time per unit mass of tissue), but, alternatively, it 
is expressed in arbitrary units which can be called perfusion units (PU). Each time the 
laser Doppler probe is applied to a new volume of tissue the optical properties and 
microvascular structure of the tissue being monitored will be different. However, so long 
as these immeasurable variables remain constant, the laser Doppler signal is very useful 
because any changes that are seen are strongly related to changes that are occurring in 
local perfusion (99). Thus, only responses in the laser Doppler signal to provocational 
manoeuvres, such as comparing before and after hyperinsulinaemia, and not the absolute 
laser Doppler signal, can be compared between individuals (99). 
Laser Doppler perfusion in the anterior tibial muscle was measured with a needle probe 
(model 402; Perimed, Stockholm, Sweden, fibre separation = 0.15mm) sterilized in 
ethylene oxide. A standard cannula (Venflon 0.9 x 25 mm; B-D) was inserted into the 
anterior tibial muscle approximately 20 cm proximal to the ankle joint of the non-
dominant leg. The needle probe was introduced through the cannula, positioned to 
protrude 0.5 cm from the tip of the cannula in order to make proper contact with the 
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muscle tissue, as indicated by a regular and pulsatile laser Doppler signal, and fixated on 
the skin with a special fixation device (PH 18 Fixation Device; Perimed). The studies 
were performed with the individuals in the supine position. In order to minimize 
movement artefacts in the laser Doppler signal, the leg was fixated by resting on a 
vacuum cushion moulded to hold the limb in a comfortable position. 
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Figure 6.1 Design of the study protocol. 0 = leg blood flow assessed with venous 
occlusion plethysmography and blood pressure measurements, X = Peak reactive 
hyperaemia measured with the intramuscular laser Doppler probe, ign = Vasomotion 
assessed with the laser Doppler probe, 	= Capillaroscopy and endothelium- 
(in)dependent vasodilation in skin of the finger 
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Table 6.1 Characteristics of the study population 
Mean±SD or N 
N (men/women) 
Age (years) 
BMI (kg/m 2) 
12 
27 
22.6 
(6/6) 
± 8 
± 1.0 
WHR 0.81 ±0.054 
MA-value (mg.kg-l .mirf l per pmo1.1 -1 ) * 100 2.0 ± 0.6 
Fasting serum total cholesterol (mmo1/1) 4.2 ± 1.0 
Fasting LDL-cholesterol (mmo1/1) 2.3 ± 0.9 
Fasting HDL-cholesterol (mmo1/1) 1.4 ± 0.3 
Fasting serum triglycerides (mmo1/1) 0.9 ± 0.5 
M/I-value = glucose infusion rate during the hyperinsulinaemic, euglycaemic clamp, 
expressed per kg bodyweight, corrected for insulin concentrations in pmol per litre 
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6.2.3 Blood pressure 
During the study days, systolic and diastolic blood pressure, and heart rate were 
determined at the times indicated in Figure 6.1 (Colin Press-Mate BP-8800; Colin, 
Japan). The average of three consecutive blood pressure and heart rate readings during 
each period was used for further analyses. 
6.2.4 Hyperinsulinaemic euglycaemic clamp 
Insulin sensitivity was determined with the euglycaemic, hyperinsulinaemic clamp 
method as described for humans by other researchers (60). The basis of the technique is 
similar to that used for rats and described in Chapter 2. Briefly, insulin (Velosulin; Novo 
Nordisk, Bagsvaerd, Denmark) was infused in a primed continuous manner at a rate of 50 
mU/kg/hr. Euglycaemia (5 mmo1/1) and was maintained by adjusting the rate of a 20% D-
glucose infusion based on plasma glucose measurements performed at 5-10 min intervals. 
Whole body glucose uptake was calculated from the infusion rate during the second hour 
of the clamp and expressed per kg body weight and per unit of plasma insulin 
concentration (M/I-value). 
To exclude non-specific changes in vascular measurements, a time- and volume-control 
study was performed. The control study was performed in an identical fashion as the 
hyperinsulinaemic clamp with the infusion of the same amount of fluids (0.65% saline) 
and with blood sampling at the same time intervals, but without glucose or insulin 
infusion. 
6.2.5 Leg blood flow 
Leg blood flow was measured by mercury-in-silastic strain gauge venous occlusion 
plethysmography (EC6; Hokanson, Bellevue, USA) on the dominant leg with individuals 
in the supine position with the foot elevated (157). An occlusive cuff was placed 
proximally around the dominant leg, and the strain gauge was placed around the calf at 
the largest circumference. Hokanson dedicated software was used (NIVP3; Hokanson) to 
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automatically balance the plethysmograph, inflate the cuff to 50 mmHg using a E20 
Rapid Cuff Inflator and an AG 101 Air Source, capture the inflow waveform, and 
calculate blood flow. Leg blood flow measurements represent the average of 7-9 
recordings. The average of two consecutive leg blood flow measurements during each 
period was used for further analyses. The day-to-day coefficient of variation was 
9.6±7.4%, as determined in ten healthy individuals on two separate days. 
6.2.6 Capillaroscopy and endothelium-(in)dependent vasodilation in skin of the 
finger 
Nailfold capillary studies and iontophoresis studies were performed as described 
previously (157). Nailfold capillaries in the dorsal skin of the third finger of the non-
dominant hand were visualised by a capillary microscope. Two separate visual fields of 1 
mm2 were recorded before and after 4 minutes of arterial occlusion with a digital cuff. 
Perfused capillaries at baseline and directly after release of the cuff were counted for, 15 
and 30 seconds, respectively, from a freeze-framed reproduction of the videotape and 
from the running videotape when it was uncertain whether a perfused capillary was 
present or not. Perfused capillary density was defined as the number of erythrocyte-
perfused capillaries per square millimetre of nailfold skin. Post-occlusive reactive 
hyperaemia after 4 minutes of arterial occlusion was used to assess functional capillary 
recruitment. This was calculated by dividing the increase in perfused capillary density 
during post-occlusive reactive hyperaemia by the baseline perfused capillary density. The 
day-to-day coefficient of variation of functional capillary recruitment was 15.9 ± 8.0% as 
determined in ten healthy individuals on two separate days. 
Endothelium-(in)dependent vasodilation of finger skin microcirculation was evaluated 
with laser Doppler measurements in combination with iontophoresis of acetylcholine and 
sodium nitroprusside, respectively. Acetylcholine (1% Miochol, IOLAB, Bourneville 
Pharma, The Netherlands) was delivered on the middle phalanx of the third finger of the 
non-dominant hand using an anodal current, consisting of 7 doses (0.1 milliamps (mA) 
for 20 s) with a 60-s interval between each dose. Sodium nitroprusside (0.01%, Nipride, 
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Roche, The Netherlands) was delivered on the same spot of the fourth finger using a 
cathodal current, consisting of 9 doses (0.2 mA for 20 s) with a 90-s interval between 
each dose. The day-to-day coefficient of variation of the relative increase from baseline 
to the final two deliveries was 12.2 ± 9.7% for the iontophoresis of acetylcholine and 
16.4 ± 8.1% for sodium nitroprusside, as determined in ten healthy individuals on two 
separate days. Skin microvascular measurements were performed with a skin temperature 
above 30 °C and the skin temperature was monitored continuously during the 
measurements. 
6.2.7 Reactive hyperaemia in muscle of the lower leg 
Intramuscular reactive hyperaemia measurements were started at least 45 minutes after 
muscle puncture and after stable laser Doppler recordings had been achieved. An 
occlusive cuff was placed around the distal thigh of the non-dominant leg. After 5 
minutes of resting laser Doppler recording, the cuff was rapidly inflated to 200 mmHg (a 
value much larger than the systolic blood pressure of these healthy volunteers). This 
pressure was maintained for 3 minutes, which was shown by others (95) to give a 
maximal hyperaemic response. After release of the cuff, intramuscular reactive 
hyperaemia was recorded. Baseline perfusion was calculated as the mean value of the 3 
minute laser Doppler recording immediately prior to inflation of the cuff. The peak 
perfusion corresponded with the maximal laser Doppler signal recorded after release of 
the cuff. The time to peak perfusion was the time between the start of the cuff deflation 
and the occurrence of the maximal perfusion measurement. Reactive hyperaemia was 
measured twice with a 20 minute interval between consecutive occlusions. The mean of 
these two measurements was used in further analyses. For two consecutive measurements 
in twelve healthy subjects, the coefficient of variation of the relative increase in perfusion 
and the time needed to reach peak perfusion during reactive hyperaemia were 10.2±4.3% 
and 16.2±11.4% respectively. 
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6.2.8 Vasomotion in the muscle of the lower leg 
The laser Doppler signal waveform was recorded for 30 minutes and vasomotion 
analyses were performed on a continuous 15 minute sample of this trace which was 
relatively free of movement artifacts. A bandpass filter with cut-off frequencies at 20 Hz 
and 20 kHz, and a time-constant of 0.2 s was used. We used Fourier transformation for 
determination of the contribution of different frequency components to the variability of 
the laser Doppler signal. The frequency band between 0.01 and 1.6 Hz was studied and 
divided into a set of intervals. Based upon the work of Stefanovska et al. (164), we chose 
five frequency intervals: 1) 0.01-0.02 Hz, which is thought to contain local endothelial 
activity; 2) 0.02-0.06 Hz, which is thought to contain neurogenic activity; 3) 0.06-0.15 
Hz, which is associated with the myogenic response of the smooth muscle cells in the 
vessel wall; 4) 0.15-0.4 Hz, which is the frequency interval of respiratory function; and 5) 
0.4-1.6 Hz, which contains the heart beat frequency. For each frequency-interval, the 
mean energy density was calculated. Data were processed on a personal computer using 
Perisoft dedicated software (PSW version 3.11, Perimed, Sweden). The day-to-day 
coefficients of variation of the mean energy density of the frequency intervals 0.01-0.02, 
0.02-0.06, 0.06-0.15, 0.15-0.40 Hz and 0.40-1.6 Hz were 23.1 ± 19.0%, 26.8 ± 25.4%, 
25.5 ± 22.7%, 27.9 ± 22.5% and 27.5 ± 17.5%, respectively, in twelve healthy subjects. 
6.2.9 Analytical methods 
Plasma insulin concentrations were measured by radio immunoassay techniques 
(Medgenix Diagnostics, Fleurus, Belgium). Blood glucose concentrations were 
determined by the glucose oxidase method with a glucose analyser YSI2300 (Yellow 
Springs, OH, USA). Serum total cholesterol, HDL cholesterol and triglyceride 
concentrations were measured by enzymatic techniques (Hitachi 747 model 100, Roche 
diagnostics, Mannheim, Germany). LDL cholesterol was calculated by the Friedewald 
formula. 
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6.2.10 Statistical analyses 
All variables were tested for normality of distribution. Data are expressed as mean ± SD 
or median (interquartile range) as appropriate. The paired Student's t-test and the Mann-
Whitney (Wilcoxon) paired test were used to study effects of the hyperinsulinaemic 
clamp and the time-volume control study, and to compare these effects. Pearson's 
correlation analysis was used to study associations between insulin-mediated effects on 
total blood flow and intramuscular and skin microvascular perfusion. A two-tailed P-
value of < 0.05 was considered significant. All analyses were performed on a personal 
computer using the statistical software package SPSS version 11.0. 
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6.3 Results 
6.3.1 Metabolic and haemodynamic variables before and during the 
hyperinsulinaemic clamp. 
Table 6.2 shows that during the clamp insulin levels were elevated to 416 ± 82 pmo1/1 
from a baseline of 65 ± 42 pmo1/1. In addition, when compared to the control study, 
hyperinsulinaemia increased total leg blood flow from 0.1 ± 0.6 to 1.0 ± 1.0 ml.min -
1 -100g tissue' (P < 0.05) as assessed by plethysmography (Table 6.2). 
6.3.2 Capillaroscopy and endothelium-(in)dependent vasodilation in skin of the 
finger 
When compared to the control study, hyperinsulinaemia was found not to have 
influenced baseline perfused capillary density, but rather to have increased functional 
capillary recruitment during peak reactive hyperaemia (13.1 ± 10.1 vs. —5.6 ± 11.0%- 
points, P < 0.01) (Table 6.3). Similarly, comparison to the control study showed that 
hyperinsulinaemia tended to increase acetylcholine-mediated vasodilation (509 ± 534 vs. 
114 ± 337%-points), although this was not significant (P = 0.07). Hyperinsulinaemia did 
not significantly change sodium-nitroprusside-mediated vasodilation (P = 0.2, Table 6.3). 
Similar results were obtained if the absolute increase in perfused capillary density and in 
laser Doppler perfusion during iontophoresis of acetylcholine and sodium nitroprusside 
was used instead of the percentage increase (data not shown). 
6.3.3 Reactive hyperaemia in muscle of the lower leg 
Compared to the control study, there was a trend of insulin to increase basal laser 
Doppler perfusion, but this was not significant (P = 0.3) (Table 6.4 and Fig. 6.2). 
However, hyperinsulinaemia increased both peak laser Doppler perfusion (218.0 ± 166.3 
vs.5.3 ± 97.1 PU, P < 0.01) and the absolute and relative increase in laser Doppler 
perfusion after arterial occlusion (210.8 ± 155.9 vs. 7.1 ± 74.3 PU, P < 0.01; 422 ± 327 
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vs. 11 ± 220%-points, P < 0.01, respectively). In addition, hyperinsulinaemia decreased 
the time needed to reach peak laser Doppler perfusion after arterial occlusion by 3.7 ± 3.1 
s (in the control experiment time to peak increased by 1.1 + 3.1 s, P < 0.01). Pearson's 
correlation analysis demonstrated that insulin-mediated changes in absolute and relative 
increase after arterial occlusion and time needed to reach peak laser Doppler perfusion 
were not significantly associated with insulin-mediated effects on total leg blood flow 
(Pearson's correlation coefficient; r = 0.19, P = 0.5; r = 0.15, P = 0.6 and r = -0.16, P = 
0.5, respectively). 
6.3.4 Vasomotion in the muscle of the lower leg. 
Table 6.5 shows energy densities of the intramuscular laser Doppler signal within each 
frequency interval and the calculated total energy density within the interval from 0.01 to 
1.6 Hz. As compared to the control study, hyperinsulinaemia increased the intramuscular 
energy density of the frequency intervals between 0.01 and 0.02 Hz (median 
(interquarti le range); 1.36 (0.49-2.52) vs. 0.44 (-1.02-2.28, P < 0.01), and the calculated 
total energy density (5.88 (1.46-8.38) vs. 0.46 (-1.59-5.32), P < 0.05). In order to gain 
insight into the effect of hyperinsulinaemia on the lower frequencies of the frequency 
interval between 0.01 and 1.6 Hz, the effect of hyperinsulinaemia on the energy densities 
of each of the registered frequencies between 0.01 and 0.15 Hz is shown in Figure 6.3. As 
compared to the control study, hyperinsulinaemia increased the contribution of all 
frequencies registered between 0.01 and 0.04 Hz in the muscle, but not of those above 
0.04 Hz. 
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Table 6.2 Metabolic and haemodynamic variables before and during the 
hyperinsulinaemic clamp (Insulin) and time-volume control study (Control) 
Before 
infusion 
Insulin 
During 
infusion 
Before 
in 
Control 
During 
infusion 
Plasma insulin (pmo1/1) 65 ± 42 416 ± 82 b 45 	12 35 ± 9b 
Blood glucose (mmo1/1) 4.3 ± 0.2 5.0 ±o. id 4.3 ± 0.4 4.1 + 0.3 a 
Systolic blood pressure (mmHg) 122 ± 13 124 ± 14 119 ± 8 123 ± 13 
Diastolic blood pressure (mmHg) 66 ± 10 65 ± 10 64 ± 9 67 ± 9 
Heart rate (bpm) 63 ± 10 67 ± 10 61 ±9 65 ± 10b 
Leg blood flow (ml.min -1 .100g 
tissue') 
2.6 ± 1.2 3.6 ± 0.8ac 2.6 + 1.0 2.7 ± 1.2 
Values are expressed as mean ± SD; a P < 0.05 and bp < 0.01 during vs. before infusion; 
P < 0.05 and d P < 0.01 change during insulin study versus during control study. 
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Table 6.3 Skin microcirculatory measurements before and during the 
hyperinsulinaemic clamp (Insulin) and time-volume control study (Control) 
Insulin 
Before 
infusion 
During 
infusion 
Control 
Before 	During 
infusion 	infusion 
Capillary recruitment 
33.8 ± 5.5 
49.0 ± 8.0 
15.1 ± 5.2 
46.6 ± 17.5 
33.8 ± 5.8 
53.3 ± 10•0ad 
19.5 ± 6.7be 
59.7 ± 21.9 1  
34.6 ± 5.6 
50.5 ± 9.2 
15.9 ± 6.4 
47.6 ± 20.2 
36.6 ± 6.6 
50.9 ± 8.0 
14.9 ± 6.4 
42.0 ± 22.0 
Baseline perfused capillary density (n/mm 2 ) 
Peak perfused capillary density (n/rnm 2) 
Perfused capillary increase (n/mm 2) 
Functional capillary recruitment (%) 
ACh-mediated vasodilation 
Skin temperature (°C) 31.1 ± 1.0 31.5 ± 0.8 30.9 ± 1.4 31.7± 1.1 
Baseline skin laser Doppler perfusion (PU) 24.0 ± 9.7 20.5 ± 7.5 28.8 ± 8.5 26.4 ± 12.0 
Plateau skin laser Doppler perfusion (PU) 148.7 ± 79.3 204.8 ± 78.01' 197.0 ± 125 191.8 ± 70.0 
ACh-mediated vasodilation (%) 491 ± 196 1000 ± 4991' 593 ± 355 707 ± 268 
SNP-mediated vasodilation 
Skin temperature (°C) 31.4 ± 0.78 31.4 ± 1.1 31.2 ± 0.8 32.2 ± 1.0 
Baseline skin laser Doppler perfusion (PU) 22.0 ± 6.7 23.4 ±9.2 24.4± 12.0 25.5± 10.2 
Plateau skin laser Doppler perfusion (PU) 166.6 ± 78.0 159.1 ± 81.2 160.1 ± 66.0 193.4 ± 98.8 
SNP-mediated vasodilation (%) 719 ± 433 623 ± 352 632 ± 278 745 ± 446 
Values are expressed as mean ± SD; n = number of perfused capillaries; ACh = acetylcholine; 
SNP = sodium nitroprusside; PU = arbitrary perfusion units; a P < 0.05 and b P < 0.01 during vs. 
before infusion; e P = 0.07, d P < 0.05 and e P < 0.01 change during insulin study versus during 
control study. 
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Table 6.4 Reactive hyperaemia measurements in the tibial muscle of the lower leg before and during 
the hyperinsulinaemic clamp (Insulin) and time-volume control study (Control) 
Insulin 
Before 
infusion 
During 
infusion 
Control 
Before 	During 
infusion 	infusion 
Baseline laser Doppler perfusion 35.7 ± 19.2 42.9 ± 18.1 30.0 ± 14.9 29.2 ± 14.1 
(PU) 
Peak laser Doppler perfusion (PU) 193.7 ± 100.0 412 ± 203ab 176.2 ± 69.6 181.5 ± 83.5 
Absolute increase (PU) 158.0 + 97.8 369 ± 202ab 146.3 ± 68.4 153.3 ± 76.1 
Relative increase (%) 565 ± 358 987 ± 605 ab 622 ± 337 633 ± 366 
Time to peak (s) 12.0 ± 5.7 8.4 ± 4.1 ab 11.1 ± 4.7 12.2 ± 5.7 
Values are expressed as mean ± SD; PU = arbitrary perfusion units; a P < 0.01 during vs. 
before infusion; bp < 0.01 change during insulin study versus during control study. 
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Table 6.5 Energy densities of microviscular laser Doppler perfusion within each of 
the five frequency intervals and the total energy density in muscle of the lower leg 
before and during the hyperinsulinaemic clamp (Insulin) and time-volume control 
study (Control) 
Frequency 
domain 
Insulin 
Before infusion During infusion 
Control 
Before infusion 	During infusion 
0.01 -0.02 Hz 2.33 (1.65-3.50) 5.78 (3•69-8.83) ad 2.01 (1.10-2.80) 2.15 (1.09-4.43) 
0.02 - 0.06 Hz 1.14 (0.92-1.86) 1.36 (0.83-2.83) 0.92 (0.58-1.43) 0.95 (0.66-3.01) 
0.06 - 0.15 Hz 0.83 (0.68-0.97) 1.14 (0.79-1.43) 0.58 (0.44-1.04) 0.51 (0.34-1.81) 
0.15 - 0.40 Hz 0.57 (0.37-0.70) 0.84 (0.54-1.48) 0.42 (0.31-0.78) 0.39 (0.27-0.95) 
0.40 - 1.60 Hz 0.46 (0.36-0.77) 0.75 (0.45-1.10) 0.40 (0.21-0.59) 0.37 (0.22-0.64) 
Total energy 
density 
5.83 (4.19-8.13) 12.87 (7.54-16.64)' 4.69 (2.84-6.62) 4.24 (2.59-10.94) 
Values are expressed as median (interquartile range); a P < 0.01 during vs. before 
infusion; b P ---- 0.07, C  P < 0.05 and, d P < 0.01 change during insulin study versus during 
control study. 
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Figure 6.2 The relative increase in intramuscular perfusion after arterial occlusion 
(upper panel) and time needed to reach peak intramuscular perfusion after arterial 
occlusion (lower panel) before and during the hyperinsulinaemic clamp (Insulin) 
and time-volume control study (Control). * P < 0.05 and **P < 0.01 during vs. before 
infusion; ***P < 0.01 change during insulin study versus during control study 
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Frequency (Hz) 
Figure 6.3 The contribution of frequencies between 0 and 0.15 Hz to the total energy 
density of microvascular intramuscular vasomotion before and during the 
hyperinsulinaemic clamp (Insulin; upper panel) and time-volume control study 
(Control; lower panel). *p < 0.05 and, "P < 0.01 change during insulin study versus 
during control study 
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6.4 Discussion 
The main finding of this Chapter is that insulin affects intramuscular microvascular 
perfusion as estimated with the laser Doppler technique. We show that hyperinsulinaemia 
increases two different measures of intramuscular microvascular activity: reactive 
hyperaemia after arterial occlusion and vasomotion. Hyperinsulinaemia increases the 
maximal reactive response in intramuscular laser Doppler perfusion following 3 minutes 
of arterial occlusion and reduces the time needed to reach this maximal response. In 
addition, hyperinsulinaemia increases intramuscular microvascular vasomotion, in a way 
indicative of an increase in the contribution of endothelial and neurogenic activity. This 
confirms previous findings of an insulin-induced increase in total leg blood flow (37;157) 
and demonstrate insulin-induced increases in skin capillary recruitment after arterial 
occlusion and endothelium-dependent vasodilation. Taken together, these data show that 
the vascular effects of insulin are not limited to total blood flow and skin microvascular 
function during provocational manoeuvres, but extend to microvascular perfusion in 
human muscle. 
The present results are in agreement with previous studies by other researchers that have 
demonstrated insulin-mediated effects on microvascular perfusion in human muscle using 
positron emission tomography or contrast-enhanced ultrasound (40;136). However, since 
each of those methods have not been used to measure muscle perfusion in real time, 
changes in vasomotion have been undetected. 
It is important to note that in the present Chapter hyperinsulinaemia stimulated the 
response of intramuscular microvascular perfusion when measured during reactive 
hyperaemia. Hyperinsulinaemia stimulated the response of intramuscular microvascular 
perfusion during reactive hyperaemia. The stimulatory effect of hyperinsulinaemia might 
be due to a decreased sensitivity to vasoconstrictor or an increased sensitivity to 
vasodilatory stimuli. The mechanisms responsible for the increase in vascular perfusion 
after arterial occlusion are not fully understood. There may be a role for accumulation of 
metabolic vasodilators, myogenic and/or neurogenic mechanisms (193). It seems unlikely 
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that hyperinsulinaemia decreases sensitivity to vasoconstrictive effects, because, both in 
the isolated rat arteriole and in the human forearm, hyperinsulinaemia has been shown to 
increase vasoconstrictive effects by inducing endothelin-1 activity (25;58). In humans, 
insulin has been shown to stimulate vasodilatory effects by inducing endothelial nitric 
oxide (NO) production (165). A role for NO in intramuscular reactive hyperaemia is 
supported by most (47;57;112), but not all studies (172) using venous occlusion 
plethysmography. Therefore, in the present study, enhanced endothelial NO production 
might contribute to insulin-mediated changes in intramuscular reactive hyperaemia. 
Evidently, this and other possible mechanisms in intramuscular reactive hyperaemia, and 
insulin-mediated effects thereon, remain to be further investigated. 
In this study, as in many previous studies, insulin induced an increase in the total leg 
blood flow (37;157;183). It cannot be excluded from the present data that insulin-
mediated changes in intramuscular reactive hyperaemia are (partly) caused by the 
increase in the total leg blood flow. However, insulin-mediated changes in intramuscular 
reactive hyperaemia were not associated with insulin-mediated changes in total leg blood 
flow. In addition, both in animal and in human studies there is increasing evidence that 
insulin influences the microvascular blood flow distribution pattern independently of 
changes in total blood flow (28;40;180). Moreover, iontophorised insulin can directly 
increase skin microvascular perfusion, indicating a direct local effect (157). 
Intramuscular reactive hyperaemia measurements with the laser Doppler have been used 
and validated in previous studies (71;95;119). Calculation of the relative increase in 
intramuscular perfusion allows correction for differences in baseline intramuscular 
perfusion. This is of importance, because previous studies have shown that intramuscular 
laser Doppler perfusion at rest shows considerable spatial variation at different 
measurement sites (71;95). The present experiments were performed in conscious, 
healthy subjects. Although movement of the leg was reduced to a minimum by the use of 
a vacuum cushion and a probe fixation device on the skin, slight changes in the probe 
measurement angle and depth could not be avoided. The laser Doppler signal consists of 
the average perfusion in all arterioles, venules and capillaries of a certain measured 
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volume of muscle tissue. Slight changes in this measured volume may shift the baseline 
of the laser Doppler signal. This limitation of the study necessitates cautious 
interpretation of basal intramuscular perfusion and may partly explain, in addition to the 
small number of participants, the absence of a significant insulin-mediated effect on basal 
intramuscular laser Doppler perfusion, which is in contrast with a previous study in 
anaesthetised rats (29) where relative movement between the probe and the target tissue 
can be effectively eliminated using clamps. The measurement volume of laser Doppler 
depends largely on the distance between the transmitting and receiving fibres, the so-
called fibre separation (99). A probe with a fibre separation of 0.15 mm, as was used in 
the current study, probably averages the signal from several different capillary networks. 
A probe with a larger fibre separation may average perfusion in a larger volume and 
therefore may be less sensitive to small changes in probe position. 
A major advantage of the laser Doppler technique is the possibility to study vasomotion. 
The origin and control of microvascular vasomotion is still a matter of debate. A central 
neurogenic regulatory mechanism is suggested by synchronicity on contralateral limbs 
(151) and by the suppressive effect of central sympathectomy (18). However, local 
administration of vasoactive substances such as acetylcholine and sodium nitroprusside 
directly influences vasomotion (94). Furthermore, vasomotion has been shown in isolated 
small arteries, indicating a local regulatory mechanism (48). In view of these 
considerations, it can be suggested that vasomotion is regulated by both local vasoactive 
substances and influences of the central nervous system. The contribution of different 
regulatory mechanisms flow can be investigated by analysing the contribution of different 
frequency intervals to the variability of laser Doppler signal (164). In the present study 
hyperinsulinaemia increased the contribution of the frequencies between 0.01 and 0.04 
Hz in muscle. Stefanovska and co-workers have demonstrated that endothelium-
dependent vasodilators specifically increase the contribution of frequencies around 0.01 
Hz and concluded that the frequency interval between 0.01 and 0.02 Hz represents 
endothelial activity (94;164). The insulin-induced increase in this frequency interval in 
the present study in muscle is in accordance with a similar insulin-induced increase in 
hand skin found in a previous study (157). It is also in agreement with present and 
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previous findings of an insulin-mediated increase in endothelium-dependent vasodilation 
in microvasculature (157) and, in general, with insulin-mediated increases in 
endothelium-dependent vasodilation in resistance vessels [17, 33]. Stefanovska and co-
workers have also demonstrated a frequency peak between 0.03 and 0.04 Hz, which is 
attributed to neurogenic activity, because it has been shown to disappear completely after 
ganglionic nerve blockade and after sympathectomy (86). Our results demonstrate an 
insulin-mediated increase in the contribution of the frequencies around 0.03 and 0.04 Hz. 
Part of the insulin-mediated effects on microvascular vasomotion might thus be explained 
by insulin-mediated effects on neurogenic activity. Other studies in larger vessels have 
demonstrated a stimulatory effect of hyperinsulinaemia on sympathetic neural activation 
(5;148). Taken together, our data suggest an insulin-mediated effect on microvascular 
vasomotion by increasing both endothelial and neurogenic activity. 
In the current study consistency in insulin-mediated increases in microvascular reactive 
hyperaemia in finger skin and leg muscle were apparent, as were insulin-mediated 
increases in microvascular endothelial activity in both finger skin and leg muscle. 
Although different methods were used to measure microvascular reactive hyperaemia and 
endothelial function in hand skin and muscle, our results suggests a simultaneous effect 
of insulin on both skin and muscle microvasculature. 
Peak reactive hyperaemia in finger skin is used to detect functional recruitment of 
initially non-perfused capillaries. Capillaries, especially in the skin, are either 
intermittently or continuously perfused in the resting state (7;155). Only continuously 
perfused capillaries were counted in the resting state (baseline perfused capillary density), 
because intermittently perfused capillaries are an important functional reserve that can be 
recruited after arterial occlusion (7;155). Functional capillary recruitment can serve as a 
mechanism to satisfy increased metabolic demands such as during insulin infusion (157). 
This study and previous data suggest that functional capillary recruitment plays a role in 
insulin sensitivity and blood pressure regulation by modifying availability of insulin and 
glucose to muscle cells and total peripheral resistance (156-158). 
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In the present study an insulin-mediated effect on endothelium-independent vasodilation 
in finger skin microvasculature was not evident, in contrast with a previous study (157), 
but this was in agreement with previous findings in resistance vessels (167;171). 
Apparently, other factors not identified in these studies modulate the effect of insulin on 
endothelium-independent vasodilation in healthy volunteers. 
Hand warming to arterialize venous blood samples during the hyperinsulinaemic clamps 
was not used in this study because this can induce unwanted systemic effects on vascular 
function (133). Theoretically it can be hypothesized that the lack of arterialisation of 
venous blood samples may slightly have overestimated insulin sensitivity (60). However, 
to our knowledge, all previous studies have demonstrated similarity in measurements of 
insulin sensitivity with and without arterialisation (6;118;133;185). In any case, this issue 
does not affect our conclusions with regard to insulin's microvascular effects. Finally, we 
clamped at euglycaemia (i.e. at 5 mmo1/1) instead of at isoglycaemia, which resulted in 
slightly higher glucose levels during insulin than during saline infusion. It is not clear that 
this difference affected our results, but, because hyperglycaemia impairs microvascular 
function (2;143), we may, if anything, have somewhat underestimated insulin-mediated 
effects on microvascular function. 
In conclusion, intramuscular laser-Doppler were successfully used to measure effects of 
insulin on microvascular perfusion in muscle and in skin. The data show that insulin 
augments the intramuscular microvascular response to reactive hyperaemia after arterial 
occlusion. In addition, insulin modulates microvascular blood flow oscillations in the 
muscle indicating an increased contribution of endothelial and neurogenic activity. 
Concomitant effects of insulin on total blood flow and skin microvascular measurements 
were evident. Hence, this study demonstrates that insulin stimulates not only total blood 
flow and skin microvascular perfusion, but also microvascular perfusion in human 
muscle. 
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CHAPTER 7 
Changes in Nutritive Blood Flow Patterns Induced by Insulin In Rat Muscle In 
Vivo: A Study Using Contrast Enhanced Ultrasound  
7.1 Introduction 
In Chapter 5 it was shown that high-dose (10 mU • min -I - kg-I ) insulin enhanced the laser 
Doppler signal in rat muscle obtained using either surface scanning or an implantable 
laser Doppler probe. Again, epinephrine infusion produced a similar increase in hindlimb 
blood flow but did not alter laser Doppler signal. These data were consistent with earlier 
findings from our group that high-dose insulin infusion (10 mU • min d - kg-I ) increased 
rat hindlimb blood flow in vivo and also enhanced the conversion of exogenously infused 
1-methylxanthine (1-MX) to 1-methylurate (1-MU) by endothelial xanthine oxidase(138). 
Because this enzyme is located on the capillary endothelial surface (83) the data indicated 
that insulin enhances the exposure of 1-MX to xanthine oxidase (138). That was the first 
report providing experimental evidence for an action of insulin on muscle microvascular 
recruitment. In addition, epinephrine infusions, which enhanced total hindlimb blood flow 
to a similar degree as insulin infusions, did not affect microvascular recruitment as 
measured by 1-MX metabolism (138). This suggested that total flow and microvascular 
recruitment could be dissociated. 
In preliminary studies ultrasound was used during albumin microbubble infusion for the 
first time to estimate microvascular volume (MV) in rat skeletal muscle in vivo (49). 
From those studies it appeared that exercise, a known stimulus for microvascular 
recruitment in muscle, enhanced MV. This technique is well suited to repeated 
measurement of microvascular perfusion in small animals and humans. 
In this Chapter, images ofmicrovascular perfusion (using CEU) in rat hindlimb muscle in 
vivo were measured to ascertain whether physiological hyperinsulinemia exerts a 
hemodynamic action to increase microvascular perfusion. CEU was also used to examine 
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whether insulin-induced changes in microvascular recruitment and total limb blood flow 
are temporally coupled. 
7.2 Methods 
The experiments for this Chapter were conducted while on a visit to the University of 
Virginia, in Charlottesville, USA. 
7.2.1 Animals 
Male Sprague-Dawley rats weighing 250-350 g were obtained from Hilltop Laboratory 
Animals (Scottdale, PA). Animals were housed at 22 ± 2°C and during a 12:12 h light: 
dark cycle. The animals were provided food and water ad libitum; however, food was 
removed the night before the experiment. All experiments were approved by the Animal 
Care and Use Committee of the University of Virginia. 
7.2.2 Surgery. 
The hyperinsulinemic clamp was used as described in detail previously (Chapter 2). In 
brief, rats were anaesthetised with an intraperitoneal injection of sodium pentobarbital (55 
mg/kg body wt). Polyethylene (PESO; Intramedic) cannulas were inserted into the carotid 
artery for arterial blood sampling and measurement of arterial blood pressure (Transpac 
IV pressure transducer; Abbott Critical Systems) and into both jugular veins for 
intravenous infusions: A tracheotomy tube was placed, and the animals breathed 
spontaneously throughout the experiment. The femoral vessels in the left leg were 
exposed by a —1.5-cm incision through the skin overlaying the vessels. The femoral artery 
was carefully separated from the femoral vein and saphenous nerve. The epigastric 
vessels were ligated, and a time transit flow probe that measured blood flow continuously 
by ultrasound (VB series 0.5 mm; Transonic Systems) was positioned over the femoral 
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artery. The flow probe was interfaced through a flow meter to an IBM-compatible 
computer. Femoral blood flow, arterial blood pressure, and heart rate were continually 
measured using Windaq data acquisition software (Dataq Instruments). The animal was 
maintained under anaesthesia for the duration of the experiment with aqueous sodium 
pentobarbital (0.6 mg • min -1 • kg-1 ) via the carotid artery. A heat lamp positioned above 
the rat maintained the rat's body temperature. 
7.2.3 Experimental protocols 
After a 60-min stabilization period following completion of the surgical procedure, rats 
were divided into two groups. Group 1 animals received either normal saline (10 Al/min, 
n = 6) or insulin (3.0 mU • min -1 • kg -1 , n = 9) intravenously while maintaining blood 
glucose at baseline via a variable-rate infusion of 30% dextrose. MV and flow velocity 
were assessed with CEU at baseline and after 120 min of infusion. In addition, 1-MX 
metabolism was determined at the end of the 120-min infusion. 
In group 2 animals (n = 5), the time course of insulin's action on microvascular blood 
• volume and velocity were assessed by CEU. Measurements were performed at baseline 
and at 30 and 90 min after initiating insulin infusion. These time points were selected to 
reflect times at which plasma insulin concentration increases most markedly after a meal 
(113;177). No measurements of 1-MX metabolism were made in these animals. 
Glucose (30% wt/vol. solution) was infused at a variable rate into all insulin-treated 
animals to maintain euglycemia, and arterial blood glucose was monitored every 10 min 
for the first hour and then every 15 min for the rest of the study, using an Accu-Chek 
blood glucose monitoring system (Roche, Indianapolis, IN). 
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7.2.4 CEU 
Details for CEU are given in Chapter 2. 
To determine the appropriate microbubble infusion dose for in vivo imaging and to ensure 
linearity in the microbubble concentration versus video intensity relation, experiments 
were performed to define a microbubble dose-response curve both in vivo and in vitro. 
For the in vitro experiment, the ultrasound probe was immersed in a beaker of water, and 
video intensity was measured after injection of incremental numbers of microbubbles 
during continuous mixing with a stir bar. For the in vivo experiment, microbubbles were 
infused into the jugular vein of the rat, and the ultrasound probe was positioned over the 
thigh of the rat as described above. Background-subtracted video intensity in resting 
skeletal muscle was determined during step-wise increases in microbubble concentration. 
A microbubble infusion rate of 120 ttl/min was selected for the in vivo study because this 
dose resulted in video intensity measurements that were well within the linear range of 
the microbubble concentration and video intensity indicated by both the in vitro and in 
vivo dose-range experiments, thus making it possible to accurately detect an increase in 
MV. For the current study, images were acquired during continuous imaging and at 
pulsing intervals from 1 to 20 s. 
7.2.5 1-MX metabolism 
To date, the best indicator that we have that 1-MX metabolism reflects microvascular 
perfusion comes from studies of the effect of electrical stimulation of muscle (49;199). 
We have shown that 1-MX metabolism increases in response to electrical stimulation (a 
known stimulus for capillary recruitment) in rat hindlimb both in vivo (49) and in a 
perfused preparation (199). In the perfused rat hindlimb preparation, total blood flow is 
held constant (199), yet 1-MX conversion to 1-MU is increased, suggesting that 
microvascular perfusion can be affected independently of total flow. 
In group 1 rats, 1-MX (0.4 mg • min -1 • kg-I ) was infused intravenously at a constant rate 
during the last 60 min of each study. It was shown in previous experiments (138) that 1- 
MX is rapidly metabolized to 1-MU and that it is necessary to partially inhibit the 
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xanthine oxidase before infusing 1-MX to slow its whole-body clearance and to allow for 
measurable concentrations in arterial and venous blood. We have performed allopurinol 
dose-response curves in the rat in vivo (data not shown) and found that 10 umol/kg 
partially inhibited the xanthine oxidase and allowed steady-state systemic levels of 1-MX 
to be obtained. 
At the end of each experiment in rats from group 1, blood from the carotid artery and 
femoral vein was sampled and immediately centrifuged, and 100 ul of plasma was added 
to 20 pi of 2 M perchloric acid. The plasma was immediately neutralized with 12 pi 2.5 
mM K2CO3 and stored at -20°C until analysis of 1-MX. 
Plasma 1-MX, 1-MU, allopurinol, and oxypurinol were analyzed using reverse-phase 
high-performance liquid chromatography from a modified version of the protocol used by 
Wynants et al. (194). The metabolites were separated and analyzed using an Ultrasphere 
ODS column (25 cm, 5-mm particles; Beckman) at 1.0 ml/min. Two buffers were used 
for the aqueous mobile phase. Buffer A consisted of 4.35 mM acetic acid, and buffer B 
consisted of 87 mM acetic acid/20% methanol/5% acetonitrile/0.2% tetrahydrofuran, p1-1 
4.0. Buffer A was used during 0-10 min, and at that time buffer B was introduced and 
buffer A was decreased by using a linear gradient from 10 to 30 min. Buffer B was used 
from 30 to 40 min. Detection between 0 and 20.5 min was at a wavelength of 250 nm, and 
between 20.5 and 40 min it was at 272 nm. 
7.2.6 Statistical analysis 
For animals studied in group 1, an unpaired Student's t test was used to test differences 
between saline- and insulin-infused rats for mean arterial blood pressure, heart rate, 
arterial blood glucose level, vascular resistance, and 1-MX metabolism after 120 min of 
infusion. A paired Student's t test was used to compare the effects of insulin or saline 
versus baseline on MV, 13, and femoral artery blood flow after 120 min of infusion. For 
group 2, where each animal served as its own control, repeated-measures analysis of 
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variance was used to test differences between baseline and 30 and 90 min of insulin 
infusion on MV, 13, and femoral artery flow. When a significant difference was found, 
pairwise comparisons by Student-Newman-Keuls test were used to determine at which 
individual times the differences were significant. For all comparisons, significance was 
recognized at P < 0.05. 
7.3 Results 
7.3.1 The effect of insulin on microvascular recruitment and femoral artery flow. 
In rats in group 1, arterial blood glucose concentrations remained constant throughout the 
experiment and were similar in insulin-and saline-treated animals (Table 7.1). To 
maintain euglycaemia, the insulin group required glucose infusion at an average rate of 
11.3 ± 2.4 mg • min -I kg -I . Insulin infusion increased the plasma insulin concentration 
from 52 ± 13 to 599 ± 58 pmo1/1 (P < 0.05, n = 4). Compared with saline, insulin infusion 
for 120 min did not alter mean arterial pressure or heart rate (Table 7.1). However, 
hindleg vascular resistance (mean arterial pressure/femoral artery flow) declined 
significantly (P < 0.05) in response to insulin, and femoral artery flow increased (0.64 ± 
0.05 to 1.02± 0.10 ml/min; P < 0.05) with insulin but not with saline (0.79 ± 0.13 to 0.68 
± 0.09 ml/min) (Figure 7.1 and Table 7.2). Table 7.2 shows that femoral artery flow was 
significantly higher after 120 min of insulin infusion compared with saline (P < 0.05). 
Compared with baseline, MV markedly increased with insulin (167.0± 39.8%) (Table 
7.2) at 120 min. This change was significantly greater (P < 0.05) than the 28.2 ± 13.8% 
increase seen with saline (Table 7.2). In response to insulin or saline, 13 did not 
significantly change from baseline (Table 7.2). 
The effect of insulin and saline on arterial 1-MX concentrations and hindleg 1-MX 
metabolism is shown in Figure 7.2. At the end of the 120-min experimental period, 
arterial 1-MX concentration was similar between saline and insulin (18.3 ± 3.6 vs. 16.8 ± 
2.7 inno1/1). Hindleg 1-MX extraction during saline infusion was 7.1 ± 0.8 [imo1/1, and 
115 
Chapter 7 — Contrast Enhanced Ultrasound 
this was not significantly different from the insulin-treated group (7.7 ± 1.2 timo1/1). 
However, because of differences in total blood flow, 1-MX metabolism was 47% higher 
(P < 0.01) for insulin than saline, consistent with the conclusion that insulin had enhanced 
the exposure of 1-MX to xanthine oxidase by recruiting capillaries. 
7.3.2 Time course of insulin's action on microvascular flow. 
Figure 7.3A shows the background-subtracted color-coded CEU images (pulsing interval 
of 20 s) at baseline and after 30 and 90 min of insulin infusion. Progression of the color 
from red to orange to yellow signifies enhanced video intensity. Insulin produced a higher 
peak video intensity (MV) at this pulsing interval at both 30 and 90 min of infusion 
compared with baseline. Figure 7.3B shows the corresponding pulsing interval (1-20 s) 
versus video intensity data at baseline and after 30 and 90 min of insulin infusion. Again, 
insulin at 30 min produced a higher plateau video intensity (27 units) than baseline (17 
units), indicating increased MV. 13, a measure of red cell velocity, did not change, 
implying that capillary recruitment had not resulted from the sharing of existent blood 
flow. The pulsing interval versus video intensity curve obtained at 30 min was similar to 
that seen at 90 min of insulin infusion. 
Table 7.3 shows the effect of insulin on MV, B, and femoral artery flow at baseline and at 
30 and 90 min of infusion in the second group of animals. MV was significantly enhanced 
by 30 min (12.9 ± 1.8 to 18.9 ± 1.8; P < 0.001) of insulin infusion, and this was of similar 
magnitude to the changes observed at 90 min (20.6 ± 2.2; P < 0.001). This occurred at 
times when there was no discernable change in femoral artery flow. We estimated that we 
have a >80% power to detect a 20% change in blood flow within 30 min of insulin 
infusion. 13 at these times did not differ from baseline. However, the percent increase in 
MV appeared to be higher at 120 min in the first group (Table 7.2) than at the shorter 
times in the second group (Table 7.3). The difference in baseline MV between the two 
experimental groups is due at least in part to two different batches of microbubbles and 
modest changes in the gain settings. However, because we measured MV and 13 at 
baseline and during the insulin or saline infusion, each animal served as its own control. 
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TABLE 7.1 
Effect of saline and insulin on systemic and hindleg hemodynamic factors, blood 
glucose concentrations, and glucose infusion rate required to maintain basal blood 
glucose at the end of a 120-min infusion period 
Saline Insulin 
Mean arterial pressure (mmHg) 105 ± 5 99 ± 5 
Heart rate (beats/min) 294 ± 21 309 ± 22 
Hindlimb vascular resistance (mmHg • min • m1') 168 ± 20 106 ± 12 * 
Arterial blood glucose (mg/di) 84 ± 7 82 ± 8 
Final glucose infusion rate (mg 	mind 	kg') 11.3 ± 2.4 
Data are means ± SE; n = 6 for the saline group and n = 8 for the insulin group. 
P < 0.05 compared with saline, Student's unpaired t test. 
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Figure 7.1 Femoral artery blood flow in response to saline (SAL) or insulin (INS) at 
the end of the 120-min infusion period. Values are the means ± SE for six (saline) and 
nine (insulin) animals. *Significantly different (P < 0.05) from baseline. 
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Figure 7.2 Systemic and hindleg 1-MX values of saline (SAL) and insulin (INS) at 
the end of the 120-min infusion period. Values are means ± SE for six and five animals, 
respectively. *Significantly different (P < 0.05) from saline value. 
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TABLE 7.2 
Effect of saline and insulin infusion for 120 min on (FBF) femoral artery blood flow 
measured by flow probe, MV (microvascular volume), and B (mean cell velocity) 
measured by CEU 
Baseline Saline Baseline Insulin P (saline vs. insulin at 
120 min) 
FBF (ml/min) 0.79 ± 0.68 ± 0.64 ± 1.02± <0.05 
0.13 0.09 0.05 0. 10* 
AF'BF (%) -11.8± 62.7 ± <0.005 
6.6 14.9 
MV (video 6.1 ± 0.9 7.5 ±0.7 6.7± 1.7 13.4± <0.05 
intensity) 1.8 t 
AMY (%) 28.2± 167.0 ± <0.05 
13.8 39.8 
B(s1 ) 0.10± 0.09± 0.11 ± 0.14± NS 
0.03 0.02 0.02 0.02 
(%) 15.0± 29.5 ± NS 
34.3 13.9 
Data are means ± SE; n = 6 for the saline group and n = 9 for the insulin group. P value 
compares saline to insulin after 120 min (Student's unpaired t test). 
* P < 0.05 and 
tP <0.001 compared with baseline (Student's paired t test). FBF, femoral artery blood 
flow. 
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Figure 7.3 A: Examples of background-subtracted colour-coded contrast ultrasound 
images observed at a pulsing interval of 20s during baseline and after 30 and 90 min 
of insulin infusion. Colour changes from red to orange to yellow represent increasing 
MV. Colour scale (256 levels) for background-subtracted video intensity is at the bottom 
of each image. B: Typical trace of pulsing interval versus video intensity during baseline 
and after 30 and 90 min of insulin infusion. Data are obtained from adductor brevis and 
semimembranosus muscles of the rat. 
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TABLE 7.3 
Time course of insulin action on femoral artery blood flow measured by flow probe, 
MV, and B measured by CEU 
Baseline 0 min Insulin 30 min Insulin 90 min 
FBF (ml/min) 0.58 ± 0.08 0.55 ± 0.05 0.65 ± 0.08 
AFBF (%) 4.0 ± 3.7 13.8 ± 9.4 
MV (video intensity) 12.9± 1.8 18.9± 1.8 * 20.6 ± 2.2 * 
MV (%) 52.8 ± 14.8 64.6 ± 9.9 
13 (s-1 ) 0.11± 0.03 0.10 ± 0.02 0.11 ±0.02 
-2.2 ± 10.2 8.6 ± 15.2 
Data are means ± SE; n = 5 for each group. 
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7.4 Discussion 
At supraphysiological doses, insulin augments total skeletal muscle blood flow in humans 
(13;197). Some but not all (197) (170) investigators have reported a similar action with 
insulin at physiological concentrations in humans (170) (14;96) and animal models (135). 
In addition to dose, the duration of insulin exposure may be important to the enhancement 
of muscle blood flow, with the effect being greatest after several hours of steady-state 
hyperinsulinemia (197). The potential importance of these vascular actions of insulin is 
underscored by the observation that NG-monomethyl-L-arginine methyl ester can block 
insulin's action on total blood flow and concomitantly inhibit up to 30% of insulin-
mediated glucose disposal (12). 
In Chapter 5 the microvascular action of insulin in rat muscle in vivo was examined using 
laser Doppler flowmetry (28). The findings suggested that pharmacological 
concentrations of insulin enhance microvascular recruitment in rat muscle in vivo. In the 
current study, the action of physiological increases in insulin to recruit microvascular 
vessels was assessed using CEU. It was clear again that insulin increased microvascular 
blood volume, consistent with microvascular recruitment within muscle. The concordant 
results observed using two very different approaches suggest that the methods are 
comparable for assessing microvascular flow, and they provide strong evidence for a 
physiological action of insulin to regulate microvascular perfusion. 
The relative changes in 1-MX metabolism and CEU were not identical; indeed, within the 
CEU, results seen in groups 1 and 2 were not quantitatively identical. There are a number 
of things that might contribute to both the 1-MX and CEU measurements and thus 
influence the quantitative nature of the responses. First, the 1-MX measurement is made 
across the whole hind limb (arteriovenous difference X flow), whereas the CEU 
measurement is made in one area and exclusively in muscle. Therefore, if insulin had no 
effect to increase flow in nonmuscle tissue (bone and skin), the proportionate rise in MV 
based on the CEU measurement would be greater than for the 1-MX measurement. 
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Likewise, it is known that there are significant differences in insulin-induced increases in 
microsphere perfusion among different types of muscle (i.e., red versus white fibers) (81). 
Beyond that, it should be recognized that 1-MX metabolism and CEU are fundamentally 
different techniques for estimating microvascular recruitment. Microbubbles are entirely 
intravascular and produce a signal that we can measure as video intensity. The 
background subtraction procedure that we use allows us to remove the contribution from 
larger vessels, in which flow is rapid; this cannot be done with 1-MX, although it is 
thought that xanthine oxidase is predominantly a microvascular endothelial marker. 
Inasmuch as CEU is a noninvasive method, it permitted repeated measurement of 
insulin's vascular action in individual animals. We observed that insulin increased MV 
well before it affected hindlimb total blood flow. Indeed, the changes in steady-state video 
intensity (MV) at 30 and 90 min during the insulin infusion was not different from those 
seen at 120 min, by which time total hindlimb flow had begun to rise. This suggests that 
microvascular recruitment occurred early and remained stable for the duration of the 
infusion period, and that it occurred independently of changes in total flow. Therefore, 
insulin-mediated microvascular recruitment and total limb flow follow a different time 
course. This result is reminiscent of previous findings in Chapter 5 using pharmacological 
doses of insulin (10 mU • min d • kg-I ). In that study, insulin infusion caused an increase in 
laser Doppler signal in muscle within 20 min that reached a maximum by 50 min. 
Femoral artery flow measured continuously for the duration of the experiment was not 
increased until at least the 60 min time point (Chapter 5). Thus, increases in laser Doppler 
signal preceded by 30-40 min any changes in total muscle blood flow. The marked 
increase in femoral artery flow seen at 60 min in the laser Doppler study in Chapter 5 was 
likely caused by the higher dose of insulin (10 mU • min -I • kg -I ) used for the former 
study. As noted earlier, epinephrine infusion increases rat hindlimb blood flow without 
recruiting capillaries, measured by either hindleg 1-MX metabolism (138) or laser 
Doppler flowmetry (Chapter 5), again providing experimental evidence that changes in 
microvascular flow can be dissociated from changes in total limb flow. Kuznetsova et al. 
(93) have also shown dissociation between total muscle flow and microvascular flow, as 
measured by microspheres and laser Doppler flowmetry, respectively. In those studies, 
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angiotensin II or phenylephrine infusion into the anaesthetised rat during ganglionic 
blockade resulted in an increase in laser Doppler signal but no change in total flow. In 
contrast, isoproterenol markedly enhanced total muscle flow, despite a reduction in laser 
Doppler signal. 
In addition to microvascular blood volume, CEU provides an estimate of 13. The current 
results showed that 13 did not change significantly during the first 90 min of insulin 
infusion but may have increased at 120 min, a time when hindlimb flow had likewise 
risen. This is not surprising because the product of 13 x MV should provide an index of 
flow rate at a microvascular level. However, because this product increased without 
accompanying changes in femoral artery blood flow at 30 and 90 min of insulin infusion, 
the possibility should be considered that in addition to microvascular recruitment, insulin 
redistributed flow at the microvascular level within the rat hindleg. Femoral artery blood 
flow is a measurement of total hindleg flow that feeds muscle, bone, skin, and fat, 
whereas our measurement of MV and 13 is determined within a discrete area of the hindleg 
that is exclusively in muscle. Thus, it is possible to find a mismatch between total hindleg 
blood flow and MV x 13 within this small area of muscle. For example, we have found in 
the constant-flow perfused rat hindlimb that microvascular recruitment can increase in 
muscle without any change in total hindleg flow, and that this is most likely caused by 
flow redistribution within the hindlimb. Also, as noted previously, muscle blood flow in 
the rat hindlimb is very heterogeneous, based on the distribution of the different fiber 
types (80). For instance, in the anaesthetised rat, blood flow (measured by 15-pm 
microspheres) to the red quadriceps is 9 ml • 100 g -I mind but is only 4 ml • 100 g -I 
min' in the white quadricep and the extensor digitorum longus. Thus, based on the 
distinct differences in total muscle blood flow for each individual muscle of the rat 
hindlimb, it is highly likely that there could be a mismatch between total hindlimb flow 
and microvascular flow within a discrete area of muscle. 
The albumin microbubbles used as the contrast-enhancing agent averaged 4 pm in 
diameter, had similar rheology to red blood cells, and were contained entirely within the 
vascular space (84). As a result, they were an excellent perfusion tracer. Furthermore, 
over the range of video intensity studied here, there was a linear correlation between the 
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concentration of microbubbles within the vasculature and video intensity. CEU is 
particularly useful because it allows background subtraction of the tissue image and thus 
elimination of signal from large vessels, which fill very rapidly, allowing microvascular 
flow (which is slower) to be imaged selectively. The CEU method has the additional 
appeal that it allows imaging of specific regions within muscle and, unlike 1-MX 
metabolism or measures of total hindlimb flow, is not influenced by contributions from 
nonmuscle tissue (skin, bone, and adipose tissue). Furthermore, compared with laser 
Doppler flowmetry, CEU samples a relatively large volume of muscle and does not 
require surgical exposure of the muscle surface. The laser Doppler method applied to 
muscle has the potential for 'producing artifacts, given that it only samples the immediate 
region around an implanted or surface probe. 
Several other investigators have attempted to determine the effect of insulin on muscle 
microvascular flow. Raitakari et al. (136) used positron emission tomography during 
inhalation of [ 150]carbon monoxide. The labeled carbon monoxide binds to erythrocytes, 
thereby providing a vascular tracer. High-dose insulin concentrations augmented leg 
blood flow and increased muscle blood volume by 9%. The high dose of insulin used 
limited any effort to separately assess effects on total flow from those on microvascular 
recruitment. Moreover, the positron emission tomography method measures blood within 
both the larger vessels and the microvasculature; thus, changes in MV may not be 
accurately quantified. 
In a subsequent study, Bonadonna et al. (20) used a very different approach and injected a 
bolus of nonmetabolizable radiolabeled L-glucose into the brachial artery to measure 
forearm transit time and to estimate extracellular volume. Pharmacological concentrations 
of insulin enhanced total forearm blood flow, as measured by the dilution of intra-
arterially infused indocyanine green dye. The mean transit time of L-glucose lengthened 
in response to insulin because of an expansion of the extracellular volume by 33%. This 
measure includes more than the vascular space, and would not report separately on large 
and small vessels. 
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More recently, Baron et al. (16) modeled the effects of insulin on microvascular flow by 
raising and lowering blood flow in the human leg during a steady-state insulin clamp and 
compared the results to the predicted values of the noncapillary recruitment model of 
Renkin (145). It was concluded that because glucose uptake was greater than predicted 
when leg blood flow was increased and smaller than predicted when leg blood flow was 
decreased, this suggested that the number of perfused capillaries changed considerably 
under insulin-stimulated conditions, assuming that glucose permeability remained 
constant. Although it was concluded that insulin-mediated increments in muscle perfusion 
are accompanied by microvascular recruitment, no direct experimental measure of 
microvascular recruitment was made. 
The relation between insulin's action on total muscle blood flow and its metabolic actions 
remains embedded in controversy. Yki-Jarvinen and Utriainen (197) have concluded that 
insulin's effect on total limb flow occurs after its metabolic effects on glucose uptake. It 
should be noted that this temporal discordance is based on the assumption that insulin's 
vascular action is restricted to increases in total blood flow. The present study indicated 
that insulin produces an early hemodynamic action at the microvascular level during a 
time that insulin is producing a metabolic action. Interestingly, microvascular recruitment 
(as measured by laser Doppler flowmetry) closely follows changes in glucose infusion 
rate and not total muscle flow (28). This relation also held for the current study because 
the glucose infusion rate at 30 min of insulin infusion was 90% of the glucose infusion 
rate used at 90 min (the plateau for insulin's metabolic action). 
Insulin-stimulated total blood flow in many insulin-resistant disease states, such as type 2 
diabetes, hypertension, and obesity, is reported to be blunted (11;13;14;96), providing 
further evidence that the hemodynamic involvement of insulin may be important for its 
action. However, controversies regarding the vascular actions of physiological doses of 
insulin persist because some investigators have failed to see an increase in blood flow 
within healthy humans (116) or an impairment during insulin-resistant states (24;182). 
None of these studies address separately the actions of insulin on microvascular 
recruitment and total flow. This is unfortunate because, based on the theoretical models of 
tissue perfusion developed by Renkin (145), microvascular recruitment might be expected 
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to be a more potent determinant of tissue glucose exchange than total flow. For instance, 
we have recently reported that when insulin-mediated microvascular recruitment is 
prevented with the vasoconstrictor Er-methyl-5-HT, an acute insulin-resistant state is 
induced (139). 
In summary, these results indicate that insulin at physiological concentrations recruits 
flow to the microvasculature in muscle, and at the insulin concentration used here, this 
effect precedes by at least 60 min any changes in total muscle blood flow. Changes in 
total muscle blood flow have later onset and do not involve further changes in the 
microvasculature. Therefore, a full assessment of the role of insulin's vascular actions in 
healthy and insulin-resistant states may require focusing on the effects on both total blood 
flow and microvascular flow, which could be the key to insulin's vascular action. 
Overall, the data from CEU measurement of microvascular volume (capillary 
recruitment) and capillary recruitment by 1-MX metabolism support the data of Chapter 5 
where LDF measurements were used. 
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CHAPTER 8 
Changes in Nutritive Blood Flow Patterns Induced by Insulin in Rat Muscle In Vivo 
of Colony, Lean and Obese Zucker Rats: A Study Using the 
Biochemical Marker, 1-Methylxanthine.  
8.1 Introduction 
In this Chapter the 1-MX method is used to assess responses to insulin in normal colony 
rats as well as lean and obese Zucker rats. The hypothesis is that the insulin response in 
the obese Zucker rats will be impaired when compared to lean Zuckers. Since the lean 
Zuckers are a mixture of homozygote leans and heterozygotes of lean and obese genes, a 
lower level of responsiveness relative to colony rats is conceiveable. 
The genetically obese Zucker rat is regarded as a useful animal model of insulin 
resistance. Not unlike the insulin resistance in humans, the obese phenotype of the Zucker 
rat shows hyperinsulinemia (204), dyslipidemia (87) and hypertension (92). The obesity 
develops as a result of a recessive mutation in the gene for the leptin receptor (134). By 
four to five weeks of age obese rats weigh significantly more than their lean littermates 
(203). Insulin resistance then develops in muscle and liver (131;175) and may involve 
reduced insulin sensitivity as well as a blunted maximal responsiveness to insulin (44). 
There is clear evidence that the insulin resistance is intrinsic to the muscle fibres or 
myocytes. Thus it is not only apparent in vivo (45;131), but in the perfused hindlimb 
(87;160) and in individual muscles once they have been isolated and incubated (44). In 
addition, glycolysis, glucose oxidation and glycogen synthesis are all impaired in the 
muscle of obese Zucker rats (44). Explanations for the insulin resistance include 
alterations in the insulin signaling pathway in the obese. For example in skeletal muscle 
there is reduced expression of IRS1 and IRS2 (4), leading to decreased insulin stimulated 
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tyrosine phosphorylation and decreased Pl3kinase activity associated with IRS1 (88). 
Insulin stimulated AKT I , AKT2 (88) and ERK2 (128) activity are reduced in obese rats, 
but there are no alterations in the levels of GLUT4 mRNA (195) or GLUT4 protein (64) 
in the obese Zucker rats. 
Within the context of this thesis the obvious question that arises is whether there are 
haemodynamic alterations that may contribute to the insulin resistance of muscle that 
manifests in vivo. Some studies with isolated vessels suggest that this may be so. For 
example, the ability of insulin to attenuate vasoconstriction is impaired in obese Zucker 
rats (188;201). The focus in this Chapter is thus on comparing the relative 
responsiveness to insulin in terms of capillary recruitment in muscle as measured by the 
l-MX method. 
8.2 Methods 
8.2.1 Animals 
Male colony rats were bred at the University of Tasmania Animal House and were a 
hooded Wistar strain as used in earlier chapters. The Zucker lean (Fa!?) and obese (fa/fa) 
rats were male and 18 weeks old. They were purchased from Monash University, 
Melbourne, Australia. All rats were housed at a constant temperature of 21 ± 1 °C in a 
12h/12h light/dark cycle and allowed free access to water and a commercial diet as 
previously described (200). All procedures adopted and experiments undertaken were 
approved by the University of Tasmania Animal Ethics Committee. 
8.2.2 Surgery 
Procedures for the hyperinsulinaemic euglycaemic clamp or saline infusion of rats in vivo 
under anaesthesia are essentially as described in Chapter 2. In brief, colony hooded 
Wistar, Zucker lean and Zucker obese rats were treated similarly and underwent either of 
two protocols after a 60 min period of equilibration when BP and HR had stabilized 
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following surgery for cannulation, and positioning the hind leg flow probe. Protocol 1: 
Saline was infused over a 2h period in an amount equivalent to the volume of insulin and 
30% glucose infused in Protocol 2. A bolus of allopurinol (10 timol/kg) was injected at 
55 min and then 1-MX was infused at 0.4 mg/min/kg over the final 60 min. A bolus of 
radioactive 2DG (50 gCi) was injected at 75 min. Arterial blood samples were taken ten 
minutes before the commencement of the saline infusion and at every ten minutes during 
the first hour and then every fifteen minutes in the second hour to monitor glucose levels. 
Arterial samples at 80, 85, 90, 105 and 120 min were also used to monitor radioactive 
2DG. Protocol 2: Insulin was infused at 30 (hooded Wistars) or 20 mU/kg/min (Zuckers) 
in place of the saline as used in Protocol 1. Muscles were excised at the completion of 
the experiment and freeze clamped in liquid nitrogen to assess the [ 3 H]2-deoxyglucose-6- 
phosphate as described previously (200). The total blood volume withdrawn from the 
animals before the final arterial and venous samples did not exceed 1.5 ml and was easily 
compensated by the volume of fluid infused. Duplicate arterial (A) and venous (V) 
samples (300 pi) were taken at the end of the experiment (120 min) and placed on ice. 
These blood samples were immediately centrifuged and 100 'al of plasma mixed with 20 
of 2M perch loric acid. The perchloric acid treated samples were then stored at -20°C 
until assayed for 1-MX. The rest of the plasma was used for glucose and insulin analysis. 
8.2.3 Analytical methods 
A glucose analyser (Yellow Springs Instruments, Model 2300 Stat Plus) was used to 
determine whole blood glucose (by the glucose oxidase method) during the insulin clamp. 
A blood sample of 25 121 was required for each determination. Insulin levels at the 
beginning and end of the experiment were determined from arterial plasma samples by 
ELISA assay (Mercodia, Sweden). Perchloric acid treated plasma samples were 
centrifuged for 10 min and the supernatant used to determine 1-MX, allopurinol and 
oxypurinol concentrations by reverse-phase HPLC as previously described (138;139). 
Xanthine oxidase activity was assessed from muscle homogenates as described 
previously (142). 
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8.2.4 2DG uptake assay 
The frozen soleus, red gastrocnemius, white gastrocnemius, extensor digitorum longus, 
tibialis and plantaris muscles were ground under liquid nitrogen and homogenized using 
an Ultra TurraxTm. Free and phosphorylated [ 3 1-1]2DG were separated by ion exchange 
chromatography using an anion exchange resin (AG1-X8) (81;91). Biodegradable 
Counting Scintillant-BCA, (Amersham, USA) was added to each radioactive sample and 
radioactivity determined using a scintillation counter (Beckman LS3801, USA). From 
this measurement and a knowledge of plasma glucose and the time course of plasma 2DG 
disappearance, R'g, which reflects glucose uptake into the muscle, was calculated as 
previously described by others (81;91). The combined data for the muscles are shown. 
8.2.5 Data analysis 
All data are expressed as means ± SE. Mean femoral blood flow was calculated from 5 
second subsamples of the data, representing 500 flow measurements every 15 minutes. 
Vascular resistance in the hindleg was calculated as mean arterial blood pressure in 
millimetres of mercury divided by femoral blood flow in millilitres per minute and 
expressed as resistance units (RUs). Glucose uptake in the hindlimb was calculated from 
A-V glucose difference and multiplied by femoral blood flow and expressed as 
iimol/min. The 1-MX disappearance was calculated from A-V plasma 1-MX difference 
and multiplied by femoral blood flow (corrected for the volume accessible to 1-MX, 
0.871, determined from plasma concentrations obtained after additions of standard 1-MX 
to whole rat blood) and expressed as nmoles/min. 
8.2.6 Statistical analysis 
In order to ascertain differences between treatment groups at the end of the experiment 
(120min), two way analysis of variance using the Student-Newman-Keuls method was 
performed. Significant differences (P<0.05) between insulin and saline treatment in each 
phenotype of rat, as well as differences between lean and obese rats undergoing the same 
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treatment were reported. An unpaired Student's t-test was used to determine whether 
there was a significant difference (P<0.05) between the glucose infusion rates at the 
conclusion of the experiments. All tests were performed using the SigmaStatTM statistical 
program (Jandel Software Corp.). 
8.3 Results 
8.3.1 Characteristics 
At the time of study, obese Zucker rats (445 ± 5g) weighed significantly more than their 
lean littermates (322 ± 4 g; Table 8.1). Obese Zucker rats exhibited hyperinsulinemia 
and hyperglycemia, prior to either insulin or saline infusions, when compared with their 
lean littermates or colony rats (Table 8.1). Lean Zuckers did not differ from colony rats 
in any other respect even though they were slightly lighter (Table 8.1). 
In order to make comparisons of insulin-mediated haemodynamic and metabolic changes 
data from colony rats were chosen where the dose of insulin infused had led to similar 
plateau insulin levels as the lean Zuckers. Thus as shown in Table 8.2 colony rats were 
infused with 30 mU/kg/min whereas both lean and obese Zuckers were infused with 20 
mU/kg/min insulin. In colony and lean Zucker rats, plasma insulin levels were 
significantly higher as a result of insulin infusion compared with saline infusion. Colony 
rats with 30 mU/kg/min insulin were 9666 ± 660 whereas with saline they were 337 ± 31 
pM. Lean Zuckers infused with 20 mU/kg/min had plasma insulin of 8630 ± 665 pM and 
infused with saline of 441 ± 70 pM. Similarly, in obese Zuckers, plasma insulin levels 
were 20190 ± 1281 pM and 5963 ± 815 pM following insulin and saline infusion, 
respectively. The higher basal insulin levels may reflect the fed state and the fact that the 
obese eat more than the lean. Clearly, an insulin infusion of 20mU.min -l .kg-1 resulted in 
significantly higher insulin levels in obese rats compared with the lean, and colony rats 
required a higher insulin infusion rate to attain similar plasma insulin levels as the lean 
Zuckers (Table 8.2). 
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Table 8.1 Characteristics of colony hooded Wistar, lean and obese Zucker rats. All 
values were measured at the commencement of saline or insulin infusion. Values are 
means ± SE for n = 14-17 rats in each group. It, Significantly different (P < 0.05) from 
lean Zucker rats; t, significantly different (P < 0.05) from colony rats. 
Colony Lean Obese 
Age (weeks) 15 ± 3 18 ± 2 18 ± 2 
Body weight (g) 245 ± 5 322 ± 4 445±5# 
Plasma Insulin (pmol/1) 183 ± 37 182 ± 21 4158 ± 491 # 
Blood Glucose (mM) 4.4± 0.1 4.8 ± 0.2 11.7± 0.6 # 
Blood Pressure (mmHg) 105 ± 3 107 ± 2 107 ± 1 
Heart Rate (Beats/min) 351 ± 7 335 ± 9 329 ± 6 
Femoral Blood Flow (ml/min) 0.76 ± 0.06 0.69 ± 0.05 0.69 ± 0.05 
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Table 8.2 Comparison of colony, Zucker lean and obese rats in terms of their response to insulin under clamp conditions 
Colony hooded Wistar 
n = 6-8 
Lean Zucker 
n = 6-8 
Obese Zucker 
n = 6-8 
Insulin infusion for clamp (mU/kg/min) 
Plasma insulin post saline control (pM) 
Plasma insulin at end of clamp (pM) 
Haemodynamics 
Change in FBF -saline (ml/min) 
Change in FBF -insulin 
30 
337 ± 31 
9666 ± 660* 
0.18 ± 0.02 
0.90 ± 0.21* 
20 
441 ± 70 
8630 ± 665 
0.12 ± 0.02 
0.63 ± 0.16* 
20 
5963 ± 815# 
20190 ± 1281# 
0.07 ± 0.04 
0.13 ± 0.03# 
Change in VR -saline (RU) -24 ± 6 -11 ± 7 -6 ± 9 
Change in VR -insulin -62 ± 10* -65 ± 12* -18 ± 13# 
1-MX metabolisml -saline (nmol/min) 4.8 ± 0.4 7.6 ± 0.6 4.8 ± 0.4# 
1-MX metabolism -insulin 7.7 ± 0.7* 9.3 ± 0.7* 3.6 ± 0.6# 
Metabolism 
GIR plateau (mg/kg/min) 25.5 ± 1.2* 22.1 ± 0.8* 8.0 ± 0.4*# 
HGU -saline (Rmol/min) 0.16 ± 0.04 0.15 ± 0.05 0.13 ± 0.04 
HGU - insulin 0.74 ± 0.08* 1.12 ± 0.10* 0.18 ± 0.05# 
Combined lower leg muscles R'g -saline (nig/min) 3.1± 0.3 5.0 ± 0.4 7.9± 1.1 
Combined lower leg muscles R'g -insulin 16.3± 1.5 25.8 ± 2.7*1 . 12.6 ± 2.6# 
Values apart from insulin infusion rates are means ± SE and were determined at the end of the experiment (120 min). Hind leg glucose 
uptake (HGU) was determined from arterio -venous difference and femoral blood flow at the end of the clamp. R'g represents values 
for 2-DG uptake by the combined lower leg muscles. All rats were fed. Values from the colony rats are from (202). *, Significantly 
different (P < 0.05) from corresponding saline treatment; #, significantly different (P < 0.05) from corresponding treatment in lean 
Zucker rat; t, lean Zucker significantly different (P < 0.05) from colony rat. 
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8.3.2 Haemodynamic effects 
There was no significant difference in the basal mean arterial pressure or heart rate 
between colony, lean or obese rats (Table 8.1), nor did any difference develop as a result 
of a 2 hour insulin or saline infusion (data not shown). Similarly, basal femoral arterial 
blood flow also did not differ between the three groups (Table 8.1). However, whereas 
there was very little increase in femoral arterial blood flow with saline infusion, insulin 
significantly increased flow in the colony rats and lean Zuckers but not in the obese 
Zucker rats (Table 8.2). Accordingly, vascular resistance was decreased by insulin only 
in the colony rats and lean Zuckers (Table 8.2). 
8.3.3 1-MX metabolism 
The arterial plasma concentrations of oxypurinol were similar at approx. 6 1.1M in all three 
groups, colony, lean Zucker and obese Zucker (data not shown). Arterial 1-MX levels 
were slightly higher in both the lean and obese Zucker rat (approx. 30 ilM) compared to 
the colony animals of approx. 23 RM (data not shown). Even so, it was clear that insulin 
increased 1-MX metabolism in both the colony and lean Zuckers but was without effect 
in the obese animals (Table 8.2). 
8.3.4 Glucose metabolism 
Basal blood glucose was significantly higher in the obese (11.7 ± 0.6 mM) than lean (4.8 
± 0.2 mM) or the colony rats (4.4 ± 0.1, Table 8.1). Glucose infusion rates were set to 
maintain these levels throughout the insulin clamp. As shown in Table 8.2, and because 
of the marked insulin resistance of the obese animals, glucose infusions were much less. 
Plateau values for glucose infusion of colony, lean and obese animals were 25.5 ± 1.2, 
22.2 ± 1.1, and 7.7 ± 1.4 mg.min i .kg -I , respectively. Glucose extraction across the 
hindleg was increased significantly by insulin in the colony and lean rats, but the small 
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increase induced by insulin in the obese rats was not significant (data not shown). 
Hindlimb glucose uptake, which is the product of glucose extraction and femoral blood 
flow, showed a similar trend (Table 8.2) with only the colony and lean Zuckers showing a 
stimulation due to insulin. Insulin resistance was also apparent in the obese rats when 
assessed by 2-deoxyglucose uptake into the combined muscles of the lower leg (Table 
8.2). Thus, for insulin-mediated 2-deoxyglucose uptake in muscles of colony, lean and 
obese animals were 16.3 ± 1.5, 25.9 ± 2.4 and 12.6 ± 2.6 lig.miri t .g-1 , respectively. 
Combined R'g for the lean Zucker was significantly higher than for the colony rat, even 
though all other related measures of glucose metabolism were similar (Table 8.2) 
8.4 Discussion 
In the present study capillary recruitment has been measured by determining arterio-
venous extraction of 1-MX across the leg and femoral arterial blood flow. A number of 
findings emerged in addition to the clearly impaired response to insulin by the obese 
animals. First, it was evident that the stimulation of capillary recruitment in lean Zuckers 
was muted particularly when compared to the insulin-responsive colony rats (200) and 
may reflect partial insulin resistance of the genotype mix of the lean Zuckers which are 
either heterozygous (Fa/fa) or homozygous (Fa/Fa). A heterozygote effect is apparent for 
body weight, total body fat and insulin secretion (19). Second, in saline infused rats the 
hindlimb 1-MX disappearance was lower in obese rats compared with the lean. This may 
result from reduced muscle mass, lower capillary density (98), or decreased perfusion of 
existing capillaries in the basal state. The xanthine oxidase activity in muscle 
homogenates from obese Zucker rats tended to be reduced. This may be a reflection of a 
lower capillary density in the obese rats (98), although there is not consensus on this issue 
(176). 
The fact that the basal hindleg glucose uptake and 2-deoxyglucose uptake were not 
elevated in the lean Zuckers in accordance with the higher 1-MX metabolism is not 
unexpected, since it is probably necessary to have insulin present to observe marked 
alterations in glucose uptake. Furthermore, it is likely that in the obese rats, the basal 
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glucose uptake is partly increased by mass action since the glucose levels were 
significantly higher than the lean group. This would offset any differences in glucose 
uptake due to the extent of perfusion, and result in similar levels in both groups. 
The present study shows for the first time major impairments of insulin's haemodynamic 
effects in Zucker obese rats in vivo. The impairments manifested as markedly decreased 
responses to insulin in terms of hindlimb femoral arterial blood flow and capillary 
recruitment in obese animals when compared to age-matched leans. These findings add 
an important in vivo perspective to data already reported by others of impaired vascular 
responses to insulin in Zucker obese rat tissues in vitro. For example, Zemel et al., (201) 
noted that isolated thoracic aortae from obese rats were more sensitive to phenylephrine-
induced constriction, and moreover, the ability of insulin to attenuate this response was 
reduced. Similarly, Walker et al., (187) found that norepinephrine induced 
vasoconstriction was attenuated by insulin in mesenteric arteries from lean rats, but not 
obese. In addition, endothelial function was abnormal in obese rats and the 
acetylcholine-induced dilation was reduced (187). 
The impaired capillary recruitment in the obese Zuckers may contribute to the insulin 
resistance seen in these rats. Consistent with reports by others (131;175), the glucose 
infusion rate was reduced by 65% with no significant effect of insulin to increase either 
hindlimb or 2-deoxyglucose uptake in the obese rats, even at supra-physiological insulin 
levels. In addition, at more physiological levels (e.g. 3mU.min -l .kg-1 ) there was no 
response to insulin with respect to either glucose uptake or haemodynamic measurements 
(data not shown). 
The present findings also add to this laboratory's previous report where resting muscle 
oxygen uptake was impaired in the obese Zucker hindimb muscle (56) leading to the 
likelihood that impaired access for insulin and glucose extends to oxygen. Thus vascular 
changes involving regulation of flow distribution and/or dominance of non-nutritive flow 
may be contributory to both the obese phenotype and the insulin resistance. However, the 
mechanism responsible for the impaired response to insulin may relate more to impaired 
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insulin signaling in the vasculature than to dominance of non-nutritive flow. This view is 
supported by data from preliminary studies which show that contraction-mediated 
capillary recruitment (1-MX metabolism) is increased by 85% attaining similar levels to 
contraction in lean rats (192). Since insulin's activation of the PI 3-kinase, but not the 
MAP-kinase pathway is diminished in vascular tissues from obese Zuckers (85) and since 
NO has been implicated in insulin mediated increases in both total flow (152) (165) and 
capillary recruitment (179), defects in either NO production or the VSMC responsiveness 
to NO may underlie the diminished vascular insulin response in vivo, that is reported 
herein. 
Failure to find a significant increase in hindleg or 2-deoxyglucose uptake in the obese rats 
in response to insulin, indicates that the insulin resistance is not solely due to the 
decreased muscle mass. Moreover, insulin resistance is apparent when muscles from 
obese rats are incubated, suggesting that there is an intrinsic defect in the tissue itself 
(44). Impairment of insulin's haemodynamic actions in vivo could contribute to the 
insulin resistance by reducing access for hormone and nutrient but would not be the sole 
cause of the insulin resistance in these animals. 
The novel finding of impaired insulin-mediated haemodynamic effects in the obese 
Zucker would imply decreased access of insulin and glucose and therefore a diminished 
supply from plasma to interstitium. While this may not necessarily create a gradient at 
steady state, the time-dependent of delivery of glucose and/or insulin to the interstitium 
may be affected. It is of interest that Holmang et al., (72) using microdialysis 
measurements in skeletal muscle found that the steady state interstitial and plasma insulin 
concentrations were similar in both lean and obese Zucker rats. They concluded that the 
insulin resistance of obese Zuckers is a result of a cellular defect, rather than a 
haemodynamic one. At this stage it is not known what effect changes in capillary 
recruitment as mediated by insulin have on steady state interstitial insulin levels, but it is 
highly likely that the time-dependent approach will be increased. 
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TNFa expression is elevated in adipose tissue of obese individuals and has been 
implicated as a cause of the associated insulin resistance (73). In support of this, 
treatment of obese Zucker rats with a soluble TNFot receptor-immunoglobulin G 
chimeric protein improved glucose infusion rate during hyperinsulinemic euglycemic 
clamp (74). Similarly, Cheung etal., (27) showed that inhibition of TNFa activity 
through the adenovirus-5 mediated transfer of a TNF inhibitor gene, improved peripheral 
and hepatic insulin sensitivity in obese Zucker rats. Raised plasma levels of TNFa have 
been reported in obese Zuckers (89) and the blunted haemodynamic effects observed in 
these rats may be a consequence of this (200). However, elevated plasma free fatty acids 
may be more important (110) and responsible for the insulin resistance of the Zucker. 
Previous data from our laboratory supports this view and shows that acutely elevated free 
fatty acids in a non-obese strain markedly impair insulin-mediated capillary recruitment 
and muscle glucose uptake in vivo (38). 
It is interesting that the colony and lean Zucker rats show very little difference. In fact the 
major difference was clearly in the handling of insulin. Thus an infusion of 30 
mU/kg/min insulin was required to reach similar plasma insulin levels to lean Zucker 
animals which were receiving 20 mU/kg/min. All responses to insulin were remarkably 
similar in the colony and lean animals with the exception of a lower insulin-mediated R'g 
for the combined muscle of the lower leg. 
To summarize, the 1-MX metabolism method was successfully used to show insulin-
mediated capillary recruitment in insulin-responsive colony rats consistent with findings 
reported in earlier chapters using either LDF or CEU. In addition the method allowed the 
detection of a marked insulin ressitance in terms of capillary recruitment in the muscle of 
obese Zucker rats. The impairment in insulin-mediated capillary recruitment in the obese 
Zucker rats may contribute to the insulin resistance of muscle in these animals. 
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CHAPTER 9 
General Discussion 
9.1 	Summary of thesis 
The focus of this thesis has been the new technologies that have been developed to 
measure changes in microvascular perfusion in muscle. In particular the emphasis has 
been on the application of laser Doppler flowmetry for this purpose and comparisons 
have been made against the more-established methods of contrast enhanced ultrasound / 
microbubbles and the metabolism of 1-methyl xanthine. A principal goal in using the 
technique of laser Doppler flowmetry was to better understand the microvascular effects 
of insulin in muscle. But to do this, changes in microvascular perfusion needed to be 
measured in pump-perfused rat hindlimb muscle when shifts in the nutritive to non-
nutritive flow ratio were altered by vasoconstrictors and total flow was maintained 
constant. Comparisons were then made in vivo with insulin action in normally responsive 
rats, in genetically obese insulin resistant Zucker rats, and in the muscle of healthy human 
subjects undergoing a hyperinsulinaemic euglycaemic clamp. Several important 
observations were made, particularly concerning LDF as a potential method for assessing 
changes in muscle microvascular perfusion. 
9.2 	Heterogeneity of nutritive and non-nutritive sites within muscle 
First, the size of the LDF probe (in terms of fibre separation) was critical when this 
technique was used to assess microvascular perfusion. Thus in the first study of this thesis 
microprobes that could be impaled into the muscle tissue revealed a heterogeneity of sites 
when randomly placed. The sites differed dramatically in the signal generated when flow 
was altered by vasoconstrictor injection into the constant flow perfused rat hindlimb. 
Bolus injection of type A vasoconstrictor that is known to increase nutritive flow at the 
expense of non-nutritive flow revealed sites of three different character. The majority 
(approx. 60%) showed an increase in LDF signal coincident with the increases in oxygen 
uptake and pressure. In these experiments oxygen uptake was used as a surrogate 
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indicator of nutritive flow. Similarly, with the probe still positioned in this same site, a 
bolus injection of a type B vasoconstrictor produced a decrease in LDF signal, again in 
close temporal association with the expected decrease in oxygen uptake. The remaining 
sites were of quite different character, with approx. 20% responding such that the LDF 
signal moved in the opposite direction to that of the oxygen uptake; i.e. decreasing with 
type A vasoconstrictor and increasing with type B vasoconstrictor. Another 10% differed 
yet again and were probably a mixture of the two previously described sites where the 
LDF signal did not respond to either type of vascoconstrictor even though the pressure 
increased, possibly reflecting an increase in LDF signal superimposed upon a decrease. A 
considerably larger LDF probe that was approx. 4-fold the diameter of the impalable 
micro-probe detected only the majority response. Thus injection of a type A 
vasoconstrictor that increased oxygen uptake increased the signal and a type B 
vasoconstrictor that decreased the oxygen uptake, decreased the LDF signal. However, it 
is important to recall that a limitation of the larger probe is that it was only able to 
measure superficial regions and these may differ to some extent from those registered by 
the impaled probe. 
Taken together these findings suggested that a heterogeneity of sites existed in muscle 
where the predominant type responded in concert with the change in nutritive flow. This 
might mean that these could be termed as nutritive and the smaller proportion sites as 
non-nutritive. 
9.3 	Capillary tortuosity 
It is important to remember that these studies with randomly placed micro-probes and 
macro-probes were all conducted using the perfusesd rat hindlimb at constant total flow. 
A key question then arose as to the nature of the change in tissue perfusion that might 
explain the change in LDF signal when the vasoconstrictors were injected. A study using 
fabricated capillary systems led to the second main observation. Of the different models 
tested, and these included switching flow from capillaries of different diameter, sharing 
of flow by recruitment of previously unperfused capillaries, and redistributing flow from 
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short to long tortuous capillaries, only the latter could explain the hindlimb perfusion 
data. Thus for a nutritive site, the LDF probe which is randomly positioned, happens to 
be where there are a majority of long tortuous capillaries. A type A vasoconstrictor 
constricts access to the shorter non-nutritive capillaries which are largely outside the LDF 
field under measurement, and flow is redistributed into the longer more tortuous 
capillaries that cross the field of measurement several times. These longer more tortuous 
vessels would fulfill a role as nutritive by having a considerably greater available surface 
area for nutrient exchange. Similarly at this nutritive site a type B vasoconstrictor 
constricts access to the long tortuous capillaries and redirects flow to the shorter non-
nutritive capillaries in the field of measurement and the LDF signal decreases. At the so-
called non-nutritive or "NE negative" site, there must be a predominance of the shorter 
non-nutritive capillaries and so the signal decreases and increases, respectively when type 
A and B vasocontrictors are injected into the whole hindlimb upstream of the area under 
measurement. If the type A vasoconstrictor was acting simply to change the diameter of 
the vessels in the region of measurement, the signal would always increase. Clearly this 
scenario is inconsistent with the outcome from the type B vasoconstrictor, which led to a 
decrease in the LDF signal. Similarly, if flow were moving from one vessel of a manifold 
that fed several vessels of comparable diameter, the mean cell velocity would decrease 
and since LDF is very sensitive to velocity, the LDF signal would also decrease. Each of 
these suppositions was confirmed with the fabricated synthetic capillaries. 
A concept involving regions of concentrated tortuous nutritive capillary networks 
separated from regions where these are relatively few fits reasonably well within the 
prespective of what is known of the muscle microvasculature Anatomical models of the 
muscle microvasculature depicted by Lindbom and Arfors and their colleagues (22) as 
well as those of Myrhage and Eriksson (114) show close co-existence of nutritive 
capillaries supplying the muscle cells with non-nutritive capillaries supplying 
neighboring connective tissue. For example, detailed drawings of the microvasculature of 
the rabbit tenuissimus muscle (22) show feed arteries that branch to supply transverse 
arterioles which in turn cross the muscle body (which in this muscle is flat) to firstly 
supply terminal arterioles and capillaries of the muscle then to end in vessels supplying 
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the connective tissue and attendant adipocytes (39). These latter capillaries are potentially 
nutritive for the fat cells and the connective tissue but can only be considered "non-
nutritive" for the more metabolically active muscle cells. A number of studies using 
intravital microscopy has shown that relative flow in the two networks can be influenced 
by various physiologically relevant agents and conditions (22;103-105) that redistribute 
flow consistent within the two regions representing the nutritive and non-nutritive routes 
of muscle (35). Inspection of the illustration of the tenuissimus muscle [(22); Figure 9.1] 
suggest the region containing nutritive capillaries to be approximately 3000 i.tm wide and 
somewhat less for the non-nutritive (104). 
If the difference between nutritive and non-nutritive capillaries was purely a result of the 
functional capacity of nutrient exchange to occur across the capillary wall (i.e. not a 
result of capillary architecture) then we would expect the LDF signal (especially from the 
larger probe) to be relatively unchanged as flow is switched from one route to another. 
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Figure 9.1 Blood flow in the tenuissimus muscle of the rabbit. This is drawn 
from intravital microscopy of this muscle during experiments where the 
distribution of flow in each route was altered by the application of various 
vasoactive substances to the superfusate (adapted from (22)). 
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Conceiveably the LDF micro-probe of 200 pm dia., as used in the present thesis might 
detect signal from one or other route, or even a mixture of the two depending on 
positioning. For muscles other than the tenuissimus that are cylindrical, the same vascular 
unit is observed (114), but now the transverse arteriole radiates out from the center of the 
muscle fibril and the connective tissue vessels are contained in the perimysium. Macro-
probes are probably too large to detect a heterogeneity of structure and thus reflect 
changes in the predominant population of nutritive sites, even though the input from 
some non-nutritive sites within the field cannot be avoided, which would, depending on 
the extent of overlap, attenuate (since it is opposite) the signal from the nutritive site. 
9.4 	Insulin improves microvascular perfusion 
The polymer tube model studies of this thesis thus provide a putative microvascular 
structure which allow at least some interpretation of the LDF signal. Thus in later 
chapters it was possible to assess the effect of insulin in vivo and to compare it with the 
effects of epinephrine, already known to increase limb blood flow without change in 
microvascular perfusion (138). It was also possible to conduct essentially identical 
experiments using the two other technologies of 1-MX metabolism and 
CEU/microbubbles and make comparisons. Application of LDF to in vivo studies led to 
the third major discovery that insulin under clamp conditions was able to increase LDF 
signal, detected either by surface scanning of the leg or by a stationay macroprobe 
positioned over the biceps femoris muscle. At the dose of insulin used (10mU/min/kg), 
the increase in LDF signal preceded the increase in limb blood flow by at least 10 min. In 
contrast, epinephrine which markedly increased limb blood flow had no effect on LDF 
signal. A flow-independent increase in LDF signal may thus be interpreted as reflecting 
an insulin-mediated increase or recruitment of nutritive flow into the long tortuous 
capillaries and a decrease in flow in the shorter non-nutritive capillaries. Epinephrine, 
although markedly increasing total blood flow did not increase capillary recruitment, the 
inference being that the increase in flow has been accommodated by the non-nutritive 
route. 
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9.5 	The vasomotion response 
The fourth major finding from this thesis was that physiological hyperinsulinaemia 
increased intramuscular microvascular reactive hyperaemia and vasomotion in healthy 
volunteers. To my knowledge this represented the first application of LDF technology to 
measuring muscle microvascular blood flow in humans in vivo during insulin clamp 
conditions. Whereas, the signal before and after insulin did not differ significantly (cf 
rats, (138)), there was a trend for an insulin-mediated increase. Perhaps more importantly, 
insulin significantly modified two aspects of vascular function. First, insulin increased the 
hyperaemic response to 3 min of ischaemia, and second, insulin increased the amplitude 
of vasomotion at low frequencies (Chapter 6). The finding that the hyperaemic response 
to ischaemia is increased following insulin treatment is similar to that already reported for 
skin (157) and suggests that insulin has acted to produce signal substances that enhance 
the relaxation of the terminal arterioles controlling entry to the nutritive capillary network 
in muscle. Vasodilation during reactive hyperaemia is thought to be determined at the 
level of the small arterioles. Thus the stimulatory effect of hyperinsulinaemia might be 
due to a decreased sensitivity to vasoconstrictor stimuli or an increased sensitivity to 
vasodilatory stimuli at the level of the small arterioles. At a molecular level, the 
mechanisms responsible for the increase in vascular perfusion after arterial occlusion are 
not fully understood. Previous studies have suggested that the hyperaemic response could 
be due to accumulation of metabolic vasodilators, such as nitric oxide, adenosine and 
prostaglandins, or to a myogenic or a neurogenic response (193). It seems unlikely that 
hyperinsulinaemia decreases sensitivity to vasoconstrictive effects, because, both in the 
isolated rat arteriole and in the human forearm, hyperinsulinaemia has been shown to 
increase vasoconstrictive effects by inducing endothelin-1 activity (25;58). In humans, 
insulin has been shown to stimulate vasodilatory effects by inducing endothelial nitric 
oxide (NO) production (166). A role for NO in the maximal hyperaemic response after 
arterial occlusion in muscle is supported by most (47;57;112), but not all studies (172) 
using venous occlusion plethysmography. The timing of the measurement may be 
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important for the determination of the relative contribution of NO, prostaglandin and 
other vasodilators in the post-ischemic hyperemia response. My view is that the findings 
are consistent with an insulin-mediated production of NO as has been proposed recently 
in rats where the insulin-mediated capillary recruitment in muscle in vivo was found to be 
blocked by a nitric oxide synthase inhibitor (179). Therefore, enhanced endothelial NO 
production might contribute to insulin-mediated changes in intramuscular reactive 
hyperaemia. Whether the production of NO by insulin can also account for the increase in 
low frequency vasomotion is not known and will be an important question to address in 
the future. In addition, the role of NO and other possible mechanisms in reactive 
hyperaemia in muscle vasculature, and insulin-mediated effects thereon, remain to be 
further investigated. 
The LDF probe used in the human muscle studies (Chapter 6) was intermediate in size 
between the micro- and macro-probes used in Chapter 3. Of consequence, this probe 
(model 402; Perimed, Stockholm, Sweden, fibre separation = 0.15mm of overall diameter 
that fitted comfortably inside a 0.9 mm catheter) largely avoided the problem of the 
heterogeneity of sites with the very fine micro-probe. Again this would be interpreted as 
having predominantly measured changes in perfusion of the nutritive capillary network. 
A major aspect of the work embodied by this thesis was to assess the applicability of 
LDF for measuring changes in microvascular perfusion, specifically muscle nutritive 
flow. The data from the perfused rat hindlimb where total flow was maintained constant, 
showed a tight correlation between nutritive flow (deduced from oxygen uptake, a 
surrogate indicator) and LDF signal (Figure 3.3). However, in vivo during the 
hyperinsulinaemic euglycaemic clamp, flow was free to change and thus a conclusion 
that the LDF signal was increased as a consequence of capillary recruitment and 
independent of flow relied on the fact that the increase in bulk blood flow was slower to 
occur (e.g. see Figure 5.5). To resolve this there was considerable value in comparing all 
three methods. Table 9.1 shows that changes in LDF signal in response to insulin or 
epinephrine were comparable to those determined using either 1-MX metabolism or 
CEU/microbubbles. However, of the three methods only LDF is sensitive to changes in 
flow. Considering firstly the 1-MX method, when bulk flow increases the extraction 
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fraction across the vascular bed in question decreases proportionately. For the CEU 
technique, the measurement of microvascular volume (Chapter 7) is completely 
independent of mean cell velocity, and therefore bulk flow, providing bulk flow per se is 
unable to influence capillary recruitment. In contrast to each of the 1-MX and CEU 
methods, the LDF is quite sensitive to flow. This can be seen in the data of Chapter 3 
when plotted as a 3-dimensional graph (Figure 9.2). Although LDF signal was increased 
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Figure 9.2 3-D Plot of LDF and oxygen uptake as a function of pump-delivered flow. 
Experiments were conducted using the isolated perfused rat hindlimb. When flow was 
held constant at 4m1/min LDF and oxygen uptake were each increased by norepinephrine, 
angiotensin II, or vasopressin (peaks to the left). When serotonin was added and again the 
flow kept constant at 4m1/min, LDF and oxygen uptake each decreased (singlepeak to the 
right) If no vasoconstrictors were added but flow was increased from 4 through 6 to 
8m1/min the LDF signal and oxygen uptake also increased (peaks moving up the plane) 
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by type A vasoconstrictors that increased nutritive flow (oxygen uptake), an increase in 
bulk flow can independently increase both LDF and oxygen uptake. This places a 
considerable caveat on the general applicability of LDF as a technique for assessing 
changes in muscle nutritive flow, when bulk flow cannot be controlled. 
9.6 	Implications 
From the experience gained in using all three techniques of 1-MX metabolism, LDF and 
CEU/microbubbles, I sought to explore whether a well-established model of insulin 
resistance, the genetically obese Zucker rat had impaired capillary recruitment in 
response to insulin. 1-MX metabolism was the method used to measure changes in 
capillary recruitment. The findings showed there was indeed a marked impairment when 
compared to the insulin responsive lean Zucker controls. This now adds to a number of 
other insulin resistant models which we have tested and all of which showed markedly 
impaired insulin-mediated capillary recruitment in association with impaired insulin-
mediated muscle glucose uptake. These include insulin resistance from acutely 
administered TNFa (200), acutely administered Intralipid with heparin (38) and the 
acutely administered serotonergic agonist, a-methyl serotonin (139). With regard to the 
obese Zucker rat it is interesting to note that our group has recently noted that capillary 
recruitment due to muscle contraction is relatively normal as is contraction-mediated 
muscle glucose uptake (189). This implies that the failure of insulin to recruit capillary 
flow is most likely a problem of impaired insulin signalling between the receptor and NO 
production. Clearly this warrants close examination in the future. 
9.7 	Conclusion 
In summary, the technique of LDF proved to be useful in further understanding the 
complexities of microvascular blood flow in muscle and its relationship to metabolism. 
Providing total flow to the muscle remained constant, changes in nutritive flow as 
manipulated by vasoconstrictors could be readily detected and there was a positive 
correlation between LDF signal and oxygen uptake. However, the fact that flow could 
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independently influence the LDF signal severly lessens the applicability to assessing 
capillary recruitment when total flow is also changing. A particular advantage of LDF 
was that it could be used to continuously record changes, where 1-MX metabolism 
technique is an end point approach and CEU can only be applied intermittently. In 
addition, LDF has provided for the first time evidence that insulin acts to enhance low 
frequency vasomotion in human muscle in vivo. Measurement of LDF signal from 
models of the microvascular networks has led to some testable concepts for the future. 
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